<?xml version="1.0" encoding="UTF-8" standalone="no"?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0"><channel><title>PP-Eye</title><description></description><managingEditor>noreply@blogger.com (Unknown)</managingEditor><pubDate>Mon, 22 Sep 2025 13:04:36 +0500</pubDate><generator>Blogger http://www.blogger.com</generator><openSearch:totalResults xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">461</openSearch:totalResults><openSearch:startIndex xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">1</openSearch:startIndex><openSearch:itemsPerPage xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">25</openSearch:itemsPerPage><link>http://pp-eye.blogspot.com/</link><language>en-us</language><itunes:explicit>no</itunes:explicit><itunes:subtitle/><itunes:owner><itunes:email>noreply@blogger.com</itunes:email></itunes:owner><item><title>Recruiting Great Sales People</title><link>http://pp-eye.blogspot.com/2012/10/recruiting-great-sales-people.html</link><category>Recruiting Great Sales People</category><author>noreply@blogger.com (Unknown)</author><pubDate>Mon, 15 Oct 2012 20:58:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-7775960432025912562</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;div&gt;
&lt;div&gt;
&lt;div style="background: none; border: none; color: #ba122b; font-family: Georgia; font-size: 20px; font-weight: bold; line-height: normal; margin: 0; overflow: auto; padding: 0; text-align: left; white-space: normal;"&gt;
&lt;div&gt;
&lt;span style="font-size: large;"&gt;&lt;b&gt;Recruiting Great
Sales People&lt;/b&gt;&lt;/span&gt;&lt;span&gt;
&lt;/span&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;div style="height: 10px; line-height: 10px;"&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-align: justify;"&gt;
&lt;span style="font-family: Verdana,sans-serif;"&gt;You say it to your sales team all the time: "ABC. Always be closing." 
Well, as a sales leader, I'd recommend that you adopt a slightly 
different mantra for yourself: ABR: Always be recruiting.Many sales 
managers settle into complacency when their team is performing well, or 
recruiting falls by the wayside when there's too much else on their 
plates. But in reality, it's essential to constantly have recruiting on 
your to-do list for three important reasons:
&lt;/span&gt;&lt;br clear="none" /&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;/span&gt;&lt;/div&gt;
&lt;ol id="yui_3_2_0_1_1350315099085568" style="text-align: justify;"&gt;
&lt;li id="yui_3_2_0_1_1350315099085567"&gt;
&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;img align="right" alt="Recruiting Great Sales People" border="0" height="182" id="yui_3_2_0_1_1350315099085566" src="https://d1yoaun8syyxxt.cloudfront.net/engage-elgdlryrgcasagenwqgpmfarsntfcuej-v2" style="background: none repeat scroll 0% 0% transparent; border: medium none; line-height: normal; margin: 0px; padding: 0px; white-space: normal;" title="Recruiting Great Sales People" width="250" /&gt;People
 leave. No matter how well you pay your team, or how well they seem to 
be performing, one thing's always certain: turnover happens. Whether 
it's someone winning the lottery, moving, or getting a better offer 
somewhere else, some of your employees will inevitably move on from your
 company. And as their manager, you'll be last to know, so don't be 
caught in a bind when one of your key team members gives notice.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
People under perform. Traditionally, sales teams fall into a pattern: 20%
 hit well above their target, they are your high performers. 60% hit 
their target fairly consistently, they are your workhorses. And 20% under perform or are too new to measure. You always want the option to 
replace your bottom 20% with better performers, and you won't have any 
options if you're not actively recruiting.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Your team will grow. Even in the best case scenario--where all of your 
team members are over performing and you're hitting it out of the park 
in your market, then it's time to start attacking new markets. And at 
that point, you'll need new reps to go after those markets.
&lt;/span&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;div style="text-align: justify;"&gt;
&lt;span style="font-family: Verdana,sans-serif;"&gt;
Recruiting is an important aspect of any sales leader's job, and there 
are some techniques that make it a more manageable task. Here are some 
of the best practices that our sales VP clients use in recruitment:
&lt;/span&gt;&lt;br clear="none" /&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;/span&gt;&lt;br clear="none" /&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;/span&gt;&lt;/div&gt;
&lt;ol id="yui_3_2_0_1_1350315099085572" style="text-align: justify;"&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Use a professional services recruiting company that focuses on sales. We
 often see companies using recruiters who are more general in nature, 
and unfortunately they sometimes just don't "get" salespeople. One of 
the best sales recruiting companies in North America is Peak Recruiting.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Develop an internal referral program. A generous referral bonus will 
encourage your employees to bring in their network. Your employees 
understand your business best, and are most likely to cultivate loyalty 
when they bring in one of their own contacts. We suggest an offer of at 
least $5,000 per employee that is referred, hired and stays beyond six 
months. It's less than you'd spend on advertising or recruiting, and 
likely a better quality candidate.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Ask clients, vendors, partners and your resale channels for referrals. 
Your new hires are going to be the first point of contact with your 
clients and partners, so why not ask them whom they'd like to buy from 
or work with? Some of your best customers might be able to draw from 
their network or refer you to other sales reps they've worked with.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Get varied interview feedback. It's important that more than one person 
interview each candidate in order to get well-rounded and objective 
feedback. I recommend that the interview process incorporate three 
different people within the company, including someone who reports to 
you--perhaps another sales rep--and someone outside the department to 
see how they react to non-sales environments.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Vary your interview locations. You should also consider varying the 
interview environment beyond just the office conference room. Can they 
focus in a more distracting environment, like a restaurant or coffee 
shop? Sales requires getting out of your own office, so you'll want to 
see how they do in a variety of situations.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Use social media. Post your openings on Facebook, LinkedIn or your blog 
in order to attract people from across the country or around the world 
if required. Also, use social media to check out potential candidates' 
profiles before beginning the interview process.
&lt;br clear="none" /&gt;&lt;/span&gt;

&lt;/li&gt;
&lt;li id="yui_3_2_0_1_1350315099085569"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;
Ask one last question. There are a lot of things you can test about a 
candidate in an interview, but one tough long-term thing to measure is 
memory, which is essential for a good sales rep. I use one simple 
question at the end of the interview to help assess this: I ask the 
candidate to relay back to me what we discussed in the interview. If he 
or she can't do so accurately, it's a bad sign that their mind was 
elsewhere during the meeting.
&lt;/span&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;div style="text-align: justify;"&gt;
&lt;span style="font-family: Verdana,sans-serif;"&gt;
By keeping these seven simple tips in mind, you can make recruiting a 
constant priority without devoting incredible amounts of time to it. 
Ensure that you're never in a bind and treat recruiting like the sales 
process, where you always have a healthy pipeline of viable prospects.&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Roots, suffixes, and prefixes</title><link>http://pp-eye.blogspot.com/2012/09/roots-suffixes-and-prefixes.html</link><category>and prefixes Roots suffixes</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 5 Sep 2012 00:09:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-3894447116070956263</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val="Cambria Math"/&gt;    &lt;m:brkBin m:val="before"/&gt;    &lt;m:brkBinSub m:val="--"/&gt;    &lt;m:smallFrac m:val="off"/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val="0"/&gt;    &lt;m:rMargin m:val="0"/&gt;    &lt;m:defJc m:val="centerGroup"/&gt;    &lt;m:wrapIndent m:val="1440"/&gt;    &lt;m:intLim m:val="subSup"/&gt;    &lt;m:naryLim m:val="undOvr"/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;br /&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267"&gt;   &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;   &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;   &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;   &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;   &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;   &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;   &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;   &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;   &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;   &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;   &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;   &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;   &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:"";
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:"Calibri","sans-serif";
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;br /&gt;
&lt;h3&gt;&lt;/h3&gt;&lt;div align="center"&gt;&lt;table border="1" cellpadding="0" cellspacing="1" class="MsoNormalTable" style="border: outset 3.0pt; mso-cellspacing: .7pt; mso-padding-alt: 2.25pt 2.25pt 2.25pt 2.25pt; mso-yfti-tbllook: 1184;"&gt;&lt;tbody&gt;
&lt;tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;"&gt;   &lt;td style="padding: 2.25pt; text-align: center;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-size: large;"&gt;&lt;b&gt;Component&lt;span style="line-height: 115%;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt; text-align: center;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-size: large;"&gt;&lt;b&gt;Meaning&lt;span style="line-height: 115%;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt; text-align: center;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-size: large;"&gt;&lt;b&gt;Example &lt;span style="line-height: 115%;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 1;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;CARDIO-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;heart&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;echocardiogram = sound wave image of the heart. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 2;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;CYTE-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;cell&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;thrombocyte = clot forming cell. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 3;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;HAEM-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;blood&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;haematoma - a tumour or swelling filled with blood. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 4;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;THROMB-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;clot, lump&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;thrombocytopenia = deficiency of thrombocytes in the blood   &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 5;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;ETHRO-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;red&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;ehtrocyte = red blood cell &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 6;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;LEUKO-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;white&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;leukocyte = white blood cell &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 7;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;SEP, SEPTIV-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;toxicity due to micro-organisms&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;septicaemia &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 8;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;VAS- &lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;vessel / duct&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;cerebrovascular = blood vessels of the cerebrum of the   brain. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 9;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;HYPER-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;excessive&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;hyperglycaemia = excessive levels of glucose in blood. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 10;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;HYPO-&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;deficient / below&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;hypoglycaemia = abnormally low glucose blood levels. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 11;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;-PENIA &lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;deficiency&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;neutropenia = low levels of neutrophilic leukocytes. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 12; mso-yfti-lastrow: yes;"&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;-EMIA&lt;/b&gt;&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;condition of blood&lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 2.25pt 2.25pt 2.25pt 2.25pt;"&gt;&lt;div class="MsoNormal"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;anaemia = abnormally low levels of red blood cells. &lt;span style="font-size: 12.0pt; line-height: 115%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;div class="MsoNormal"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Abbreviations and Acronyms (Cardiovascular)</title><link>http://pp-eye.blogspot.com/2012/09/abbreviations-and-acronyms.html</link><category>Abbreviations and Acronyms (Cardiovascular)</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 5 Sep 2012 00:04:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-6336040061780604708</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val="Cambria Math"/&gt;    &lt;m:brkBin m:val="before"/&gt;    &lt;m:brkBinSub m:val="--"/&gt;    &lt;m:smallFrac m:val="off"/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val="0"/&gt;    &lt;m:rMargin m:val="0"/&gt;    &lt;m:defJc m:val="centerGroup"/&gt;    &lt;m:wrapIndent m:val="1440"/&gt;    &lt;m:intLim m:val="subSup"/&gt;    &lt;m:naryLim m:val="undOvr"/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;br /&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267"&gt;   &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;   &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;   &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;   &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;   &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;   &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;   &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;   &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;   &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;   &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;   &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;   &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;   &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:"";
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:"Calibri","sans-serif";
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;table border="0" cellpadding="0" class="MsoNormalTable" style="margin-left: .5in; mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184;"&gt;&lt;tbody&gt;
&lt;tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;"&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;AA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Anaplastic Anaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;ALL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Acute lymphoblastic leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;AML&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Acute Myeloid leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;ANC&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Absolute neutrophil count &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;ANLL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Acute non-lymphatic leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;ASH&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;American Society for Hematology &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;B-ALL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;B-cell Acute Lymphoblastic   Leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;BP&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Blood pressure &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CALGB&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Cancer and Leukemia Group B (USA) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;cALL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Common ALL &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CGL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Chronic Granulocytic Leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CHF&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Congestive heart failure &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CLL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Chronic lymphocytic Leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CML&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Chronic myeloid leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CMML&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;chronic myelomonocytic leukemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CPR&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Cardio pulmonary resuscitation &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CVA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Cardiovascular Accident (stroke) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;CVC&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Central venous catheters &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;ECG&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Electrocardiogram - heart scan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;FAB&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;French American and British   classification scheme for leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;FBC&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Full Blood Count &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;G-CSF&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Granulocyte colony stimulating   factor promotes production of white blood cells &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;GM-CSF&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Granulocyte and macrophage colony   stimulating factor &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;Hb&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Haemoglobin &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;HCL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Hairy Cell Leukaemia &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;HD&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Hodgkin's Disease (lymphoma) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;HTLV&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Human T-cell leukemia-lymphoma   virus &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;IV&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Intravenous - into a vein &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;LRF&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Leukaemia Research Fund (UK) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;LVEF&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Left Ventricular Fjection Fraction   - a heart function test &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;LVSF&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Left Ventricular Shortening   Fraction - a heart function test &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;MM&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Multiple Myeloma &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;RBC&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Red blood cell / red blood count &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;WBC&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;White blood cell count &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;tr style="mso-yfti-irow: 34; mso-yfti-lastrow: yes;"&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;div class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Arial,Helvetica,sans-serif;"&gt;&lt;span style="font-size: large;"&gt;WCC&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;   &lt;td style="padding: 0.75pt; text-align: justify;"&gt;   &lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;White cell count &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;  &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>What Are the Organs of the Cardiovascular System?</title><link>http://pp-eye.blogspot.com/2012/09/what-are-organs-of-cardiovascular-system.html</link><category>What Are the Organs of the Cardiovascular System?</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 4 Sep 2012 23:54:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-2932062778448690385</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div style="text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val="Cambria Math"/&gt;    &lt;m:brkBin m:val="before"/&gt;    &lt;m:brkBinSub m:val="--"/&gt;    &lt;m:smallFrac m:val="off"/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val="0"/&gt;    &lt;m:rMargin m:val="0"/&gt;    &lt;m:defJc m:val="centerGroup"/&gt;    &lt;m:wrapIndent m:val="1440"/&gt;    &lt;m:intLim m:val="subSup"/&gt;    &lt;m:naryLim m:val="undOvr"/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhNtXNXaUnEGlZGJRrOpDZjJyzjXmWFRhwQqvKCiwCM69uJc9tydm426J6Ux1pmgfk7t21C0K6bq_EqFYiRph-8JSrn4Nt03MCh0mHfDxzvRmyAthRSLXt-kthL9pjRulZsTX17pHGB_uw/s1600/kjk.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img border="0" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhNtXNXaUnEGlZGJRrOpDZjJyzjXmWFRhwQqvKCiwCM69uJc9tydm426J6Ux1pmgfk7t21C0K6bq_EqFYiRph-8JSrn4Nt03MCh0mHfDxzvRmyAthRSLXt-kthL9pjRulZsTX17pHGB_uw/s200/kjk.jpg" width="161" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="description"&gt;&lt;span style="color: #990000;"&gt;&lt;b&gt;&lt;span style="font-family: &amp;quot;Trebuchet MS&amp;quot;,sans-serif;"&gt;&lt;span style="font-size: small;"&gt;At first glance, the cardiovascular system appears to consist of only a single organ--the heart. This organ is certain a key player in the system; it’s responsible for pumping blood rich in nutrients and oxygen to the body cells, and its pumping action helps return oxygen-deficient blood back to the heart for re-oxygenation at the lungs. However, the heart is not the only organ of the cardiovascular system; other organs synthesize blood, process and clean the blood, and assist in distribution.&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;br style="mso-special-character: line-break;" /&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;/span&gt;  &lt;section class="section"&gt;  &lt;h2&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Bone Marrow&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;div class="description"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The primary purpose of the circulatory system--to distribute blood--would be rendered impossible if there were no blood to distribute. As such, the bone marrow, or soft, active tissue found inside the long bones of the body, is a crucial component of this system. Red blood cells, called erythrocytes, are responsible for transporting oxygen to the tissues. Dr. Gary Thibodeau notes in his text, “Anatomy and Physiology,” that the erythrocytes are synthesized in bone marrow localized in the ends of long bones. White blood cells, or leukocytes, are also important components of blood, and help to fight infection. They’re made in the marrow localized in smaller ends of bones.&lt;/span&gt;&lt;/div&gt;&lt;/section&gt;  &lt;h2&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Blood Vessels&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;div class="description"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The arteries, capillaries, and veins are necessary components of the cardiovascular system as well. These are the vessels designed to carry blood to and from the heart, and their morphology reflects their function. Arteries, which carry blood from the heart, must withstand the force of high-pressure blood. They are muscular and tough. Arteries branch into smaller and smaller vessels the further they get from the heart, eventually branching into the tiny capillaries, which are so narrow that blood can only pass through a single cell at a time. Capillaries have very thin walls, to allow nutrient, waste, and gas exchange between cells outside the vessel and blood inside the vessel. Veins, then, return blood to the heart. Venous blood is at much lower pressure than arterial blood, so veins are not as tough as arteries. They do, however, have one-way valves inside to prevent backflow of blood, notes Dr. Thibodeau.&lt;/span&gt;&lt;/div&gt;&lt;section class="section"&gt;  &lt;h2&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Heart&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;div class="description"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The heart is the circulatory system’s pump, and its job is to receive blood from body cells, send that blood to the lungs for oxygenation, receive oxygenated blood back from the lungs, and then send the blood to the body cells once more. To accomplish this without mixing of blood, the heart has two sides. The right side receives blood from the body and sends it out to the lungs, while the left side receives blood from the lungs and sends it out to the body. Since the left side has to push blood through a much longer network of vessels, this side of the heart is much more muscular and much larger than the right side.&lt;/span&gt;&lt;/div&gt;&lt;/section&gt;&lt;section class="section"&gt;  &lt;h2&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Spleen&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;div class="description"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Located near the top of the abdomen, the spleen is blood storage and cleaning organ. It is filled with cells of the immune system, so as blood passes through, it is checked for pathogens and impurities. In addition, however, the spleen acts as a source of an emergency blood transfusion; if a person is bleeding badly, the spleen contracts and increases blood volume and blood pressure to try to maintain consciousness, notes &lt;span style="color: #cc0000;"&gt;Dr. Lauralee Sherwood&lt;/span&gt; in her book &lt;span style="color: #cc0000;"&gt;“Human Physiology.”&lt;/span&gt; The spleen’s tendency to store large quantities of blood makes it prone to rupture during traumatic injuries, however. Fortunately, it’s a nonessential organ, and ruptured spleens can be removed surgically with no negative long-term consequences.&lt;/span&gt;&lt;/div&gt;&lt;/section&gt;    &lt;div class="MsoNormal"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhNtXNXaUnEGlZGJRrOpDZjJyzjXmWFRhwQqvKCiwCM69uJc9tydm426J6Ux1pmgfk7t21C0K6bq_EqFYiRph-8JSrn4Nt03MCh0mHfDxzvRmyAthRSLXt-kthL9pjRulZsTX17pHGB_uw/s72-c/kjk.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Function of the Cardiovascular System</title><link>http://pp-eye.blogspot.com/2012/09/function-of-cardiovascular-system.html</link><category>Function of the Cardiovascular System</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 4 Sep 2012 23:38:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-4746432954857781088</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div style="text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val="Cambria Math"/&gt;    &lt;m:brkBin m:val="before"/&gt;    &lt;m:brkBinSub m:val="--"/&gt;    &lt;m:smallFrac m:val="off"/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val="0"/&gt;    &lt;m:rMargin m:val="0"/&gt;    &lt;m:defJc m:val="centerGroup"/&gt;    &lt;m:wrapIndent m:val="1440"/&gt;    &lt;m:intLim m:val="subSup"/&gt;    &lt;m:naryLim m:val="undOvr"/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267"&gt;   &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;   &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;   &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;   &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;   &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;   &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;   &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;   &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;   &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;   &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;   &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;   &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;   &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:"";
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:"Calibri","sans-serif";
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;/div&gt;&lt;h1 style="text-align: justify;"&gt;&lt;/h1&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;It is important to understand the function of the cardiovascular system in order to see how your lifestyle choices affect your heart. It is a very efficient and complex network. &lt;br /&gt;
&lt;br /&gt;
Our very existence relies on the function of the cardiovascular system.&lt;/span&gt; &lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The function of the cardiovascular system is to circulate blood through a network of vessels throughout the body to provide individual cells with oxygen and nutrients and help dispose of metabolic wastes. The oxygen rich blood leaves the heart via the arteries and delivers nutrients and oxygen to the body in exchange for waste and carbon dioxide. The oxygen-depleted blood travels back to the heart via the veins. At the heart the blood acquires more oxygen and makes the journey thought the body again. This is an involuntary network that works 24 hours a day. Here are some of the important functions of the cardiovascular system:&lt;/span&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4w0fadXWj2mAMtbSVzTItz_GgZKZ1MZQj5m8TCJKXM1QpWP0rZB3ic5T_hea8JZlYk0WhaBfC8XiWP7WTV421wRo37mtctw6KYuwcPq7zHD8X-uypszf0zwb5k4hkUklFbmHX2MXhI8k/s1600/cardiovascular-system-269x300.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4w0fadXWj2mAMtbSVzTItz_GgZKZ1MZQj5m8TCJKXM1QpWP0rZB3ic5T_hea8JZlYk0WhaBfC8XiWP7WTV421wRo37mtctw6KYuwcPq7zHD8X-uypszf0zwb5k4hkUklFbmHX2MXhI8k/s1600/cardiovascular-system-269x300.jpg" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;ul style="text-align: justify;" type="disc"&gt;&lt;li class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;Circulates oxygen and removes carbon dioxide &lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;Provides cells with nutrients&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;Protects the body against disease and infection&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;Stops bleeding after injury by clotting&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;Regulates body temperature. &lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;Removes the waste products &lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt;Transports hormones to cells and organs. &lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
&lt;/ul&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Each day the heart beats about 100,000 times and pumps about 2,000 gallons of blood. This network exists in conjunction with the pulmonary network - as it is the lungs that supply the oxygen to the heart and eliminates the waste of carbon dioxide.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4w0fadXWj2mAMtbSVzTItz_GgZKZ1MZQj5m8TCJKXM1QpWP0rZB3ic5T_hea8JZlYk0WhaBfC8XiWP7WTV421wRo37mtctw6KYuwcPq7zHD8X-uypszf0zwb5k4hkUklFbmHX2MXhI8k/s72-c/cardiovascular-system-269x300.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>What are the functions of the cardiovascular system?</title><link>http://pp-eye.blogspot.com/2012/09/what-are-functions-of-cardiovascular.html</link><category>What are the functions of the cardiovascular system?</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 4 Sep 2012 23:21:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-6596533764508908264</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val="Cambria Math"/&gt;    &lt;m:brkBin m:val="before"/&gt;    &lt;m:brkBinSub m:val="--"/&gt;    &lt;m:smallFrac m:val="off"/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val="0"/&gt;    &lt;m:rMargin m:val="0"/&gt;    &lt;m:defJc m:val="centerGroup"/&gt;    &lt;m:wrapIndent m:val="1440"/&gt;    &lt;m:intLim m:val="subSup"/&gt;    &lt;m:naryLim m:val="undOvr"/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;br /&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267"&gt;   &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;   &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;   &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;   &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;   &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;   &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;   &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;   &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;   &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;   &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;   &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;   &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;   &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:"";
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:"Calibri","sans-serif";
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-fareast-font-family:"Times New Roman";
 mso-fareast-theme-font:minor-fareast;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;br /&gt;
&lt;div class="MsoNormal" style="line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; mso-outline-level: 1;"&gt;&lt;b&gt;&lt;span style="font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 24.0pt; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-font-kerning: 18.0pt;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;&lt;h2 class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: left;"&gt;&lt;span style="color: #990000;"&gt;&lt;span style="background-color: white;"&gt;&lt;span style="font-size: x-large;"&gt;&lt;span style="font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;"&gt;Best Answer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;h2 class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: left;"&gt;&lt;span style="font-size: x-large;"&gt;&lt;span style="font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;u&gt;To name a few&lt;/u&gt;&lt;/h2&gt;&lt;h2 class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: left;"&gt;&lt;br /&gt;
&lt;/h2&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEieQhvSw_NlkHWk-4wJ1Ncc8bIHp9UedbB_JlCb10lX0csu3CZXaTY0a_bdsGXF9GUcoeZ0eQcBc4n7RdCkxRZtFurYlKzbZ8NNaGZH5-8H2TcGf0s21HglspClQTH2ZnlZ-jDNiINv81s/s1600/circulatory-system.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEieQhvSw_NlkHWk-4wJ1Ncc8bIHp9UedbB_JlCb10lX0csu3CZXaTY0a_bdsGXF9GUcoeZ0eQcBc4n7RdCkxRZtFurYlKzbZ8NNaGZH5-8H2TcGf0s21HglspClQTH2ZnlZ-jDNiINv81s/s320/circulatory-system.jpg" width="187" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="line-height: normal; margin-bottom: 0.0001pt; text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span style="font-size: 12pt;"&gt; 1) supplying oxygen to the body&lt;br /&gt;
2) supplying nutrients to the body&lt;br /&gt;
3) supplying the wastes to the excretory organs of the body for elimination&lt;br /&gt;
4) immunological&lt;br /&gt;
5) maintaining body temperature&lt;br /&gt;
6) supplying the drugs and medicine to the target organ&lt;br /&gt;
7) maintaining the internal body pressure&lt;br /&gt;
8) transporting hormones from source gland to the target body part&lt;br /&gt;
9) absorption of the digested food from the elementary canal (not lipids &amp;amp; fats)&lt;br /&gt;
10) the level of various blood contents is of great significance in diagnosing any deviation of the body functioning from normal, eg. B.urea, B. sugar, etc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEieQhvSw_NlkHWk-4wJ1Ncc8bIHp9UedbB_JlCb10lX0csu3CZXaTY0a_bdsGXF9GUcoeZ0eQcBc4n7RdCkxRZtFurYlKzbZ8NNaGZH5-8H2TcGf0s21HglspClQTH2ZnlZ-jDNiINv81s/s72-c/circulatory-system.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Cardiovascular System Function</title><link>http://pp-eye.blogspot.com/2012/09/cardiovascular-system-function.html</link><category>Cardiovascular System Function</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 4 Sep 2012 19:35:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-5270537590763761158</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div style="text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val="Cambria Math"/&gt;    &lt;m:brkBin m:val="before"/&gt;    &lt;m:brkBinSub m:val="--"/&gt;    &lt;m:smallFrac m:val="off"/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val="0"/&gt;    &lt;m:rMargin m:val="0"/&gt;    &lt;m:defJc m:val="centerGroup"/&gt;    &lt;m:wrapIndent m:val="1440"/&gt;    &lt;m:intLim m:val="subSup"/&gt;    &lt;m:naryLim m:val="undOvr"/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267"&gt;   &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;   &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;   &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;   &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;   &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;   &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;   &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;   &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;   &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;   &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;   &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;   &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;   &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:"";
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:"Calibri","sans-serif";
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRMamUQgiXN1oKoRlOH4WShaQPZR6h3_FJfHlqkEOvle0jbu7qVttrc_W0Jyk_MmbdDhH4QYQ8QkMce4exW6xi9fRwLKU_p5AsWLq7POfpJmKme8xo64lwmKw4FkViPORrLryjXK_aOtI/s1600/327978-50119-2.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRMamUQgiXN1oKoRlOH4WShaQPZR6h3_FJfHlqkEOvle0jbu7qVttrc_W0Jyk_MmbdDhH4QYQ8QkMce4exW6xi9fRwLKU_p5AsWLq7POfpJmKme8xo64lwmKw4FkViPORrLryjXK_aOtI/s200/327978-50119-2.jpg" width="150" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The cardiovascular system, the most important of the human body system, consists of organs that are responsible for carrying out many of the important functions. The system consists of organs like the heart, the spleen and the blood vessels that are spread throughout the body. The cardiovascular system is a complex system and understanding its functions will help understand the overall human physiology better.&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;u&gt;&lt;/u&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;br /&gt;
&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;br /&gt;
&lt;/span&gt;&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;b&gt;Functions of the Cardiovascular System&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;br /&gt;
&lt;br /&gt;
Its functions can be categorized into three main domains: transport, regulation and protection. The organs of the system carry out these functions in coordination with the functions of the other systems for the proper functioning of the body. These are the main functions of the cardiovascular system and they are explained in detail below.&lt;/span&gt; &lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Transport&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;: It transports oxygen from the lungs to the various cells of the body. Its primary function is to transport nutrients from the intestines to the lungs and other parts of the body, and carbon dioxide from the cells to the lungs. Hormones from the various endocrine glands and heat from the cells are also transported by this system. Removal of waste products like carbon dioxide and nitrogen from the body is also performed by this system. This function of transport is mainly carried out by the blood and the network of blood vessels present in the system.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Protection&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;: It performs the function of protecting the body and its organs from infection and diseases by providing white blood cells that have the ability to fight against them. Proteins and antibodies required for destroying viruses, bacteria and disease causing germs are also provided by this system to the various parts of the body. Another important function of this system is to protect the body from excessive blood loss through the process of blood clotting during an injury. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Regulation&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;: Another important function is the regulation of the concentration of hydrogen ions (pH) in the body, the body temperature and body heat, and the regulation of the salt and water content of the cells in the body.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;&lt;u&gt;Structure&lt;/u&gt;&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;br /&gt;
&lt;br /&gt;
It is important to know and understand the structure of the cardiovascular system to understand its functions better. As mentioned before, it is made up of the heart, the blood vessels, the spleen and blood. Each of these perform individual functions to make the overall functioning of the system possible.&lt;/span&gt; &lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;The Heart&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;: The human heart is situated at the center of the chest and is approximately the size of a clenched fist. It performs the function of a muscular pump, wherein it expands and contracts to pump blood into the blood vessels and the rest of your body. it consists of four chambers, the upper two are known as the left and the right atria and the lower two are known as the left and right ventricles. The deoxygenated blood is carried to the right side of the heart which pumps it into the lungs where blood absorbs more oxygen. This oxygenated blood moves to the left side of the heart which pumps it into the blood stream and is carried to the various body parts.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Blood Vessels&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;: There are three different types of blood vessels in the human body, the arteries, the capillaries and the veins. The arteries are of three types, the pulmonary artery, the aorta and the coronary arteries. They perform the function of carrying oxygenated blood from the heart to the other parts of the body, but the pulmonary artery carried deoxygenated blood from the heart to the lungs. The capillaries carry oxygen and nutrients to the tissues and cells of the body and the veins carry deoxygenated blood from the various organs of the body to the heart. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;The Spleen&lt;/b&gt;&lt;/span&gt;  &lt;span style="font-family: Verdana,sans-serif;"&gt;: The spleen is a large organ situated below the diaphragm and performs an important function of storing blood.&lt;br /&gt;
&lt;br /&gt;
By now you must have got an idea of how the cardiovascular system functions. To sum it up, De-oxygenated blood is carried by the veins to the right side of the heart which pumps it into the lungs for oxygen absorption. Once the oxygen has been absorbed, the blood is pumped into the left side of the heart and from here the arteries carry it to the other parts of the body. The capillaries distribute the oxygen and nutrients supplied to them by the arteries and remove waste products from the blood stream.&lt;/span&gt; &lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;br /&gt;
&lt;br /&gt;
Now that you know about the functions of the cardiovascular system, it will be easier for you to understand its importance and how essential it is to protect this system from damage. To keep it healthy, it is essential to eat right, exercise and follow a healthy lifestyle.&lt;/span&gt; &lt;/div&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRMamUQgiXN1oKoRlOH4WShaQPZR6h3_FJfHlqkEOvle0jbu7qVttrc_W0Jyk_MmbdDhH4QYQ8QkMce4exW6xi9fRwLKU_p5AsWLq7POfpJmKme8xo64lwmKw4FkViPORrLryjXK_aOtI/s72-c/327978-50119-2.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>5 Major Functions of the Cardiovascular System</title><link>http://pp-eye.blogspot.com/2012/09/5-major-functions-of-cardiovascular.html</link><category>5 Major Functions of the Cardiovascular System</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 4 Sep 2012 19:16:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-391449948869528403</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div style="text-align: left;"&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiJTT5i0xwqf2bSbq8383wNWPAsz03tePQp9_XCA8ZpQFsDAhOA_fsQZgesAgi-MnVmhWvGghb2H5097G87-pQ79x-596X0JCkH72hOV6CDJ9N6hHE0To6xCHLKxqBSVKAHLWNPskMGSqM/s1600/images.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiJTT5i0xwqf2bSbq8383wNWPAsz03tePQp9_XCA8ZpQFsDAhOA_fsQZgesAgi-MnVmhWvGghb2H5097G87-pQ79x-596X0JCkH72hOV6CDJ9N6hHE0To6xCHLKxqBSVKAHLWNPskMGSqM/s1600/images.jpg" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:WordDocument&gt;   &lt;w:View&gt;Normal&lt;/w:View&gt;   &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:TrackMoves/&gt;   &lt;w:TrackFormatting/&gt;   &lt;w:PunctuationKerning/&gt;   &lt;w:ValidateAgainstSchemas/&gt;   &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:DoNotPromoteQF/&gt;   &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:Compatibility&gt;    &lt;w:BreakWrappedTables/&gt;    &lt;w:SnapToGridInCell/&gt;    &lt;w:WrapTextWithPunct/&gt;    &lt;w:UseAsianBreakRules/&gt;    &lt;w:DontGrowAutofit/&gt;    &lt;w:SplitPgBreakAndParaMark/&gt;    &lt;w:DontVertAlignCellWithSp/&gt;    &lt;w:DontBreakConstrainedForcedTables/&gt;    &lt;w:DontVertAlignInTxbx/&gt;    &lt;w:Word11KerningPairs/&gt;    &lt;w:CachedColBalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathPr&gt;    &lt;m:mathFont m:val="Cambria Math"/&gt;    &lt;m:brkBin m:val="before"/&gt;    &lt;m:brkBinSub m:val="--"/&gt;    &lt;m:smallFrac m:val="off"/&gt;    &lt;m:dispDef/&gt;    &lt;m:lMargin m:val="0"/&gt;    &lt;m:rMargin m:val="0"/&gt;    &lt;m:defJc m:val="centerGroup"/&gt;    &lt;m:wrapIndent m:val="1440"/&gt;    &lt;m:intLim m:val="subSup"/&gt;    &lt;m:naryLim m:val="undOvr"/&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267"&gt;   &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;   &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;   &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;   &lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;   &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;   &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;   &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;   &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;   &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;   &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;   &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;   &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;   &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;   &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;   &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;   &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;   &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;   &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;   &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:"";
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:"Calibri","sans-serif";
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt; &lt;![endif]--&gt;  &lt;/div&gt;&lt;div class="description" style="text-align: justify;"&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;h4&gt;&lt;span style="color: #cc0000;"&gt;&lt;b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The cardiovascular system, also known as the circulatory system, is composed of blood, blood vessels and the heart. The heart functions as a pump to move blood through the blood vessels of the body. A circulatory system is essential for large, multi-cellular organisms, such as humans and animals, and provide at least five major functions that are necessary for life.&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/h4&gt;&lt;/div&gt;&lt;br /&gt;
&lt;section class="section"&gt;  &lt;h2 style="text-align: left;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;h2 style="text-align: left;"&gt;&lt;span style="color: #cc0000;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;h2 style="text-align: left;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Transporting Oxygen and Removing Carbon Dioxide&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;div class="description" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;One of the most important functions of the circulatory system is to supply oxygen to all the cells in the body. Every cell in the body requires a constant supply of oxygen to stay alive. Because most of the cells are not in contact with air, the circulatory system must supply them with oxygen. &lt;br /&gt;
&lt;br /&gt;
When a person inhales, air enters the lungs, and oxygen is then absorbed across the membrane of the lungs into the bloodstream. This oxygen-rich blood is pumped through the heart to smaller and smaller blood vessels throughout the body. In the tiniest blood vessels, called capillaries, oxygen diffuses out of blood and into cells. At the same time, carbon dioxide produced by the cells is absorbed back into blood, which then returns to the lungs, releases carbon dioxide and picks up more oxygen.&lt;/span&gt; &lt;/div&gt;&lt;/section&gt;  &lt;br /&gt;
&lt;h2 style="text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;&lt;span name="KonaFilter"&gt;Transporting Nutrients and Removing Wastes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;div class="description" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;A second critical function of the circulatory system is to supply all the cells in the body with nutrients and energy. After food is digested in the stomach, it migrates through the intestines, where nutrients from food are absorbed into the bloodstream. The blood also absorbs glucose, an energy source, from the liver, which is the body's glucose distribution center. These nutrients and energy are then transported to all the cells of the body, in a manner similar to the transport of oxygen. Blood also absorbs the waste products made by cells, and transports them to the excretory organs for removal from the body.&lt;/span&gt;&lt;/div&gt;&lt;h2 style="text-align: justify;"&gt;&lt;section class="section"&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Fighting Disease&lt;/span&gt;&lt;/span&gt;&lt;/section&gt;&lt;/h2&gt;&lt;div class="description" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;In addition to nutrients and oxygen, the blood also carries around important disease-fighting cells. The organs of the immune system, such as the spleen, create many types of specialized cells that can kill foreign cells trying to invade the body. The circulatory system is responsible for transporting these cells from the immune system to all other parts of the body.&lt;/span&gt;&lt;/div&gt;&lt;h2 style="text-align: justify;"&gt;&lt;section class="section"&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Transporting Hormones&lt;/span&gt;&lt;/span&gt;&lt;/section&gt;&lt;/h2&gt;&lt;div class="description" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Hormones are crucial chemical signals that the body uses to communicate with itself. Hormones control many things such as growth, the reproductive cycle and glucose metabolism. Hormones are created in one part of the body, such as the brain or the liver, and then must be transported to another part of the body by the cardiovascular system in order to deliver their message.&lt;/span&gt;&lt;/div&gt;&lt;h2 style="text-align: justify;"&gt;&lt;section class="section"&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Regulating Body Temperature&lt;/span&gt;&lt;/span&gt;&lt;/section&gt;&lt;/h2&gt;&lt;div class="description" style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The cardiovascular system also plays a role in regulating body temperature. If body temperature rises too high, blood vessels close to the skin dilate, increasing in size. The larger surface area of blood vessels close to the skin means more heat is conducted across the skin into the air. Conversely, if body temperature drops, the blood vessels constrict, decreasing in size. The smaller surface area of blood vessels next to the skin causes less heat to be lost across the skin and retains more heat in the body.&lt;/span&gt;&lt;/div&gt;&lt;h3 style="text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;References&lt;/span&gt;&lt;/span&gt;&lt;/h3&gt;&lt;ul type="disc"&gt;&lt;li class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;i&gt;&lt;span style="font-size: x-small;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;CencerIndex.org: The Cardiovascular System&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;i&gt;&lt;span style="font-size: x-small;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Clinton College: Circulatory System&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;i&gt;&lt;span style="font-size: x-small;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Virginia State Department of Health: Care of the Circulatory      System&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;i&gt;&lt;span style="font-size: x-small;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;National Digestive Diseases Information Clearinghouse: Your      Digestive System and How it Words&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/li&gt;
&lt;li class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style="color: #0b5394;"&gt;&lt;i&gt;&lt;span style="font-size: x-small;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Georgia State University: Temperature Regulation of the Human      Body&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/li&gt;
&lt;/ul&gt;&lt;br /&gt;
&lt;footer class="subSection"&gt;&lt;span style="color: #0b5394;"&gt;&lt;i&gt;&lt;span style="font-size: x-small;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;Article reviewed by Libby Swope Wiersema Last updated on: Jul 3, 2010 &lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;  &lt;div class="MsoNormal" style="text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/footer&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiJTT5i0xwqf2bSbq8383wNWPAsz03tePQp9_XCA8ZpQFsDAhOA_fsQZgesAgi-MnVmhWvGghb2H5097G87-pQ79x-596X0JCkH72hOV6CDJ9N6hHE0To6xCHLKxqBSVKAHLWNPskMGSqM/s72-c/images.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Speak in the customer’s language</title><link>http://pp-eye.blogspot.com/2012/04/speak-in-customers-language.html</link><category>Speak in the customer’s language</category><author>noreply@blogger.com (Unknown)</author><pubDate>Sat, 21 Apr 2012 18:28:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-6376611732595423952</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;img alt="" height="199" src="data:image/png;base64,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" width="200" /&gt;&lt;span style="font-size: large;"&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;span style="font-size: large;"&gt;&lt;strong&gt;If you want to be a &lt;span style="color: red;"&gt;bad&lt;/span&gt; product manager, have your messaging reflect language that makes sense to you and your competitors.&lt;/strong&gt; &lt;/span&gt; Write down the words which are used during your office meetings and  make sure to use those in your press releases and brochures. Look at how  your competitors market their product and make sure the words you use  are “cooler” and more buzz-worthy. &lt;br /&gt;
&lt;span style="font-size: large;"&gt;&lt;strong&gt;If you want to be a &lt;span style="color: green;"&gt;good&lt;/span&gt; product manager,&lt;/strong&gt;&lt;span id="more-293"&gt;&lt;/span&gt; &lt;strong&gt;speak in the language your customers use.&lt;/strong&gt;&lt;/span&gt;  Speaking in the customers’ language means two things: making sure that  your language and approach resonates with the market, and making sure  that you are tailoring your marketing effectively to the type of  buyer/persona. &lt;br /&gt;
If you’ve told family members or friends that you work in marketing,  you may have received responses of chuckles and eye rolls. Have they  followed up with jokes about “paradigm” and “synergy” and “world class”?  Their reaction is understandable, given the sheer amount of bad product  marketing that is out there in the world. Bad marketing gives marketers  a bad name, but good marketing can improve the impression of marketers  by increasing overall marketing effectiveness and driving companies’  success and revenues.&lt;br /&gt;
Too often websites, brochures, and other marketing materials are  filled with jargon that only makes sense to people within the company or  to industry insiders. Sure, your whole product development team might  know what the acronym means, but does the customer? Does a “scalable,  best-of-breed cloud-based framework leveraging cutting-edge XYZ  technology” mean anything to your buyer (or even your sales team, for  that matter)?&lt;br /&gt;
Customers don’t care about features, they care about benefits. They  don’t care about whether your solution is “built on the newest JRE  platform” or not, so long as it “works on all devices.” Saying that your  product “addresses key government regulations” is much clearer — and  more concise — than listing a handful of acronyms.&lt;br /&gt;
Not only do you need to talk about benefits in language the reader  will understand, you also need to think about the target reader(s). For  most products — especially those in business-to-business markets — there  is not a single individual “customer,” and you need to address those  buyer personas differently. With an enterprise IT purchase, for example,  the IT manager deciding which product fits the organization’s needs the  best is going to have different questions, concerns, and lingo than the  finance manager approving the expenditure. In that case, the IT buyer  may really want to know about the technical jargon, while the finance  buyer may be more concerned about long-term maintenance costs and  licensing terms.&lt;br /&gt;
When you address the right buyer in their terminology, it allows them  to determine better whether the product addresses their needs and  allows you to overcome any potential hurdles they may have in the  purchase process. There are few things worse than convincing several key  stakeholders that you have the right solution for them, only to be hung  up on one required approver because your messaging didn’t speak their  language.&lt;br /&gt;
The most ineffective product marketing is filled with internal  jargon, overused hyperbole, and targets the wrong audience. The best  product marketing connects with the customer by speaking in terms which  they understand and which resonate with their needs.&lt;br /&gt;
By understanding the language your buyers use, and understanding the  differences between your different buyer personas, you’ll not only make  your marketing much more effective, but your company revenues may grow  dramatically. Plus, as a side benefit, you just may change the reaction  you get from family and friends.&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>SWOT analysis method and examples, with free SWOT template</title><link>http://pp-eye.blogspot.com/2012/01/swot-analysis-method-and-examples-with.html</link><category>SWOT analysis method and examples</category><category>with free SWOT template</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 13:33:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-4178794986972970954</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;h1&gt;&lt;/h1&gt;&lt;h3&gt;&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The SWOT analysis is an extremely useful tool for understanding and     decision-making for all sorts of situations in business and organizations. SWOT     is an acronym for Strengths, Weaknesses, Opportunities, Threats. Information     about the     origins     and inventors of SWOT analysis is below. The SWOT analysis headings provide     a good framework for reviewing strategy, position and direction of a company or     business proposition, &lt;b&gt;or any other idea&lt;/b&gt;.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Completing a SWOT analysis is very simple, and is a good subject for     workshop sessions. SWOT analysis also works well in     brainstorming meetings.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Use SWOT analysis for business planning, strategic planning,     competitor evaluation, marketing, business and product development and research     reports. You can also use     SWOT analysis     exercises for team building games. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Note that SWOT analysis is often interpreted and used as a     SWOT Analysis 2x2 Matrix, especially in     business and marketing planning.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;In addition to this 2x2 matrix method, SWOT analysis is also a     widely recognized method for gathering, structuring, presenting and reviewing     extensive planning data within a larger business or project planning process.     &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;See also PEST analysis,     which measures a business's market and potential according to external factors;     Political, Economic, Social and Technological. It is often helpful to complete     a PEST analysis prior to a SWOT analysis. In other situations it may be more     useful to complete a PEST analysis as part of, or after, a SWOT analysis. See     also Porter's Five Forces     model, which is used to analyse competitive position.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Please note:&lt;/b&gt; If you use SWOT Analysis as a 2x2 matrix method     , then technically &lt;b&gt;Strengths &lt;/b&gt;and&lt;b&gt; Weaknesses &lt;/b&gt;are&lt;b&gt; internal     factors&lt;/b&gt; (generally the case anyway), whereas &lt;b&gt;Opportunities &lt;/b&gt;and&lt;b&gt;     Threats &lt;/b&gt;are&lt;b&gt; external factors&lt;/b&gt; (this can be more difficult, since it     requires you to ignore internal threats and opportunities). The     SWOT 2x2 'internal/external' matrix method     thus only considers &lt;b&gt;external&lt;/b&gt; threats and opportunities.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;As a more general guide, here is a     &lt;a href="http://www.businessballs.com/freematerialsinword/free_SWOT_analysis_template.doc" target="_blank"&gt;free SWOT analysis template worksheet (doc file)&lt;/a&gt;, and the     same &lt;a href="http://www.businessballs.com/free_SWOT_analysis_template.pdf" target="_blank"&gt;free SWOT     analysis tool (pdf format)&lt;/a&gt;.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;If you have difficulty opening the above doc file here are two other     formats:&lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;&lt;a href="http://www.businessballs.com/freematerialsinword/SWOT_analysis_template_doc.doc" target="_blank"&gt;SWOT Analysis Template doc file using table format instead of     text-boxes&lt;/a&gt; (portrait layout)&lt;/li&gt;
&lt;li&gt;&lt;a href="http://www.businessballs.com/freematerialsinword/free_SWOT_analysis_template_Mac.doc" target="_blank"&gt;SWOT Analysis Template doc for Apple Mac&lt;/a&gt; (thanks U     Weissbach)&lt;/li&gt;
&lt;/ul&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;A SWOT analysis measures a business unit, a proposition or idea; a     PEST analysis measures a market.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;A SWOT analysis is a subjective assessment of data which is     organized by the SWOT format into a logical order that helps understanding,     presentation, discussion and decision-making. The four dimensions are a useful     extension of a basic two heading list of pro's and con's .&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;SWOT analysis can be used for all sorts of decision-making, and the     SWOT template enables proactive thinking, rather than relying on habitual or     instinctive reactions.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The SWOT analysis template is normally presented as a grid,     comprising four sections, one for each of the SWOT headings: Strengths,     Weaknesses, Opportunities, and Threats. The free SWOT template below includes     sample questions, whose answers are inserted into the relevant section of the     SWOT grid. The questions are examples, or discussion points, and obviously can     be altered depending on the subject of the SWOT analysis. Note that many of the     SWOT questions are also talking points for other headings - use them as you     find most helpful, and make up your own to suit the issue being analysed. It is     important to clearly identify the subject of a SWOT analysis, because a SWOT     analysis is a perspective of one thing, be it a company, a product, a     proposition, and idea, a method, or option, etc.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;SWOT analysis is commonly presented and developed into a 2x2 matrix,     which is shown and explained within the SWOT     analysis matrix section.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: left;"&gt;&lt;a href="" name="swot-analysis-matrix"&gt;swot analysis matrix&lt;/a&gt; - in     business/marketing - internal v external factors &lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Modern SWOT analysis in business and marketing situations is     normally structured so that a 2x2 matrix grid can be produced, according to two     pairs of dimensions.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;b&gt;Strengths and Weaknesses&lt;/b&gt;, are 'mapped' or 'graphed' against     &lt;b&gt;Opportunities and Threats&lt;/b&gt;.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;To enable this to happen cleanly and clearly, and from a logical     point of view anyway when completing a SWOT analysis in most business and     marketing situations,&lt;b&gt; Strengths and Weaknesses&lt;/b&gt; are regarded distinctly     as &lt;b&gt;internal factors&lt;/b&gt;, whereas &lt;b&gt;Opportunities and Threats &lt;/b&gt;are     regarded distinctly as &lt;b&gt;external factors&lt;/b&gt;.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;Here is the explanation in more detail:&lt;/div&gt;&lt;table border="1" cellpadding="5" cellspacing="0" style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr valign="TOP"&gt;      &lt;td valign="TOP" width="165"&gt;        &lt;b&gt;Strengths&lt;/b&gt; and &lt;b&gt;Weaknesses&lt;/b&gt; &lt;/td&gt;      &lt;td valign="TOP" width="309"&gt; the &lt;b&gt;internal&lt;/b&gt; environment - the       situation &lt;b&gt;inside &lt;/b&gt;the company or organization &lt;/td&gt;      &lt;td valign="TOP" width="371"&gt;for example, factors relating to       products, pricing, costs, profitability, performance, quality, people, skills,       adaptability, brands, services, reputation, processes, infrastructure, etc.       &lt;/td&gt;      &lt;td valign="TOP" width="142"&gt; factors tend to be in the       &lt;b&gt;present&lt;/b&gt;&amp;nbsp;&lt;/td&gt;      &lt;/tr&gt;
&lt;tr valign="TOP"&gt;      &lt;td valign="TOP" width="165"&gt;&lt;b&gt;Opportunities&lt;/b&gt; and       &lt;b&gt;Threats&lt;/b&gt;&lt;/td&gt;      &lt;td valign="TOP" width="309"&gt; the &lt;b&gt;external&lt;/b&gt; environment - the       situation &lt;b&gt;outside &lt;/b&gt;the company or organization&lt;/td&gt;      &lt;td valign="TOP" width="371"&gt;for example, factors relating to&lt;b&gt;       &lt;/b&gt;markets, sectors, audience, fashion, seasonality, trends, competition,       economics, politics, society, culture, technology, environmental, media, law,       etc. &lt;/td&gt;      &lt;td valign="TOP" width="142"&gt; factors tend to be in the       &lt;b&gt;future&lt;/b&gt;&lt;/td&gt;      &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: left;"&gt;swot matrix (2x2 matrix using internal/external categories)&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Here is a typical extension of the basic SWOT analysis grid into a     useful 'action-based' 2x2 SWOT matrix. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The SWOT analysis in this format acts as a quick decision-making     tool, quite aside from the more detailed data that would typically be fed into     business planning process for each of the SWOT factors.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Here the 2x2 matrix model automatically suggests actions for issues     arising from the SWOT analysis, according to four different categories:&lt;/div&gt;&lt;table border="1" cellpadding="5" cellspacing="0" style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr&gt;      &lt;td width="148"&gt;&amp;nbsp;&lt;/td&gt;      &lt;td style="background-color: #741b47; color: #f1c232;" width="296"&gt;&lt;span&gt;&lt;b&gt; strengths       (internal)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;      &lt;td style="background-color: #741b47; color: #f1c232;" width="312"&gt;&lt;span&gt;&lt;b&gt;weaknesses (internal)&lt;/b&gt;&lt;/span&gt;       &lt;/td&gt;      &lt;/tr&gt;
&lt;tr&gt;      &lt;td style="background-color: red;" width="148"&gt;&lt;span&gt;&lt;b&gt;opportunities&lt;br /&gt;
(external)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;      &lt;td valign="TOP" width="296"&gt;&lt;b&gt;&lt;span style="color: red;"&gt;strengths/opportunities&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;obvious natural       priorities&lt;/b&gt;        Likely to produce greatest ROI (Return On Investment)&lt;br /&gt;
Likely to be quickest and easiest to implement.&lt;br /&gt;
Probably justifying immediate action-planning or feasibility       study.&lt;br /&gt;
Executive question: "If we are not already looking at these       areas and prioritising them, then why not?"&lt;br /&gt;
&lt;/td&gt;      &lt;td valign="TOP" width="312"&gt;&lt;b&gt;&lt;span style="color: red;"&gt;weaknesses/opportunities&lt;/span&gt;&lt;/b&gt; &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;potentially       attractive options&lt;/b&gt;        Likely to produce good returns if capability and       implementation are viable. &lt;br /&gt;
Potentially more exciting and stimulating and rewarding than       S/O due to change, challenge, surprise tactics, and benefits from addressing       and achieving improvements. &lt;br /&gt;
Executive questions: "What's actually stopping us doing these       things, provided they truly fit strategically and are realistic and       substantial?" &lt;/td&gt;      &lt;/tr&gt;
&lt;tr&gt;      &lt;td style="background-color: #e69138;" width="148"&gt;&lt;span&gt;&lt;b&gt;threats&lt;br /&gt;
(external)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;      &lt;td align="LEFT" valign="TOP" width="296"&gt;&lt;span&gt;&lt;b&gt;&lt;span style="color: red;"&gt;strengths/threats&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;easy       to defend and counter&lt;/b&gt;        Only basic awareness, planning, and implementation required to       meet these challenges. &lt;br /&gt;
Investment in these issues is generally safe and       necessary.&lt;br /&gt;
Executive question: "Are we properly informed and organized to       deal with these issues, and are we certain there are no hidden surprises?" -       and - "Since we are strong here, can any of these threats be turned into       opportunities?" &lt;/td&gt;      &lt;td valign="TOP" width="312"&gt;&lt;b&gt;&lt;span style="color: red;"&gt;weaknesses/threats&lt;/span&gt;&lt;/b&gt;       &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;potentially high risk&lt;/b&gt;        Assessment of risk crucial. &lt;br /&gt;
Where risk is low then we must ignore these issues and not be       distracted by them.&lt;br /&gt;
Where risk is high we must assess capability gaps and plan to       defend/avert in very specific controlled ways. &lt;br /&gt;
Executive question: "Have we accurately assessed the risks of       these issues, and where the risks are high do we have specific controlled       reliable plans to avoid/avert/defend?"&lt;br /&gt;
&lt;/td&gt;      &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;N.B. SWOT analysis is a very flexible tool. Its use is not     restricted to business and marketing. Be mindful that when SWOT is used in     situations outside of business and marketing, strict categorization of the SWOT     dimensions (according to 'internal' and 'external' factors) can be limiting,     and so a more open interpretation of the model can be helpful in such     circumstances, especially when assessing Opportunities and Threats.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Also be mindful that if using the SWOT analysis model only as a 2x2     matrix, which assumes the categorization of internal and external factors (and     notably limiting the assessment of threats and opportunities to external     factors only), that it is very easy then to miss certain threats and     opportunities that can exist (internally) within the company/organization. Some     internal threats and opportunities can be substantial, for example,     opportunities such as: energy-saving, process-improvement, training,     advertising, or discontinuing loss-making products, or threats such as:     desertion or key staff, the loss of major contracts, to name just a couple of     typically ever-present threats within large commercial corporations. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Be mindful therefore that the 'simplified' SWOT 2x2 matrix     'internal/external' method is not a reliable tool alone for identifying all     threats and opportunities within organizations, or indeed any other     situation.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;You will note from the origins of     SWOT analysis below that the methodology did not begin, and was not     operated as the simple 2x2 'internal/external' matrix that we commonly see     today. Particularly, the original application of the model did not restrict     threats and opportunities to just external factors. Instead, six key aspects of     the business in question (namely: product, process, customer, distribution,     finance, admin) were each assessed using the SWOT model. Each aspect was     considered according to all four SWOT elements. Thus today when we apply the     SWOT model to an entire business, if we disregard internal threats and     opportunities, so the analysis can exclude some potentially serious issues.     &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;swot analysis - different applications&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;SWOT analysis is a powerful model for many different situations. The     SWOT tool is not just for business and marketing. Here are some examples of     what a SWOT analysis can be used to assess:&lt;/div&gt;&lt;ul style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;a company (its position in the market, commercial viability,     etc)&lt;/li&gt;
&lt;li&gt;a method of sales distribution&lt;/li&gt;
&lt;li&gt;a product or brand&lt;/li&gt;
&lt;li&gt;a business idea&lt;/li&gt;
&lt;li&gt;a strategic option, such as entering a new market or launching a     new product&lt;/li&gt;
&lt;li&gt;a opportunity to make an acquisition&lt;/li&gt;
&lt;li&gt;a potential partnership&lt;/li&gt;
&lt;li&gt;changing a supplier&lt;/li&gt;
&lt;li&gt;outsourcing a service, activity or resource&lt;/li&gt;
&lt;li&gt;project planning and project management&lt;/li&gt;
&lt;li&gt;an investment opportunity&lt;/li&gt;
&lt;li&gt;personal financial planning&lt;/li&gt;
&lt;li&gt;personal career development - direction, choice, change,     etc.&lt;/li&gt;
&lt;li&gt;education and qualifications planning and decision-making&lt;/li&gt;
&lt;li&gt;life-change - downshifting, relocation, &lt;/li&gt;
&lt;li&gt;relationships, perhaps even family planning?.. &lt;/li&gt;
&lt;/ul&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Whatever the application, be sure to describe the subject (or     purpose or question) for the SWOT analysis clearly so you remain focused on the     central issue. This is especially crucial when others are involved in the     process. People contributing to the analysis and seeing the finished SWOT     analysis must be able to understand properly the purpose of the SWOT assessment     and the implications arising.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;SWOT analysis template&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&amp;nbsp;Here is a larger illustration of SWOT analysis.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Note that this format is not presented or proposed as a 2x2     'internal/external' matrix; it's a more open demonstration of the sorts of     issues and questions which can be addressed when using the SWOT format as part     of business planning and decision-making. &lt;/div&gt;&lt;table border="1" cellpadding="5" cellspacing="0" style="background-color: #38761d; font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr&gt;      &lt;td style="text-align: center;"&gt;        &lt;h3&gt;Subject of SWOT analysis: (define the subject of the analysis       here)&lt;/h3&gt;&lt;/td&gt;      &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;table border="1" cellpadding="5" cellspacing="0" style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr&gt;      &lt;td width="383"&gt;        &lt;h3&gt;strengths&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;Advantages of proposition?&lt;/li&gt;
&lt;li&gt;Capabilities?&lt;/li&gt;
&lt;li&gt;Competitive advantages?&lt;/li&gt;
&lt;li&gt; USP's (unique selling points)?&lt;/li&gt;
&lt;li&gt;Resources, Assets, People?&lt;/li&gt;
&lt;li&gt;Experience, knowledge, data?&lt;/li&gt;
&lt;li&gt;Financial reserves, likely returns?&lt;/li&gt;
&lt;li&gt;Marketing - reach, distribution, awareness?&lt;/li&gt;
&lt;li&gt;Innovative aspects?&lt;/li&gt;
&lt;li&gt;Location and geographical?&lt;/li&gt;
&lt;li&gt;Price, value, quality?&lt;/li&gt;
&lt;li&gt;Accreditations, qualifications, certifications?&lt;/li&gt;
&lt;li&gt;Processes, systems, IT, communications?&lt;/li&gt;
&lt;li&gt;Cultural, attitudinal, behavioural?&lt;/li&gt;
&lt;li&gt;Management cover, succession?&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;td width="383"&gt;        &lt;h3&gt;weaknesses&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;Disadvantages of proposition?&lt;/li&gt;
&lt;li&gt;Gaps in capabilities?&lt;/li&gt;
&lt;li&gt;Lack of competitive strength?&lt;/li&gt;
&lt;li&gt;Reputation, presence and reach?&lt;/li&gt;
&lt;li&gt;Financials?&lt;/li&gt;
&lt;li&gt;Own known vulnerabilities?&lt;/li&gt;
&lt;li&gt;Timescales, deadlines and pressures?&lt;/li&gt;
&lt;li&gt;Cashflow, start-up cash-drain?&lt;/li&gt;
&lt;li&gt;Continuity, supply chain robustness?&lt;/li&gt;
&lt;li&gt;Effects on core activities, distraction?&lt;/li&gt;
&lt;li&gt;Reliability of data, plan predictability?&lt;/li&gt;
&lt;li&gt;Morale, commitment, leadership?&lt;/li&gt;
&lt;li&gt;Accreditations, etc?&lt;/li&gt;
&lt;li&gt;Processes and systems, etc?&lt;/li&gt;
&lt;li&gt;Management cover, succession?&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;/tr&gt;
&lt;tr&gt;      &lt;td width="383"&gt;        &lt;h3&gt;opportunities&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;Market developments?&lt;/li&gt;
&lt;li&gt;Competitors' vulnerabilities?&lt;/li&gt;
&lt;li&gt;Industry or lifestyle trends?&lt;/li&gt;
&lt;li&gt;Technology development and innovation?&lt;/li&gt;
&lt;li&gt;Global influences?&lt;/li&gt;
&lt;li&gt;New markets, vertical, horizontal?&lt;/li&gt;
&lt;li&gt;Niche target markets?&lt;/li&gt;
&lt;li&gt;Geographical, export, import?&lt;/li&gt;
&lt;li&gt;Market need for new USP's?&lt;/li&gt;
&lt;li&gt;Market response to tactics, e.g., surprise?&lt;/li&gt;
&lt;li&gt;Major contracts, tenders?&lt;/li&gt;
&lt;li&gt;Business and product development?&lt;/li&gt;
&lt;li&gt;Information and research?&lt;/li&gt;
&lt;li&gt;Partnerships, agencies, distribution?&lt;/li&gt;
&lt;li&gt;Market volume demand trends?&lt;/li&gt;
&lt;li&gt;Seasonal, weather, fashion influences?&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;td width="383"&gt;        &lt;h3&gt;threats&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;Political effects?&lt;/li&gt;
&lt;li&gt;Legislative effects?&lt;/li&gt;
&lt;li&gt;Environmental effects?&lt;/li&gt;
&lt;li&gt;IT developments?&lt;/li&gt;
&lt;li&gt;Competitor intentions - various?&lt;/li&gt;
&lt;li&gt;Market demand?&lt;/li&gt;
&lt;li&gt;New technologies, services, ideas?&lt;/li&gt;
&lt;li&gt;Vital contracts and partners?&lt;/li&gt;
&lt;li&gt;Obstacles faced?&lt;/li&gt;
&lt;li&gt;Insurmountable weaknesses?&lt;/li&gt;
&lt;li&gt;Employment market?&lt;/li&gt;
&lt;li&gt;Financial and credit pressures?&lt;/li&gt;
&lt;li&gt;Economy - home, abroad?&lt;/li&gt;
&lt;li&gt;Seasonality, weather effects?&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;a href="http://www.businessballs.com/freematerialsinword/free_SWOT_analysis_template.doc" target="_blank"&gt;free SWOT analysis template worksheet version (doc file)&lt;/a&gt;&lt;/div&gt;&lt;h2 style="font-family: Verdana,sans-serif; text-align: justify;"&gt;     &lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;swot analysis example&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;This SWOT analysis example is based on an imaginary situation. The     scenario is based on a business-to-business manufacturing company, who     historically rely on distributors to take their products to the end user     market. The opportunity, and therefore the subject for the SWOT analysis, is     for the manufacturer to create a new company of its own to distribute its     products direct to certain end-user sectors, which are not being covered or     developed by its normal distributors.&lt;/div&gt;&lt;table border="1" cellpadding="5" cellspacing="0" style="background-color: #741b47; font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr&gt;      &lt;td&gt;        &lt;h3&gt;Subject of SWOT analysis example: the creation of own       distributor company to access new end-user sectors not currently being       developed.&lt;/h3&gt;&lt;/td&gt;      &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;table border="1" cellpadding="5" cellspacing="0" style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr&gt;      &lt;td width="383"&gt;        &lt;h3&gt;strengths&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;End-user sales control and direction.&lt;/li&gt;
&lt;li&gt;Right products, quality and reliability.&lt;/li&gt;
&lt;li&gt;Superior product performance vs competitors.&lt;/li&gt;
&lt;li&gt; Better product life and durability.&lt;/li&gt;
&lt;li&gt;Spare manufacturing capacity.&lt;/li&gt;
&lt;li&gt;Some staff have experience of end-user sector.&lt;/li&gt;
&lt;li&gt;Have customer lists.&lt;/li&gt;
&lt;li&gt;Direct delivery capability.&lt;/li&gt;
&lt;li&gt;Product innovations ongoing.&lt;/li&gt;
&lt;li&gt;Can serve from existing sites.&lt;/li&gt;
&lt;li&gt;Products have required accreditations.&lt;/li&gt;
&lt;li&gt;Processes and IT should cope.&lt;/li&gt;
&lt;li&gt;Management is committed and confident.&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;td width="383"&gt;        &lt;h3&gt;weaknesses&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;Customer lists not tested.&lt;/li&gt;
&lt;li&gt;Some gaps in range for certain sectors.&lt;/li&gt;
&lt;li&gt;We would be a small player.&lt;/li&gt;
&lt;li&gt;No direct marketing experience.&lt;/li&gt;
&lt;li&gt;We cannot supply end-users abroad.&lt;/li&gt;
&lt;li&gt;Need more sales people.&lt;/li&gt;
&lt;li&gt;Limited budget.&lt;/li&gt;
&lt;li&gt;No pilot or trial done yet.&lt;/li&gt;
&lt;li&gt;Don't have a detailed plan yet.&lt;/li&gt;
&lt;li&gt;Delivery-staff need training.&lt;/li&gt;
&lt;li&gt;Customer service staff need training.&lt;/li&gt;
&lt;li&gt;Processes and systems, etc&lt;/li&gt;
&lt;li&gt;Management cover insufficient.&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;/tr&gt;
&lt;tr&gt;      &lt;td width="383"&gt;        &lt;h3&gt;opportunities&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;Could develop new products.&lt;/li&gt;
&lt;li&gt;Local competitors have poor products.&lt;/li&gt;
&lt;li&gt;Profit margins will be good. &lt;/li&gt;
&lt;li&gt;End-users respond to new ideas.&lt;/li&gt;
&lt;li&gt;Could extend to overseas.&lt;/li&gt;
&lt;li&gt;New specialist applications.&lt;/li&gt;
&lt;li&gt;Can surprise competitors.&lt;/li&gt;
&lt;li&gt;Support core business economies.&lt;/li&gt;
&lt;li&gt;Could seek better supplier deals.&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;td width="383"&gt;        &lt;h3&gt;threats&lt;/h3&gt;&lt;ul&gt;&lt;li&gt;Legislation could impact.&lt;/li&gt;
&lt;li&gt;Environmental effects would favour larger competitors.&lt;/li&gt;
&lt;li&gt;Existing core business distribution risk.&lt;/li&gt;
&lt;li&gt;Market demand very seasonal.&lt;/li&gt;
&lt;li&gt;Retention of key staff critical.&lt;/li&gt;
&lt;li&gt;Could distract from core business.&lt;/li&gt;
&lt;li&gt;Possible negative publicity.&lt;/li&gt;
&lt;li&gt;Vulnerable to reactive attack by major competitors.&lt;/li&gt;
&lt;/ul&gt;&lt;/td&gt;      &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;See also the PEST     analysis template and method, which measures a business according to     external factors; Political, Economic, Social and Technological. It is often     helpful to complete a PEST analysis prior to competing a SWOT analysis.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;more on the difference and relationship between PEST and SWOT&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;There is some overlap between PEST and SWOT. Similar factors appear     in each. That said, PEST and SWOT are certainly two different perspectives:     &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;PEST tends to assess a market, including competitors, from the     standpoint of a particular proposition or a business. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;SWOT in business and marketing tends to be an assessment of a     business or a proposition, whether it is your own business or (less commonly) a     competitor's business or proposition.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Strategic planning is not a precise science - no tool is mandatory -     it's a matter of pragmatic choice as to what helps best to identify and explain     the issues. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;PEST analysis may useful before SWOT analysis where it helps to     identify SWOT factors. Alternatively PEST analysis may be incorporated within a     SWOT analysis, to achieve the same effect.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;PEST becomes more useful and relevant the larger and more complex     the business or proposition, but even for a very small local businesses a PEST     analysis can still throw up one or two very significant issues that might     otherwise be missed.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The four quadrants in PEST vary in significance depending on the     type of business, for example, social factors are more obviously relevant to     consumer businesses or a B2B (business-to-business) organization close to the     consumer-end of the supply chain, whereas political factors are more obviously     relevant to a global munitions supplier or aerosol propellant manufacturer.     &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;All businesses benefit from a SWOT analysis, and all businesses     benefit from completing a SWOT analysis of their main competitors, which     interestingly can then provide useful points back into the economic aspects of     the PEST analysis.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: left;"&gt;&lt;a href="" name="swot-analysis-history"&gt;swot analysis history&lt;/a&gt; -     &lt;a href="" name="SWOT analysis inventors, origins and history of SWOT analysis"&gt;the     origins of the SWOT analysis model&lt;/a&gt;&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;This remarkable piece of history as to the origins of SWOT analysis     was provided by Albert S Humphrey, one of     the founding fathers of what we know today as SWOT analysis. I am indebted to     him for sharing this fascinating contribution. Albert Humphrey died on 31     October 2005. He was one of the good guys.&lt;/div&gt;&lt;hr style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px;" /&gt;            &lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;SWOT analysis came from the research conducted at Stanford Research     Institute from 1960-1970. The background to SWOT stemmed from the need to find     out why corporate planning failed. The research was funded by the fortune 500     companies to find out what could be done about this failure. The Research Team     were Marion Dosher, Dr Otis Benepe, Albert Humphrey, Robert Stewart, Birger     Lie. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;It all began with the corporate planning trend, which seemed to     appear first at Du Pont in 1949. By 1960 every Fortune 500 company had a     'corporate planning manager' (or equivalent) and 'associations of long range     corporate planners' had sprung up in both the USA and the UK.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;However a unanimous opinion developed in all of these companies that     corporate planning in the shape of long range planning was not working, did not     pay off, and was an expensive investment in futility. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;It was widely held that managing change and setting realistic     objectives which carry the conviction of those responsible was difficult and     often resulted in questionable compromises.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The fact remained, despite the corporate and long range planners,     that the one and only missing link was how to get the management team agreed     and committed to a comprehensive set of action programmes. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;To create this link, starting in 1960, Robert F Stewart at SRI in     Menlo Park California lead a research team to discover what was going wrong     with corporate planning, and then to find some sort of solution, or to create a     system for enabling management teams agreed and committed to development work,     which today we call 'managing change'.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The research carried on from 1960 through 1969. 1100 companies and     organizations were interviewed and a 250-item questionnaire was designed and     completed by over 5,000 executives. Seven key findings lead to the     conclusion that in corporations chief executive should be the chief planner and     that his immediate functional directors should be the planning team. Dr Otis     Benepe defined the 'Chain of Logic' which became the core of system designed to     fix the link for obtaining agreement and commitment. &lt;/div&gt;&lt;ol style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;&lt;b&gt;Values &lt;/b&gt;&lt;/li&gt;
&lt;li&gt;&lt;b&gt; Appraise &lt;/b&gt;&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Motivation &lt;/b&gt;&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Search &lt;/b&gt;&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Select&lt;/b&gt;&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Programme&lt;/b&gt;&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Act &lt;/b&gt;&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Monitor and repeat steps 1 2 and 3 &lt;/b&gt;&lt;/li&gt;
&lt;/ol&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;We discovered that we could not change the values of the team nor     set the objectives for the team so we started as the first step by asking the     appraisal question, for example, what's good and bad about the operation. We     began the system by asking what is good and bad about the present and the     future. What is good in the present is Satisfactory, good in the future is an     Opportunity; bad in the present is a Fault and bad in the future is a Threat.     This was called the SOFT analysis.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;When this was presented to Urick and Orr in 1964 at the Seminar in     Long Range Planning at the Dolder Grand in Zurich Switzerland they changed the     F to a W and called it SWOT Analysis. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;SWOT was then promoted in Britain by Urick and Orr as an exercise in     and of itself. As such it has no benefit. What was necessary was the sorting of     the issues into the programme planning categories of: &lt;/div&gt;&lt;ol style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;&lt;b&gt;Product&lt;/b&gt; (what are we selling?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Process&lt;/b&gt; (how are we selling it?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Customer&lt;/b&gt; (to whom are we selling it?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Distribution&lt;/b&gt; (how does it reach them?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Finance&lt;/b&gt; (what are the prices, costs and investments?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Administration&lt;/b&gt; (and how do we manage all this?)&lt;/li&gt;
&lt;/ol&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The second step then becomes 'what shall the team do' about the     issues in each of these categories. The planning process was then designed     through trial and error and resulted finally in a 17 step process beginning     with SOFT/SWOT with each issue recorded separately on a single page called a     planning issue.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; The first prototype was tested and published in 1966 based on the     work done at 'Erie Technological Corp' in Erie Pa. In 1970 the prototype was     brought to the UK, under the sponsorship of W H Smith &amp;amp; Sons plc, and     completed by 1973. The operational programme was used to merge the CWS milling     and baking operations with those of J W French Ltd. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The process has been used successfully ever since. By 2004, now,     this system has been fully developed, and proven to cope with today's problems     of setting and agreeing realistic annual objectives without depending on     outside consultants or expensive staff resources. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;span style="color: red;"&gt;&lt;a href="" name="swot research seven key findings"&gt;the seven key research     findings&lt;/a&gt;&lt;/span&gt;&lt;a href="" name="swot research seven key findings"&gt;&lt;/a&gt;&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The key findings were never published because it was felt they were     too controversial. This is what was found: &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;1) A business was divided into two parts. The base business plus the     development business. This was re-discovered by Dr Peter Senge at MIT in 1998     and published in his book the Fifth Discipline (not '5th Dimension' as     previously stated here - thanks J Hoffman for this correction, 28 Jan 2011).     The amount of development business which become operational is equal to or     greater than that business on the books within a period of 5 to 7 years. This     was a major surprise and urged the need for discovering a better method for     planning and managing change. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;2) Dr Hal Eyring published his findings on 'Distributive Justice'     and pointed out that all people measure what they get from their work and     divide it by what they give to the work and this ratio is compared to others.     If it is not equal then the person first re-perceives and secondly slows down     if added demands are not met. (See for interest Adams Equity Theory and the     &lt;a href="http://www.businessballs.com/adamsequitytheory.pdf" target="_blank"&gt;Equity Theory Diagram     pdf&lt;/a&gt;)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;3) The introduction of a corporate planner upset the sense of fair     play at senior level, making the job of the corporate planner impossible. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;4) The gap between what could be done by the organisation and what     was actually done was about 35%. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;5) The senior man will over-supervise the area he comes from.     Finance- Finance, Engineering-Engineering etc. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;6) There are 3 factors which separate excellence from mediocrity:     &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;a. Overt attention to purchasing &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;b. Short-term written down departmental plans for improvement &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;c. Continued education of the Senior Executive &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;7) Some form of formal documentation is required to obtain approval     for development work. In short we could not solve the problem by stopping     planning.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;h3 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;in conclusion &lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;By sorting the SWOT issues into the 6 planning categories one can     obtain a system which presents a practical way of assimilating the internal and     external information about the business unit, delineating short and long term     priorities, and allowing an easy way to build the management team which can     achieve the objectives of profit growth. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;This approach captures the collective agreement and commitment of     those who will ultimately have to do the work of meeting or exceeding the     objectives finally set. It permits the team leader to define and develop     co-ordinated, goal-directed actions, which underpin the overall agreed     objectives between levels of the business hierarchy.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Albert S Humphrey &lt;br /&gt;
August 2004&lt;/div&gt;&lt;hr style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px;" /&gt;            &lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: left;"&gt;translating SWOT issues into actions under the six categories&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Albert Humphrey advocated that the six categories: &lt;/div&gt;&lt;ol style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;&lt;b&gt;Product&lt;/b&gt; (what are we selling?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Process&lt;/b&gt; (how are we selling it?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Customer&lt;/b&gt; (to whom are we selling it?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Distribution&lt;/b&gt; (how does it reach them?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Finance&lt;/b&gt; (what are the prices, costs and investments?)&lt;/li&gt;
&lt;li&gt;&lt;b&gt;Administration&lt;/b&gt; (and how do we manage all this?)&lt;/li&gt;
&lt;/ol&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;provide a framework by which SWOT issues can be developed into     actions and managed using teams.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;This can be something of a 'leap', and so the stage warrants further     explanation. Translating the SWOT issues into actions, are best sorted into (or     if necessary broken down into) the six categories, because in the context of     the way that business and organizations work, this makes them more quantifiable     and measurable, responsible teams more accountable, and therefore the     activities more manageable. The other pivotal part in the process is of course     achieving the commitment from the team(s) involved, which is partly explained     in the item summarising Humphrey's TAM&lt;span&gt;®&lt;/span&gt; model and     process.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;As far as identifying actions from SWOT issues is concerned, it all     very much depends on your reasons and aims for using SWOT, and also your     authority/ability to manage others, whom by implication of SWOT's breadth and     depth, are likely to be involved in the agreement and delivery of actions. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Depending on pretext and situation, a SWOT analysis can produce     issues which very readily translate into (one of the six) category actions, or     a SWOT analysis can produce issues which overlay a number of categories. Or a     mixture. Whatever, SWOT essentially tells you what is good and bad about a     business or a particular proposition. If it's a business, and the aim is to     improve it, then work on translating: &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;strengths (maintain, build and leverage)&lt;/b&gt;,     &lt;b&gt;&lt;br /&gt;
opportunities (prioritise and optimise)&lt;/b&gt;, &lt;b&gt;&lt;br /&gt;
weaknesses (remedy     or exit)&lt;/b&gt;, &lt;b&gt;&lt;br /&gt;
threats (counter)&lt;/b&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;into actions (each within one of the six categories) that can be     agreed and owned by a team or number of teams.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;If the SWOT analysis is being used to assess a proposition, then it     could be that the analysis shows that the proposition is too weak (especially     if compared with other SWOT's for alternative propositions) to warrant further     investment, in which case further action planning, other than exit, is not     required.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;If the proposition is clearly strong (presumably you will have     indicated this using other methods as well), then proceed as for a business,     and translate issues into category actions with suitable ownership by team(s).&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;This is my understanding of Albert Humphrey's theory relating to     developing SWOT issues into organizational change actions and accountabilities.     (I'm pleased to say that Albert kindly confirmed that this is indeed     correct.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;There are other ways of applying SWOT of course, depending on your     circumstances and aims, for instance if concentrating on a department rather     than a whole business, then it could make sense to revise the six categories to     reflect the functional parts of the department, or whatever will enable the     issues to be translatable into manageable, accountable and owned aims. &lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><enclosure length="77824" type="application/msword" url="http://www.businessballs.com/freematerialsinword/free_SWOT_analysis_template.doc"/><itunes:explicit>no</itunes:explicit><itunes:subtitle>The SWOT analysis is an extremely useful tool for understanding and decision-making for all sorts of situations in business and organizations. SWOT is an acronym for Strengths, Weaknesses, Opportunities, Threats. Information about the origins and inventors of SWOT analysis is below. The SWOT analysis headings provide a good framework for reviewing strategy, position and direction of a company or business proposition, or any other idea.&amp;nbsp; Completing a SWOT analysis is very simple, and is a good subject for workshop sessions. SWOT analysis also works well in brainstorming meetings.&amp;nbsp; Use SWOT analysis for business planning, strategic planning, competitor evaluation, marketing, business and product development and research reports. You can also use SWOT analysis exercises for team building games. Note that SWOT analysis is often interpreted and used as a SWOT Analysis 2x2 Matrix, especially in business and marketing planning.In addition to this 2x2 matrix method, SWOT analysis is also a widely recognized method for gathering, structuring, presenting and reviewing extensive planning data within a larger business or project planning process. See also PEST analysis, which measures a business's market and potential according to external factors; Political, Economic, Social and Technological. It is often helpful to complete a PEST analysis prior to a SWOT analysis. In other situations it may be more useful to complete a PEST analysis as part of, or after, a SWOT analysis. See also Porter's Five Forces model, which is used to analyse competitive position. Please note: If you use SWOT Analysis as a 2x2 matrix method , then technically Strengths and Weaknesses are internal factors (generally the case anyway), whereas Opportunities and Threats are external factors (this can be more difficult, since it requires you to ignore internal threats and opportunities). The SWOT 2x2 'internal/external' matrix method thus only considers external threats and opportunities.&amp;nbsp; As a more general guide, here is a free SWOT analysis template worksheet (doc file), and the same free SWOT analysis tool (pdf format).If you have difficulty opening the above doc file here are two other formats:SWOT Analysis Template doc file using table format instead of text-boxes (portrait layout) SWOT Analysis Template doc for Apple Mac (thanks U Weissbach) A SWOT analysis measures a business unit, a proposition or idea; a PEST analysis measures a market.A SWOT analysis is a subjective assessment of data which is organized by the SWOT format into a logical order that helps understanding, presentation, discussion and decision-making. The four dimensions are a useful extension of a basic two heading list of pro's and con's . SWOT analysis can be used for all sorts of decision-making, and the SWOT template enables proactive thinking, rather than relying on habitual or instinctive reactions. The SWOT analysis template is normally presented as a grid, comprising four sections, one for each of the SWOT headings: Strengths, Weaknesses, Opportunities, and Threats. The free SWOT template below includes sample questions, whose answers are inserted into the relevant section of the SWOT grid. The questions are examples, or discussion points, and obviously can be altered depending on the subject of the SWOT analysis. Note that many of the SWOT questions are also talking points for other headings - use them as you find most helpful, and make up your own to suit the issue being analysed. It is important to clearly identify the subject of a SWOT analysis, because a SWOT analysis is a perspective of one thing, be it a company, a product, a proposition, and idea, a method, or option, etc. SWOT analysis is commonly presented and developed into a 2x2 matrix, which is shown and explained within the SWOT analysis matrix section. swot analysis matrix - in business/marketing - internal v external factors Modern SWOT analysis in business and marketing situations is normally structured so that a 2x2 matrix grid can be produced, according to two pairs of dimensions. Strengths and Weaknesses, are 'mapped' or 'graphed' against Opportunities and Threats.&amp;nbsp; To enable this to happen cleanly and clearly, and from a logical point of view anyway when completing a SWOT analysis in most business and marketing situations, Strengths and Weaknesses are regarded distinctly as internal factors, whereas Opportunities and Threats are regarded distinctly as external factors. Here is the explanation in more detail: Strengths and Weaknesses the internal environment - the situation inside the company or organization for example, factors relating to products, pricing, costs, profitability, performance, quality, people, skills, adaptability, brands, services, reputation, processes, infrastructure, etc. factors tend to be in the present&amp;nbsp; Opportunities and Threats the external environment - the situation outside the company or organization for example, factors relating to markets, sectors, audience, fashion, seasonality, trends, competition, economics, politics, society, culture, technology, environmental, media, law, etc. factors tend to be in the future swot matrix (2x2 matrix using internal/external categories)Here is a typical extension of the basic SWOT analysis grid into a useful 'action-based' 2x2 SWOT matrix. The SWOT analysis in this format acts as a quick decision-making tool, quite aside from the more detailed data that would typically be fed into business planning process for each of the SWOT factors.Here the 2x2 matrix model automatically suggests actions for issues arising from the SWOT analysis, according to four different categories: &amp;nbsp; strengths (internal) weaknesses (internal) opportunities (external) strengths/opportunities obvious natural priorities Likely to produce greatest ROI (Return On Investment) Likely to be quickest and easiest to implement. Probably justifying immediate action-planning or feasibility study. Executive question: "If we are not already looking at these areas and prioritising them, then why not?" weaknesses/opportunities potentially attractive options Likely to produce good returns if capability and implementation are viable. Potentially more exciting and stimulating and rewarding than S/O due to change, challenge, surprise tactics, and benefits from addressing and achieving improvements. Executive questions: "What's actually stopping us doing these things, provided they truly fit strategically and are realistic and substantial?" threats (external) strengths/threats easy to defend and counter Only basic awareness, planning, and implementation required to meet these challenges. Investment in these issues is generally safe and necessary. Executive question: "Are we properly informed and organized to deal with these issues, and are we certain there are no hidden surprises?" - and - "Since we are strong here, can any of these threats be turned into opportunities?" weaknesses/threats potentially high risk Assessment of risk crucial. Where risk is low then we must ignore these issues and not be distracted by them. Where risk is high we must assess capability gaps and plan to defend/avert in very specific controlled ways. Executive question: "Have we accurately assessed the risks of these issues, and where the risks are high do we have specific controlled reliable plans to avoid/avert/defend?" N.B. SWOT analysis is a very flexible tool. Its use is not restricted to business and marketing. Be mindful that when SWOT is used in situations outside of business and marketing, strict categorization of the SWOT dimensions (according to 'internal' and 'external' factors) can be limiting, and so a more open interpretation of the model can be helpful in such circumstances, especially when assessing Opportunities and Threats. Also be mindful that if using the SWOT analysis model only as a 2x2 matrix, which assumes the categorization of internal and external factors (and notably limiting the assessment of threats and opportunities to external factors only), that it is very easy then to miss certain threats and opportunities that can exist (internally) within the company/organization. Some internal threats and opportunities can be substantial, for example, opportunities such as: energy-saving, process-improvement, training, advertising, or discontinuing loss-making products, or threats such as: desertion or key staff, the loss of major contracts, to name just a couple of typically ever-present threats within large commercial corporations. Be mindful therefore that the 'simplified' SWOT 2x2 matrix 'internal/external' method is not a reliable tool alone for identifying all threats and opportunities within organizations, or indeed any other situation. You will note from the origins of SWOT analysis below that the methodology did not begin, and was not operated as the simple 2x2 'internal/external' matrix that we commonly see today. Particularly, the original application of the model did not restrict threats and opportunities to just external factors. Instead, six key aspects of the business in question (namely: product, process, customer, distribution, finance, admin) were each assessed using the SWOT model. Each aspect was considered according to all four SWOT elements. Thus today when we apply the SWOT model to an entire business, if we disregard internal threats and opportunities, so the analysis can exclude some potentially serious issues. swot analysis - different applicationsSWOT analysis is a powerful model for many different situations. The SWOT tool is not just for business and marketing. Here are some examples of what a SWOT analysis can be used to assess:a company (its position in the market, commercial viability, etc) a method of sales distribution a product or brand a business idea a strategic option, such as entering a new market or launching a new product a opportunity to make an acquisition a potential partnership changing a supplier outsourcing a service, activity or resource project planning and project management an investment opportunity personal financial planning personal career development - direction, choice, change, etc. education and qualifications planning and decision-making life-change - downshifting, relocation, relationships, perhaps even family planning?.. Whatever the application, be sure to describe the subject (or purpose or question) for the SWOT analysis clearly so you remain focused on the central issue. This is especially crucial when others are involved in the process. People contributing to the analysis and seeing the finished SWOT analysis must be able to understand properly the purpose of the SWOT assessment and the implications arising. SWOT analysis template&amp;nbsp;Here is a larger illustration of SWOT analysis.Note that this format is not presented or proposed as a 2x2 'internal/external' matrix; it's a more open demonstration of the sorts of issues and questions which can be addressed when using the SWOT format as part of business planning and decision-making. Subject of SWOT analysis: (define the subject of the analysis here) strengthsAdvantages of proposition? Capabilities? Competitive advantages? USP's (unique selling points)? Resources, Assets, People? Experience, knowledge, data? Financial reserves, likely returns? Marketing - reach, distribution, awareness? Innovative aspects? Location and geographical? Price, value, quality? Accreditations, qualifications, certifications? Processes, systems, IT, communications? Cultural, attitudinal, behavioural? Management cover, succession? weaknessesDisadvantages of proposition? Gaps in capabilities? Lack of competitive strength? Reputation, presence and reach? Financials? Own known vulnerabilities? Timescales, deadlines and pressures? Cashflow, start-up cash-drain? Continuity, supply chain robustness? Effects on core activities, distraction? Reliability of data, plan predictability? Morale, commitment, leadership? Accreditations, etc? Processes and systems, etc? Management cover, succession? opportunitiesMarket developments? Competitors' vulnerabilities? Industry or lifestyle trends? Technology development and innovation? Global influences? New markets, vertical, horizontal? Niche target markets? Geographical, export, import? Market need for new USP's? Market response to tactics, e.g., surprise? Major contracts, tenders? Business and product development? Information and research? Partnerships, agencies, distribution? Market volume demand trends? Seasonal, weather, fashion influences? threatsPolitical effects? Legislative effects? Environmental effects? IT developments? Competitor intentions - various? Market demand? New technologies, services, ideas? Vital contracts and partners? Obstacles faced? Insurmountable weaknesses? Employment market? Financial and credit pressures? Economy - home, abroad? Seasonality, weather effects? free SWOT analysis template worksheet version (doc file) swot analysis exampleThis SWOT analysis example is based on an imaginary situation. The scenario is based on a business-to-business manufacturing company, who historically rely on distributors to take their products to the end user market. The opportunity, and therefore the subject for the SWOT analysis, is for the manufacturer to create a new company of its own to distribute its products direct to certain end-user sectors, which are not being covered or developed by its normal distributors. Subject of SWOT analysis example: the creation of own distributor company to access new end-user sectors not currently being developed. strengthsEnd-user sales control and direction. Right products, quality and reliability. Superior product performance vs competitors. Better product life and durability. Spare manufacturing capacity. Some staff have experience of end-user sector. Have customer lists. Direct delivery capability. Product innovations ongoing. Can serve from existing sites. Products have required accreditations. Processes and IT should cope. Management is committed and confident. weaknessesCustomer lists not tested. Some gaps in range for certain sectors. We would be a small player. No direct marketing experience. We cannot supply end-users abroad. Need more sales people. Limited budget. No pilot or trial done yet. Don't have a detailed plan yet. Delivery-staff need training. Customer service staff need training. Processes and systems, etc Management cover insufficient. opportunitiesCould develop new products. Local competitors have poor products. Profit margins will be good. End-users respond to new ideas. Could extend to overseas. New specialist applications. Can surprise competitors. Support core business economies. Could seek better supplier deals. threatsLegislation could impact. Environmental effects would favour larger competitors. Existing core business distribution risk. Market demand very seasonal. Retention of key staff critical. Could distract from core business. Possible negative publicity. Vulnerable to reactive attack by major competitors. See also the PEST analysis template and method, which measures a business according to external factors; Political, Economic, Social and Technological. It is often helpful to complete a PEST analysis prior to competing a SWOT analysis. more on the difference and relationship between PEST and SWOTThere is some overlap between PEST and SWOT. Similar factors appear in each. That said, PEST and SWOT are certainly two different perspectives: PEST tends to assess a market, including competitors, from the standpoint of a particular proposition or a business. SWOT in business and marketing tends to be an assessment of a business or a proposition, whether it is your own business or (less commonly) a competitor's business or proposition.&amp;nbsp; Strategic planning is not a precise science - no tool is mandatory - it's a matter of pragmatic choice as to what helps best to identify and explain the issues. PEST analysis may useful before SWOT analysis where it helps to identify SWOT factors. Alternatively PEST analysis may be incorporated within a SWOT analysis, to achieve the same effect.&amp;nbsp; PEST becomes more useful and relevant the larger and more complex the business or proposition, but even for a very small local businesses a PEST analysis can still throw up one or two very significant issues that might otherwise be missed.&amp;nbsp; The four quadrants in PEST vary in significance depending on the type of business, for example, social factors are more obviously relevant to consumer businesses or a B2B (business-to-business) organization close to the consumer-end of the supply chain, whereas political factors are more obviously relevant to a global munitions supplier or aerosol propellant manufacturer. All businesses benefit from a SWOT analysis, and all businesses benefit from completing a SWOT analysis of their main competitors, which interestingly can then provide useful points back into the economic aspects of the PEST analysis. swot analysis history - the origins of the SWOT analysis modelThis remarkable piece of history as to the origins of SWOT analysis was provided by Albert S Humphrey, one of the founding fathers of what we know today as SWOT analysis. I am indebted to him for sharing this fascinating contribution. Albert Humphrey died on 31 October 2005. He was one of the good guys. SWOT analysis came from the research conducted at Stanford Research Institute from 1960-1970. The background to SWOT stemmed from the need to find out why corporate planning failed. The research was funded by the fortune 500 companies to find out what could be done about this failure. The Research Team were Marion Dosher, Dr Otis Benepe, Albert Humphrey, Robert Stewart, Birger Lie. It all began with the corporate planning trend, which seemed to appear first at Du Pont in 1949. By 1960 every Fortune 500 company had a 'corporate planning manager' (or equivalent) and 'associations of long range corporate planners' had sprung up in both the USA and the UK. However a unanimous opinion developed in all of these companies that corporate planning in the shape of long range planning was not working, did not pay off, and was an expensive investment in futility. It was widely held that managing change and setting realistic objectives which carry the conviction of those responsible was difficult and often resulted in questionable compromises.&amp;nbsp; The fact remained, despite the corporate and long range planners, that the one and only missing link was how to get the management team agreed and committed to a comprehensive set of action programmes. To create this link, starting in 1960, Robert F Stewart at SRI in Menlo Park California lead a research team to discover what was going wrong with corporate planning, and then to find some sort of solution, or to create a system for enabling management teams agreed and committed to development work, which today we call 'managing change'.&amp;nbsp; The research carried on from 1960 through 1969. 1100 companies and organizations were interviewed and a 250-item questionnaire was designed and completed by over 5,000 executives. Seven key findings lead to the conclusion that in corporations chief executive should be the chief planner and that his immediate functional directors should be the planning team. Dr Otis Benepe defined the 'Chain of Logic' which became the core of system designed to fix the link for obtaining agreement and commitment. Values Appraise Motivation Search Select Programme Act Monitor and repeat steps 1 2 and 3 We discovered that we could not change the values of the team nor set the objectives for the team so we started as the first step by asking the appraisal question, for example, what's good and bad about the operation. We began the system by asking what is good and bad about the present and the future. What is good in the present is Satisfactory, good in the future is an Opportunity; bad in the present is a Fault and bad in the future is a Threat. This was called the SOFT analysis.&amp;nbsp; When this was presented to Urick and Orr in 1964 at the Seminar in Long Range Planning at the Dolder Grand in Zurich Switzerland they changed the F to a W and called it SWOT Analysis. SWOT was then promoted in Britain by Urick and Orr as an exercise in and of itself. As such it has no benefit. What was necessary was the sorting of the issues into the programme planning categories of: Product (what are we selling?) Process (how are we selling it?) Customer (to whom are we selling it?) Distribution (how does it reach them?) Finance (what are the prices, costs and investments?) Administration (and how do we manage all this?) The second step then becomes 'what shall the team do' about the issues in each of these categories. The planning process was then designed through trial and error and resulted finally in a 17 step process beginning with SOFT/SWOT with each issue recorded separately on a single page called a planning issue. The first prototype was tested and published in 1966 based on the work done at 'Erie Technological Corp' in Erie Pa. In 1970 the prototype was brought to the UK, under the sponsorship of W H Smith &amp;amp; Sons plc, and completed by 1973. The operational programme was used to merge the CWS milling and baking operations with those of J W French Ltd. The process has been used successfully ever since. By 2004, now, this system has been fully developed, and proven to cope with today's problems of setting and agreeing realistic annual objectives without depending on outside consultants or expensive staff resources. the seven key research findingsThe key findings were never published because it was felt they were too controversial. This is what was found: 1) A business was divided into two parts. The base business plus the development business. This was re-discovered by Dr Peter Senge at MIT in 1998 and published in his book the Fifth Discipline (not '5th Dimension' as previously stated here - thanks J Hoffman for this correction, 28 Jan 2011). The amount of development business which become operational is equal to or greater than that business on the books within a period of 5 to 7 years. This was a major surprise and urged the need for discovering a better method for planning and managing change. 2) Dr Hal Eyring published his findings on 'Distributive Justice' and pointed out that all people measure what they get from their work and divide it by what they give to the work and this ratio is compared to others. If it is not equal then the person first re-perceives and secondly slows down if added demands are not met. (See for interest Adams Equity Theory and the Equity Theory Diagram pdf)3) The introduction of a corporate planner upset the sense of fair play at senior level, making the job of the corporate planner impossible. 4) The gap between what could be done by the organisation and what was actually done was about 35%. 5) The senior man will over-supervise the area he comes from. Finance- Finance, Engineering-Engineering etc. 6) There are 3 factors which separate excellence from mediocrity: a. Overt attention to purchasing b. Short-term written down departmental plans for improvement c. Continued education of the Senior Executive 7) Some form of formal documentation is required to obtain approval for development work. In short we could not solve the problem by stopping planning. in conclusion By sorting the SWOT issues into the 6 planning categories one can obtain a system which presents a practical way of assimilating the internal and external information about the business unit, delineating short and long term priorities, and allowing an easy way to build the management team which can achieve the objectives of profit growth. This approach captures the collective agreement and commitment of those who will ultimately have to do the work of meeting or exceeding the objectives finally set. It permits the team leader to define and develop co-ordinated, goal-directed actions, which underpin the overall agreed objectives between levels of the business hierarchy.Albert S Humphrey August 2004 translating SWOT issues into actions under the six categoriesAlbert Humphrey advocated that the six categories: Product (what are we selling?) Process (how are we selling it?) Customer (to whom are we selling it?) Distribution (how does it reach them?) Finance (what are the prices, costs and investments?) Administration (and how do we manage all this?) provide a framework by which SWOT issues can be developed into actions and managed using teams.&amp;nbsp; This can be something of a 'leap', and so the stage warrants further explanation. Translating the SWOT issues into actions, are best sorted into (or if necessary broken down into) the six categories, because in the context of the way that business and organizations work, this makes them more quantifiable and measurable, responsible teams more accountable, and therefore the activities more manageable. The other pivotal part in the process is of course achieving the commitment from the team(s) involved, which is partly explained in the item summarising Humphrey's TAM® model and process.As far as identifying actions from SWOT issues is concerned, it all very much depends on your reasons and aims for using SWOT, and also your authority/ability to manage others, whom by implication of SWOT's breadth and depth, are likely to be involved in the agreement and delivery of actions. Depending on pretext and situation, a SWOT analysis can produce issues which very readily translate into (one of the six) category actions, or a SWOT analysis can produce issues which overlay a number of categories. Or a mixture. Whatever, SWOT essentially tells you what is good and bad about a business or a particular proposition. If it's a business, and the aim is to improve it, then work on translating: strengths (maintain, build and leverage), opportunities (prioritise and optimise), weaknesses (remedy or exit), threats (counter) into actions (each within one of the six categories) that can be agreed and owned by a team or number of teams.&amp;nbsp; If the SWOT analysis is being used to assess a proposition, then it could be that the analysis shows that the proposition is too weak (especially if compared with other SWOT's for alternative propositions) to warrant further investment, in which case further action planning, other than exit, is not required.&amp;nbsp; If the proposition is clearly strong (presumably you will have indicated this using other methods as well), then proceed as for a business, and translate issues into category actions with suitable ownership by team(s).&amp;nbsp; This is my understanding of Albert Humphrey's theory relating to developing SWOT issues into organizational change actions and accountabilities. (I'm pleased to say that Albert kindly confirmed that this is indeed correct.) There are other ways of applying SWOT of course, depending on your circumstances and aims, for instance if concentrating on a department rather than a whole business, then it could make sense to revise the six categories to reflect the functional parts of the department, or whatever will enable the issues to be translatable into manageable, accountable and owned aims.</itunes:subtitle><itunes:author>noreply@blogger.com (Unknown)</itunes:author><itunes:summary>The SWOT analysis is an extremely useful tool for understanding and decision-making for all sorts of situations in business and organizations. SWOT is an acronym for Strengths, Weaknesses, Opportunities, Threats. Information about the origins and inventors of SWOT analysis is below. The SWOT analysis headings provide a good framework for reviewing strategy, position and direction of a company or business proposition, or any other idea.&amp;nbsp; Completing a SWOT analysis is very simple, and is a good subject for workshop sessions. SWOT analysis also works well in brainstorming meetings.&amp;nbsp; Use SWOT analysis for business planning, strategic planning, competitor evaluation, marketing, business and product development and research reports. You can also use SWOT analysis exercises for team building games. Note that SWOT analysis is often interpreted and used as a SWOT Analysis 2x2 Matrix, especially in business and marketing planning.In addition to this 2x2 matrix method, SWOT analysis is also a widely recognized method for gathering, structuring, presenting and reviewing extensive planning data within a larger business or project planning process. See also PEST analysis, which measures a business's market and potential according to external factors; Political, Economic, Social and Technological. It is often helpful to complete a PEST analysis prior to a SWOT analysis. In other situations it may be more useful to complete a PEST analysis as part of, or after, a SWOT analysis. See also Porter's Five Forces model, which is used to analyse competitive position. Please note: If you use SWOT Analysis as a 2x2 matrix method , then technically Strengths and Weaknesses are internal factors (generally the case anyway), whereas Opportunities and Threats are external factors (this can be more difficult, since it requires you to ignore internal threats and opportunities). The SWOT 2x2 'internal/external' matrix method thus only considers external threats and opportunities.&amp;nbsp; As a more general guide, here is a free SWOT analysis template worksheet (doc file), and the same free SWOT analysis tool (pdf format).If you have difficulty opening the above doc file here are two other formats:SWOT Analysis Template doc file using table format instead of text-boxes (portrait layout) SWOT Analysis Template doc for Apple Mac (thanks U Weissbach) A SWOT analysis measures a business unit, a proposition or idea; a PEST analysis measures a market.A SWOT analysis is a subjective assessment of data which is organized by the SWOT format into a logical order that helps understanding, presentation, discussion and decision-making. The four dimensions are a useful extension of a basic two heading list of pro's and con's . SWOT analysis can be used for all sorts of decision-making, and the SWOT template enables proactive thinking, rather than relying on habitual or instinctive reactions. The SWOT analysis template is normally presented as a grid, comprising four sections, one for each of the SWOT headings: Strengths, Weaknesses, Opportunities, and Threats. The free SWOT template below includes sample questions, whose answers are inserted into the relevant section of the SWOT grid. The questions are examples, or discussion points, and obviously can be altered depending on the subject of the SWOT analysis. Note that many of the SWOT questions are also talking points for other headings - use them as you find most helpful, and make up your own to suit the issue being analysed. It is important to clearly identify the subject of a SWOT analysis, because a SWOT analysis is a perspective of one thing, be it a company, a product, a proposition, and idea, a method, or option, etc. SWOT analysis is commonly presented and developed into a 2x2 matrix, which is shown and explained within the SWOT analysis matrix section. swot analysis matrix - in business/marketing - internal v external factors Modern SWOT analysis in business and marketing situations is normally structured so that a 2x2 matrix grid can be produced, according to two pairs of dimensions. Strengths and Weaknesses, are 'mapped' or 'graphed' against Opportunities and Threats.&amp;nbsp; To enable this to happen cleanly and clearly, and from a logical point of view anyway when completing a SWOT analysis in most business and marketing situations, Strengths and Weaknesses are regarded distinctly as internal factors, whereas Opportunities and Threats are regarded distinctly as external factors. Here is the explanation in more detail: Strengths and Weaknesses the internal environment - the situation inside the company or organization for example, factors relating to products, pricing, costs, profitability, performance, quality, people, skills, adaptability, brands, services, reputation, processes, infrastructure, etc. factors tend to be in the present&amp;nbsp; Opportunities and Threats the external environment - the situation outside the company or organization for example, factors relating to markets, sectors, audience, fashion, seasonality, trends, competition, economics, politics, society, culture, technology, environmental, media, law, etc. factors tend to be in the future swot matrix (2x2 matrix using internal/external categories)Here is a typical extension of the basic SWOT analysis grid into a useful 'action-based' 2x2 SWOT matrix. The SWOT analysis in this format acts as a quick decision-making tool, quite aside from the more detailed data that would typically be fed into business planning process for each of the SWOT factors.Here the 2x2 matrix model automatically suggests actions for issues arising from the SWOT analysis, according to four different categories: &amp;nbsp; strengths (internal) weaknesses (internal) opportunities (external) strengths/opportunities obvious natural priorities Likely to produce greatest ROI (Return On Investment) Likely to be quickest and easiest to implement. Probably justifying immediate action-planning or feasibility study. Executive question: "If we are not already looking at these areas and prioritising them, then why not?" weaknesses/opportunities potentially attractive options Likely to produce good returns if capability and implementation are viable. Potentially more exciting and stimulating and rewarding than S/O due to change, challenge, surprise tactics, and benefits from addressing and achieving improvements. Executive questions: "What's actually stopping us doing these things, provided they truly fit strategically and are realistic and substantial?" threats (external) strengths/threats easy to defend and counter Only basic awareness, planning, and implementation required to meet these challenges. Investment in these issues is generally safe and necessary. Executive question: "Are we properly informed and organized to deal with these issues, and are we certain there are no hidden surprises?" - and - "Since we are strong here, can any of these threats be turned into opportunities?" weaknesses/threats potentially high risk Assessment of risk crucial. Where risk is low then we must ignore these issues and not be distracted by them. Where risk is high we must assess capability gaps and plan to defend/avert in very specific controlled ways. Executive question: "Have we accurately assessed the risks of these issues, and where the risks are high do we have specific controlled reliable plans to avoid/avert/defend?" N.B. SWOT analysis is a very flexible tool. Its use is not restricted to business and marketing. Be mindful that when SWOT is used in situations outside of business and marketing, strict categorization of the SWOT dimensions (according to 'internal' and 'external' factors) can be limiting, and so a more open interpretation of the model can be helpful in such circumstances, especially when assessing Opportunities and Threats. Also be mindful that if using the SWOT analysis model only as a 2x2 matrix, which assumes the categorization of internal and external factors (and notably limiting the assessment of threats and opportunities to external factors only), that it is very easy then to miss certain threats and opportunities that can exist (internally) within the company/organization. Some internal threats and opportunities can be substantial, for example, opportunities such as: energy-saving, process-improvement, training, advertising, or discontinuing loss-making products, or threats such as: desertion or key staff, the loss of major contracts, to name just a couple of typically ever-present threats within large commercial corporations. Be mindful therefore that the 'simplified' SWOT 2x2 matrix 'internal/external' method is not a reliable tool alone for identifying all threats and opportunities within organizations, or indeed any other situation. You will note from the origins of SWOT analysis below that the methodology did not begin, and was not operated as the simple 2x2 'internal/external' matrix that we commonly see today. Particularly, the original application of the model did not restrict threats and opportunities to just external factors. Instead, six key aspects of the business in question (namely: product, process, customer, distribution, finance, admin) were each assessed using the SWOT model. Each aspect was considered according to all four SWOT elements. Thus today when we apply the SWOT model to an entire business, if we disregard internal threats and opportunities, so the analysis can exclude some potentially serious issues. swot analysis - different applicationsSWOT analysis is a powerful model for many different situations. The SWOT tool is not just for business and marketing. Here are some examples of what a SWOT analysis can be used to assess:a company (its position in the market, commercial viability, etc) a method of sales distribution a product or brand a business idea a strategic option, such as entering a new market or launching a new product a opportunity to make an acquisition a potential partnership changing a supplier outsourcing a service, activity or resource project planning and project management an investment opportunity personal financial planning personal career development - direction, choice, change, etc. education and qualifications planning and decision-making life-change - downshifting, relocation, relationships, perhaps even family planning?.. Whatever the application, be sure to describe the subject (or purpose or question) for the SWOT analysis clearly so you remain focused on the central issue. This is especially crucial when others are involved in the process. People contributing to the analysis and seeing the finished SWOT analysis must be able to understand properly the purpose of the SWOT assessment and the implications arising. SWOT analysis template&amp;nbsp;Here is a larger illustration of SWOT analysis.Note that this format is not presented or proposed as a 2x2 'internal/external' matrix; it's a more open demonstration of the sorts of issues and questions which can be addressed when using the SWOT format as part of business planning and decision-making. Subject of SWOT analysis: (define the subject of the analysis here) strengthsAdvantages of proposition? Capabilities? Competitive advantages? USP's (unique selling points)? Resources, Assets, People? Experience, knowledge, data? Financial reserves, likely returns? Marketing - reach, distribution, awareness? Innovative aspects? Location and geographical? Price, value, quality? Accreditations, qualifications, certifications? Processes, systems, IT, communications? Cultural, attitudinal, behavioural? Management cover, succession? weaknessesDisadvantages of proposition? Gaps in capabilities? Lack of competitive strength? Reputation, presence and reach? Financials? Own known vulnerabilities? Timescales, deadlines and pressures? Cashflow, start-up cash-drain? Continuity, supply chain robustness? Effects on core activities, distraction? Reliability of data, plan predictability? Morale, commitment, leadership? Accreditations, etc? Processes and systems, etc? Management cover, succession? opportunitiesMarket developments? Competitors' vulnerabilities? Industry or lifestyle trends? Technology development and innovation? Global influences? New markets, vertical, horizontal? Niche target markets? Geographical, export, import? Market need for new USP's? Market response to tactics, e.g., surprise? Major contracts, tenders? Business and product development? Information and research? Partnerships, agencies, distribution? Market volume demand trends? Seasonal, weather, fashion influences? threatsPolitical effects? Legislative effects? Environmental effects? IT developments? Competitor intentions - various? Market demand? New technologies, services, ideas? Vital contracts and partners? Obstacles faced? Insurmountable weaknesses? Employment market? Financial and credit pressures? Economy - home, abroad? Seasonality, weather effects? free SWOT analysis template worksheet version (doc file) swot analysis exampleThis SWOT analysis example is based on an imaginary situation. The scenario is based on a business-to-business manufacturing company, who historically rely on distributors to take their products to the end user market. The opportunity, and therefore the subject for the SWOT analysis, is for the manufacturer to create a new company of its own to distribute its products direct to certain end-user sectors, which are not being covered or developed by its normal distributors. Subject of SWOT analysis example: the creation of own distributor company to access new end-user sectors not currently being developed. strengthsEnd-user sales control and direction. Right products, quality and reliability. Superior product performance vs competitors. Better product life and durability. Spare manufacturing capacity. Some staff have experience of end-user sector. Have customer lists. Direct delivery capability. Product innovations ongoing. Can serve from existing sites. Products have required accreditations. Processes and IT should cope. Management is committed and confident. weaknessesCustomer lists not tested. Some gaps in range for certain sectors. We would be a small player. No direct marketing experience. We cannot supply end-users abroad. Need more sales people. Limited budget. No pilot or trial done yet. Don't have a detailed plan yet. Delivery-staff need training. Customer service staff need training. Processes and systems, etc Management cover insufficient. opportunitiesCould develop new products. Local competitors have poor products. Profit margins will be good. End-users respond to new ideas. Could extend to overseas. New specialist applications. Can surprise competitors. Support core business economies. Could seek better supplier deals. threatsLegislation could impact. Environmental effects would favour larger competitors. Existing core business distribution risk. Market demand very seasonal. Retention of key staff critical. Could distract from core business. Possible negative publicity. Vulnerable to reactive attack by major competitors. See also the PEST analysis template and method, which measures a business according to external factors; Political, Economic, Social and Technological. It is often helpful to complete a PEST analysis prior to competing a SWOT analysis. more on the difference and relationship between PEST and SWOTThere is some overlap between PEST and SWOT. Similar factors appear in each. That said, PEST and SWOT are certainly two different perspectives: PEST tends to assess a market, including competitors, from the standpoint of a particular proposition or a business. SWOT in business and marketing tends to be an assessment of a business or a proposition, whether it is your own business or (less commonly) a competitor's business or proposition.&amp;nbsp; Strategic planning is not a precise science - no tool is mandatory - it's a matter of pragmatic choice as to what helps best to identify and explain the issues. PEST analysis may useful before SWOT analysis where it helps to identify SWOT factors. Alternatively PEST analysis may be incorporated within a SWOT analysis, to achieve the same effect.&amp;nbsp; PEST becomes more useful and relevant the larger and more complex the business or proposition, but even for a very small local businesses a PEST analysis can still throw up one or two very significant issues that might otherwise be missed.&amp;nbsp; The four quadrants in PEST vary in significance depending on the type of business, for example, social factors are more obviously relevant to consumer businesses or a B2B (business-to-business) organization close to the consumer-end of the supply chain, whereas political factors are more obviously relevant to a global munitions supplier or aerosol propellant manufacturer. All businesses benefit from a SWOT analysis, and all businesses benefit from completing a SWOT analysis of their main competitors, which interestingly can then provide useful points back into the economic aspects of the PEST analysis. swot analysis history - the origins of the SWOT analysis modelThis remarkable piece of history as to the origins of SWOT analysis was provided by Albert S Humphrey, one of the founding fathers of what we know today as SWOT analysis. I am indebted to him for sharing this fascinating contribution. Albert Humphrey died on 31 October 2005. He was one of the good guys. SWOT analysis came from the research conducted at Stanford Research Institute from 1960-1970. The background to SWOT stemmed from the need to find out why corporate planning failed. The research was funded by the fortune 500 companies to find out what could be done about this failure. The Research Team were Marion Dosher, Dr Otis Benepe, Albert Humphrey, Robert Stewart, Birger Lie. It all began with the corporate planning trend, which seemed to appear first at Du Pont in 1949. By 1960 every Fortune 500 company had a 'corporate planning manager' (or equivalent) and 'associations of long range corporate planners' had sprung up in both the USA and the UK. However a unanimous opinion developed in all of these companies that corporate planning in the shape of long range planning was not working, did not pay off, and was an expensive investment in futility. It was widely held that managing change and setting realistic objectives which carry the conviction of those responsible was difficult and often resulted in questionable compromises.&amp;nbsp; The fact remained, despite the corporate and long range planners, that the one and only missing link was how to get the management team agreed and committed to a comprehensive set of action programmes. To create this link, starting in 1960, Robert F Stewart at SRI in Menlo Park California lead a research team to discover what was going wrong with corporate planning, and then to find some sort of solution, or to create a system for enabling management teams agreed and committed to development work, which today we call 'managing change'.&amp;nbsp; The research carried on from 1960 through 1969. 1100 companies and organizations were interviewed and a 250-item questionnaire was designed and completed by over 5,000 executives. Seven key findings lead to the conclusion that in corporations chief executive should be the chief planner and that his immediate functional directors should be the planning team. Dr Otis Benepe defined the 'Chain of Logic' which became the core of system designed to fix the link for obtaining agreement and commitment. Values Appraise Motivation Search Select Programme Act Monitor and repeat steps 1 2 and 3 We discovered that we could not change the values of the team nor set the objectives for the team so we started as the first step by asking the appraisal question, for example, what's good and bad about the operation. We began the system by asking what is good and bad about the present and the future. What is good in the present is Satisfactory, good in the future is an Opportunity; bad in the present is a Fault and bad in the future is a Threat. This was called the SOFT analysis.&amp;nbsp; When this was presented to Urick and Orr in 1964 at the Seminar in Long Range Planning at the Dolder Grand in Zurich Switzerland they changed the F to a W and called it SWOT Analysis. SWOT was then promoted in Britain by Urick and Orr as an exercise in and of itself. As such it has no benefit. What was necessary was the sorting of the issues into the programme planning categories of: Product (what are we selling?) Process (how are we selling it?) Customer (to whom are we selling it?) Distribution (how does it reach them?) Finance (what are the prices, costs and investments?) Administration (and how do we manage all this?) The second step then becomes 'what shall the team do' about the issues in each of these categories. The planning process was then designed through trial and error and resulted finally in a 17 step process beginning with SOFT/SWOT with each issue recorded separately on a single page called a planning issue. The first prototype was tested and published in 1966 based on the work done at 'Erie Technological Corp' in Erie Pa. In 1970 the prototype was brought to the UK, under the sponsorship of W H Smith &amp;amp; Sons plc, and completed by 1973. The operational programme was used to merge the CWS milling and baking operations with those of J W French Ltd. The process has been used successfully ever since. By 2004, now, this system has been fully developed, and proven to cope with today's problems of setting and agreeing realistic annual objectives without depending on outside consultants or expensive staff resources. the seven key research findingsThe key findings were never published because it was felt they were too controversial. This is what was found: 1) A business was divided into two parts. The base business plus the development business. This was re-discovered by Dr Peter Senge at MIT in 1998 and published in his book the Fifth Discipline (not '5th Dimension' as previously stated here - thanks J Hoffman for this correction, 28 Jan 2011). The amount of development business which become operational is equal to or greater than that business on the books within a period of 5 to 7 years. This was a major surprise and urged the need for discovering a better method for planning and managing change. 2) Dr Hal Eyring published his findings on 'Distributive Justice' and pointed out that all people measure what they get from their work and divide it by what they give to the work and this ratio is compared to others. If it is not equal then the person first re-perceives and secondly slows down if added demands are not met. (See for interest Adams Equity Theory and the Equity Theory Diagram pdf)3) The introduction of a corporate planner upset the sense of fair play at senior level, making the job of the corporate planner impossible. 4) The gap between what could be done by the organisation and what was actually done was about 35%. 5) The senior man will over-supervise the area he comes from. Finance- Finance, Engineering-Engineering etc. 6) There are 3 factors which separate excellence from mediocrity: a. Overt attention to purchasing b. Short-term written down departmental plans for improvement c. Continued education of the Senior Executive 7) Some form of formal documentation is required to obtain approval for development work. In short we could not solve the problem by stopping planning. in conclusion By sorting the SWOT issues into the 6 planning categories one can obtain a system which presents a practical way of assimilating the internal and external information about the business unit, delineating short and long term priorities, and allowing an easy way to build the management team which can achieve the objectives of profit growth. This approach captures the collective agreement and commitment of those who will ultimately have to do the work of meeting or exceeding the objectives finally set. It permits the team leader to define and develop co-ordinated, goal-directed actions, which underpin the overall agreed objectives between levels of the business hierarchy.Albert S Humphrey August 2004 translating SWOT issues into actions under the six categoriesAlbert Humphrey advocated that the six categories: Product (what are we selling?) Process (how are we selling it?) Customer (to whom are we selling it?) Distribution (how does it reach them?) Finance (what are the prices, costs and investments?) Administration (and how do we manage all this?) provide a framework by which SWOT issues can be developed into actions and managed using teams.&amp;nbsp; This can be something of a 'leap', and so the stage warrants further explanation. Translating the SWOT issues into actions, are best sorted into (or if necessary broken down into) the six categories, because in the context of the way that business and organizations work, this makes them more quantifiable and measurable, responsible teams more accountable, and therefore the activities more manageable. The other pivotal part in the process is of course achieving the commitment from the team(s) involved, which is partly explained in the item summarising Humphrey's TAM® model and process.As far as identifying actions from SWOT issues is concerned, it all very much depends on your reasons and aims for using SWOT, and also your authority/ability to manage others, whom by implication of SWOT's breadth and depth, are likely to be involved in the agreement and delivery of actions. Depending on pretext and situation, a SWOT analysis can produce issues which very readily translate into (one of the six) category actions, or a SWOT analysis can produce issues which overlay a number of categories. Or a mixture. Whatever, SWOT essentially tells you what is good and bad about a business or a particular proposition. If it's a business, and the aim is to improve it, then work on translating: strengths (maintain, build and leverage), opportunities (prioritise and optimise), weaknesses (remedy or exit), threats (counter) into actions (each within one of the six categories) that can be agreed and owned by a team or number of teams.&amp;nbsp; If the SWOT analysis is being used to assess a proposition, then it could be that the analysis shows that the proposition is too weak (especially if compared with other SWOT's for alternative propositions) to warrant further investment, in which case further action planning, other than exit, is not required.&amp;nbsp; If the proposition is clearly strong (presumably you will have indicated this using other methods as well), then proceed as for a business, and translate issues into category actions with suitable ownership by team(s).&amp;nbsp; This is my understanding of Albert Humphrey's theory relating to developing SWOT issues into organizational change actions and accountabilities. (I'm pleased to say that Albert kindly confirmed that this is indeed correct.) There are other ways of applying SWOT of course, depending on your circumstances and aims, for instance if concentrating on a department rather than a whole business, then it could make sense to revise the six categories to reflect the functional parts of the department, or whatever will enable the issues to be translatable into manageable, accountable and owned aims.</itunes:summary><itunes:keywords>SWOT analysis method and examples, with free SWOT template</itunes:keywords></item><item><title>SWOT Analysis - POWER SWOT</title><link>http://pp-eye.blogspot.com/2012/01/swot-analysis-power-swot.html</link><category>SWOT Analysis - POWER SWOT</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 13:12:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-2515631304003982149</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEa0GDTVHKM0GRC3BHsD-Kd3DE9Y65n_S_1B-JP-OoE_uPphufW9gt0zKZqmq9nj9syWUQB4vOxbrefUP9Kx70gSkfNgX3zPx5pBgTljxz00G92LMYxancbRllSWPv4BbO3lnsKYIZpe8/s400/1694_chap2_swotthumb.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="316" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEa0GDTVHKM0GRC3BHsD-Kd3DE9Y65n_S_1B-JP-OoE_uPphufW9gt0zKZqmq9nj9syWUQB4vOxbrefUP9Kx70gSkfNgX3zPx5pBgTljxz00G92LMYxancbRllSWPv4BbO3lnsKYIZpe8/s320/1694_chap2_swotthumb.png" width="320" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h2 style="color: #0b5394;"&gt;&amp;nbsp;&lt;/h2&gt;&lt;h2 style="color: #0b5394;"&gt;Marketing Teacher's Approach to SWOT Analysis.&lt;/h2&gt;&lt;div style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;em&gt;Why is there a need for an advanced approach to SWOT Analysis?&lt;/em&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;            &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong style="color: #0b5394;"&gt;SWOT analysis&lt;/strong&gt;&lt;span style="color: #0b5394;"&gt; &lt;/span&gt;is a marketing audit that considers an organization's &lt;em&gt;strengths, weaknesses, opportunities and threats.&lt;/em&gt;  Our introductory lesson gives you the basics of how to complete your  SWOT as you begin to learn about marketing tools. As you learn more  about SWOT analysis, you will become aware of a number of potential  limitations with this popular tool. This lesson aims to help you  overcome potential pitfalls.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;              &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Some of the problems that you may encounter with SWOT are as a  result of one of its key benefits i.e. its flexibility. Since SWOT  analysis can be used in a variety of scenarios, it has to be flexible.  However this can lead to a number of anomalies. Problems with basic SWOT  analysis can be addressed using a more critical &lt;strong&gt;&amp;nbsp;&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong style="color: #cc0000;"&gt;POWER SWOT&lt;/strong&gt;&lt;span style="color: #cc0000;"&gt;.&lt;/span&gt; POWER is an acronym for &lt;em&gt;Personal experience, Order, Weighting, Emphasize detail, and Rank and prioritize&lt;/em&gt;. This is how it works.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;        &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;P = Personal experience.&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;How do you the marketing manger fit in relation with the SWOT  analysis? You bring your experiences, skills, knowledge, attitudes and  beliefs to the audit. Your perception or simple gut feeling will impact  the SWOT.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;O = Order - strengths or weaknesses, opportunities or threats.&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Often marketing managers will inadvertently reverse  opportunities and strengths, and threats and weaknesses. This is because  the line between internal strengths and weaknesses, and external  opportunities and threats is sometimes difficult to spot. For example,  in relation to global warming and climate change, one could mistake  environmentalism as a threat rather than a potential opportunity.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;W = Weighting.&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Too often elements of a SWOT analysis are not weighted.  Naturally some points will be more controversial than others. So weight  the factors. One way would be to use percentages e.g. Threat A = 10%,  Threat B = 70%, and Threat C = 20% (they total 100%).&lt;strong&gt;&amp;nbsp;&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;E = Emphasize detail.&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Detail, reasoning and justification are often omitted from the  SWOT analysis. What one tends to find is that the analysis contains  lists of single words. For example, under opportunities one might find  the term &lt;em&gt;'Technology.'&lt;/em&gt; This single word does not tell a reader very much. What is really meant is:&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;em&gt;'Technology enables marketers to communicate via mobile  devices close to the point of purchase. This provides the opportunity of  a distinct competitive advantage for our company.'&lt;/em&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;This will greatly assist you when deciding upon how best to score and weight each element.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;R = Rank and prioritize.&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;      &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Once detail has been added, and factors have been reviewed for  weighting, you can then progress to give the SWOT analysis some  strategic meaning i.e. you can begin to select those factors that will  most greatly influence your marketing strategy albeit a mix of  strengths, weaknesses, opportunities and threats. Essentially you rank  them highest to lowest, and then prioritize those with the highest rank  e.g. Where Opportunity C = 60%, Opportunity A = 25%, and Opportunity B =  10% - your marketing plan would address Opportunity C first, and  Opportunity B last. It is important to address opportunities primarily  since your business should be market oriented. Then match strengths to  opportunities and look for a fit. Address any gaps between current  strengths and future opportunities. Finally attempt to rephrase threats  as opportunities (as with global warming and climate change above), and  address weaknesses so that they become strengths. Gap analysis would be useful at this point i.e. where we are now, and where do we want to be? Strategies would bridge the gap between them.&lt;/div&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEa0GDTVHKM0GRC3BHsD-Kd3DE9Y65n_S_1B-JP-OoE_uPphufW9gt0zKZqmq9nj9syWUQB4vOxbrefUP9Kx70gSkfNgX3zPx5pBgTljxz00G92LMYxancbRllSWPv4BbO3lnsKYIZpe8/s72-c/1694_chap2_swotthumb.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>History of SWOT Analysis</title><link>http://pp-eye.blogspot.com/2012/01/history-of-swot-analysis.html</link><category>History of SWOT Analysis</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 13:05:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-8093660439948945296</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style="text-align: center;"&gt;&lt;a href="http://hrmadvice.com/assets/images/swotanalysis.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"&gt;&lt;img border="0" height="312" src="http://hrmadvice.com/assets/images/swotanalysis.jpg" width="320" /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="color: #351c75;"&gt;&lt;td class="tr-caption" style="text-align: center;"&gt;&lt;span style="font-size: small;"&gt;by Tim Friesner&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div class="author" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Having arrived on this page you have probably surfed the Internet and scoured books and journals in search of the history of SWOT Analysis.  The simple answer to the question What is SWOT? is that there is no  simple answer, and one needs to demonstrate a little academic wisdom in  that nobody took the trouble to write the first definitive journal paper  or book that announced the birth of SWOT Analysis.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;            &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;There are a number of contrasting, if not contradictory views on  the origin of SWOT. Here are a few of the leading thinkers on the topic  (and if you have more please let us know so that we can add them).&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Stanford University’s Albert Humphrey led a research project in  the   1960s-1970s based   upon the United States’ Fortune 500.  Humphrey  lead a research project   which ultimately developed   his Team Action  Model (TAM) which is a management concept that enables   groups of  executives   to manage change.  SWOT was to have originated from his  ‘Stakeholders   Concept and SWOT Analysis.’   However, if one proceeds  to find out more about the author in academic   libraries there is  nothing   accredited to him. It is unusual for such a prolifically cited  piece of   research not to have an   original definitive publication as  its centrepiece. The TAM approach is   one of a number that are   used  by trainers around the World, although for us the crediting to    Humphrey as the creator   of SWOT cannot be supported.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;King (2004) also recognised that it was tricky to track down the    origins of the acronym SWOT.   He cites Haberberg (2000) as stating  that SWOT was a concept used by   Harvard academics in the 1960s,   and  Turner (2002) attributing SWOT to Igor Ansoff (1987), of Ansoff’s    Matrix fame. Koch (2000)   considered the contributions of Weihrich  (1982), Dealtry (1992) and   Wheelan and Hunger (1998).   Again whilst  these are the commonly accepted views of thinkers on the   topic of  SWOT, even the   common observer would recognise that Weihrich (1982)  was not the   originator of the concept but   rather an innovator of it.  As Koch (2004) comments he recognised that a   series of SWOT/TOWS  analyses   had the advantages of a single arbitrary matrix. Wheelan and  Hunger   (1998) used SWOT to look for gaps   and matches between  competences and resources and the business   environment.  Dealtry  (1992) considered   SWOT in terms or groups and vectors with common  themes and interactions.   Shinno et al (2006) amalgamated   SWOT  analysis with an Analytic Hierarchy Process (AHP) which ranked and    prioritised each element   using software. Shinno et al (2006) do not  really deal with the obvious   limitations of SWOT   (see our &lt;a href="http://marketingteacher.com/lesson-store/lesson-swot.html"&gt;SWOT   lesson&lt;/a&gt; for a refresher).&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;                          &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;                                 &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;A refocusing of SWOT was offered by Panagiotou (2003). He  introduces a   TELESCOPIC   OBSERVATIONS strategic framework which in  effect maps strengths,   weaknesses, opportunities and   threats against  his suggested acronym - TELESCOPIC OBSERVATIONS. So, for   example T =  technological   advancements, E= economic considerations, L = legal and  regulatory   requirements, etc. The most useful   aspect of Panagiotou’s  article is that not only does he recognise the   difficulty in finding  the   origins of SWOT, but he also manages to unearth some interesting    alternatives. In contrast to crediting   the tool to Stanford  University’s Albert Humphrey, SWOT is credited to   two Harvard Business  School   Policy Unit professors – George Albert Smith Jr and C Roland    Christiensen during the early 1950s.   Later in the 1950s another HBS  Policy Unit professor Kenneth Andrews   developed its usage and  application.   All professors were specialists in organizational  strategy as opposed to   marketing. SWOT went on to   be developed by  the HBS during the 1960s until SWOT became the tool that   we use today.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;      &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Again despite their interest in the concept of SWOT Analysis,  none of   these respected authors   actually cite its origins. It may be  that SWOT’s origins have been   forgotten and are confined to   the  corner of the library labelled ‘folklore.’ It may be that SWOT    originated in a number of places,   or became common place in the  training rooms of corporate America in the   1950s and 1960s. One thing    is true and that is if you conduct your own review of the literature  on   SWOT that there is no obvious   history of thinking on the topic  i.e. that it has no documented   epistemology. In this case – marketing    student beware! Web based searches proclaim to have an answer to &lt;em&gt;What   is SWOT?&lt;/em&gt; but they do not.   They perpetuate plagiarised views. There is no documented history of   SWOT – that is the answer!&lt;/div&gt;&lt;div class="note" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;em&gt;Tim Friesner&lt;/em&gt; is Senior Lecturer in Marketing at the University   of Chichester, West Sussex, United Kingdom&lt;/div&gt;&lt;h1 style="color: #0b5394;"&gt;SWOT References&lt;/h1&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Ansoff, H.I. (1987), Corporate Strategy, revised edition, Penguin Books.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Brooksbank, R (1996) The BASIC marketing planning process: a practical   framework for the smaller business, Journal      of Marketing Intelligence   &amp;amp; Planning, Vol 14,  4, P 16-23.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Dealtry, R. (1992) Dynamic SWOT Analysis, DSA Associates, Birmingham,     Haberberg, A. (2000), "Swatting SWOT", Strategy, (Strategic Planning    Society), September.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Hill, T. &amp;amp; R. Westbrook (1997), “SWOT Analysis: It’s Time for a   Product Recall,” Long Range Planning, 30, No. 1, 46-52.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;King R.K. (2004), ENHANCING SWOT ANALYSIS USING TRIZ AND THE BIPOLAR    CONFLICT GRAPH: A Case Study on the Microsoft Corporation, Proceedings    of TRIZCON2004, 6th Annual Altshuller Institute.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Koch, A.J. (2000), SWOT Deos Not Need to be Recalled: It Needs to be    Enhanced, http://www.westga.edu/~bquest/2001/swot2.htm - accessed 15th    September 2008.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;S.F. Lee, K.K. Lo, Ruth F. Leung, Andrew Sai On Ko (2000), Strategy    formulation framework for vocational education: integrating SWOT    analysis, balanced scorecard, QFD methodology and MBNQA education    criteria, Managerial Auditing Journal Vol 15 (8), pp407-423.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Menon, A. et al. (1999), “Antecedents and Consequences of Marketing   Strategy Making,” Journal of Marketing, 63, 18-40.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Piercy, N. and Giles, W. (1989) Making SWOT Analysis Work  Journal of    Marketing Intelligence &amp;amp; Planning, Vol 7, Issue 5/6, P 5-7.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Panagiotou, G. (2003) Bringing SWOT into Focus, Business Strategy   Review, Vol 14, Issue 2, pp8-10.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Shinno, H., Yoshioka, S., Marpaung, S., and Hachiga, S. (2006),    Qualitative SWOT analysis on the global competiveness of machine tool    industry, Journal of Engineering Design, Vol 17, No.3, June 2006,    pp251-258.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Tiles, S. (1968), Making Strategy Explicit, in I. Ansoff (ed),  Business   Strategy, Penguin.  Turner, S. (2002), Tools for Success: A  Manager’s Guide. London:   McGraw-Hill.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Valentin, E.K. (2001), SWOT analysis from a resource-based view  - journal of marketing theory and practice, 9(2): 54-68.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Wheelan, T.L. and Hunger, J.D. (1998), Strategic Management and Business   Policy, 5th Edition, Addison-Wesley, Reading, MA.&lt;/div&gt;&lt;div style="color: #cc0000; text-align: justify;"&gt;Weihrich, H. (1982). The Tows Matrix – a Tool for Situational Analysis,   Long Range Planning, April (60).&lt;/div&gt;&lt;div class="clearer" style="color: #cc0000; text-align: justify;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Marketing Acronyms and Terms</title><link>http://pp-eye.blogspot.com/2012/01/marketing-acronyms-and-terms.html</link><category>Marketing Acronyms and Terms</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 03:40:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-4637021496742126026</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div class="copy fix"&gt;                   &lt;div class="post-header fix post-nothumb"&gt;       &lt;div class="post-title-section fix"&gt;        &lt;div class="post-title fix"&gt;                  &lt;div class="metabar" style="color: #cc0000;"&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;&amp;nbsp;&lt;em&gt;by John                   &lt;/em&gt;&lt;/b&gt;&lt;/span&gt;         &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div id="content_div-174"&gt; &lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;As you explore the world of marketing—and especially online  marketing—you will inevitably run across an alphabet soup of acronyms,  terms, phrases and other jargon that you will need to decipher. Most  seasoned marketers throw these terms around with ease and confidence,  forgetting that up-and-coming marketers may not be as familiar with  them. And most junior marketers are unwilling to admit they are in the  dark about terminology, so they suffer in silence. To help new marketers  decipher this alphabet soup of terminology, and refresh senior  marketers’ memories of what the terms actually mean, I’ve put together a  list of some acronyms and terms below. Of course this is not meant as  an exhaustive list, so feel free to add some of your own terms in the  comment section.&lt;/div&gt;&lt;div style="text-align: center;"&gt;&lt;img alt="Marketing Acronym Translator" class="aligncenter" height="313" src="http://www.johnmossmarketing.com/images/marketing_acronyms/acronym_translator_cartoon.jpg" title="Marketing Acronym Translator" width="400" /&gt;&lt;/div&gt;&lt;span id="more-174"&gt;&lt;/span&gt;&lt;br /&gt;
&lt;h1 style="color: #cc0000;"&gt;Glossary of Marketing Terms&lt;/h1&gt;&lt;br /&gt;
&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Above the fold:&lt;/strong&gt; Refers to any information or content  that appears at the top of a web page or other marketing piece. The  point of origin for this phrase comes from newspapers, and it referred  to content above the fold running through the middle of the page.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Adsense:&lt;/strong&gt; Google’s contextual advertising program. You can incorporate Adsense into your own site to generate advertising revenue.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Adwords:&lt;/strong&gt; Google’s Pay Per Click advertising program.  You can use this program to advertising your offering and drive traffic  to your site.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Affiliate:&lt;/strong&gt; Someone who resells a company’s product/services. Affiliates typically do not handle the product/service,  but rather help in the advertising. Affiliates are typically paid for  every buyer (completes a transaction) they refer to a company’s website.  Software programs track every visitor and every sale, allowing  affiliate a way to track their progress online.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Alt Text:&lt;/strong&gt; Also known as alternative text, Alt Text  is text used to describe images and links in the HTML code of a webpage  or email. If someone has the images turned off in their web browser, alt  text that will appear in place of the image. (Also referred to as Tool Tips.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;B2B:&lt;/strong&gt; &lt;em&gt;Business to Business.&lt;/em&gt; Refers to a business marketing to another business, rather than directly to consumers.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;B2C:&lt;/strong&gt; &lt;em&gt;Business to Consumer.&lt;/em&gt; Refers to businesses marketing directly to end-user consumers.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;B2G:&lt;/strong&gt; &lt;em&gt;Business to Government.&lt;/em&gt; Refers to  businesses marketing to government entities and/or agencies (federal,  state and local). Similar to B2B marketing, but may involve a more  bureaucratic sales process and several layers of approvals.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Backlinks:&lt;/strong&gt; Links on other sites/pages that refer  back to your site/page. Backlinks from sites, especially highly ranked  and trafficked sites, help your own page rank and drive traffic to your  site.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Below the Fold:&lt;/strong&gt; Any content that appears at the bottom of a webpage, requiring the user to scroll down, or at the bottom of a marketing piece.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CMS:&lt;/strong&gt; &lt;em&gt;Content Management System.&lt;/em&gt; A program  or application that allows non-technical users edit, update, maintain  and create a websites, webpages and content using built-in templates.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Contextual Advertising:&lt;/strong&gt; Online ads targeted directly  toward the individual user visiting a web page. Contextual advertising  systems scan the content of a site/webpage, determine what the page is  about, and then display topical ads related to the content.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Cookie:&lt;/strong&gt; A unique code or file automatically embedded  within a visitor’s web browser. A cookie allows a website to track that  visitor during his current visit and any subsequent visits.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CPA:&lt;/strong&gt; &lt;em&gt;Cost Per Action/Acquisition.&lt;/em&gt; Cost an  advertiser incurs for each specific action a visitor takes in response  to an ad. This commonly includes subscribing to a newsletter, requesting  a free trial, requesting more information of a sales-call follow-up, or  even making a purchase. It doesn’t matter how many people see your ad  or click on it. You pay for the number of people who complete the action  you determine, leading to an acquisition. (Sometimes referred to as  PPA, Pay Per Action/Acquisition.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CPC:&lt;/strong&gt; &lt;em&gt;Cost Per Click.&lt;/em&gt; This is the cost to an  advertiser for each click on a link by a site visitor, search engine  user or even a newsletter reader. Many search networks/engines, such as  Google, use this model to generate revenue from advertisers. With this  setup, you only pay a set cost for every click recorded, regardless of  the number impressions. (Sometimes referred to as PPC, Pay Per Click.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CPL:&lt;/strong&gt; &lt;em&gt;Cost Per Lead&lt;/em&gt;. This is usually an  internally defined metric that measures the marketing expenditure needed  to obtain each new sales lead. Comparing CPL between marketing  activities is a good way to gauge the effectiveness of how you are  dedicating resources. (Sometimes referred to as PPL, Pay Per Lead.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CPM:&lt;/strong&gt; &lt;em&gt;Cost Per Mille (Thousand).&lt;/em&gt; This is the amount charged for every 1,000 impressions of an ad. With this model, you pay a set price for every 1,000 impressions, regardless of how many clicks are recorded. (Sometimes referred to as PPM, Pay Per Mille.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CPS:&lt;/strong&gt; &lt;em&gt;Cost Per Sale.&lt;/em&gt; This is a broad  internal metric generated by dividing costs (usually marketing related)  by sales revenue generated to determine the cost to make each sale. This  metric is great at determining the effectiveness and efficiency of your  sales process.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CR:&lt;/strong&gt; &lt;em&gt;Conversion Rate/Ratio.&lt;/em&gt; The percentage  of prospects who complete a desired action (make a purchase, subscribe  to a newsletter, etc.). Usually the higher the CR, the better.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CRM:&lt;/strong&gt; &lt;em&gt;Customer Relationship Management/Manager.&lt;/em&gt;  Involves improving customer interactions by better understanding their  needs and wants, as well as their history and behaviors. Also sometimes  refers to software or systems that track customer interactions with the  aim of increasing sales, customer satisfaction and customer loyalty (and  therefore increasing profits).&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CSS:&lt;/strong&gt; Cas&lt;em&gt;cading Style Sheets.&lt;/em&gt; Used in conjunction with (and sometimes in place of) HTML to render webpages and emails. CSS helps make designs more flexible and can result in reduced HTML file sizes.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;CTR:&lt;/strong&gt; &lt;em&gt;Click-Through Rate/Ratio.&lt;/em&gt; Percentage of visitors/users who click on a link.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Cyber Squatting:&lt;/strong&gt; A practice of registering a domain  name with the sole intent of selling it to someone else who may actually  want to use the domain for a website. Some cyber squatters register  domain names of known or new trademarks, hoping to sell those domain  names to the trademark owner. Others simply register many domain names  using commonly used words and terms at a very low cost, and then wait  for someone to buy it.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Dead Link:&lt;/strong&gt; A link that no longer works.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;DM:&lt;/strong&gt; &lt;em&gt;Direct Marketing.&lt;/em&gt; A type of advertising meant to elicit an action (place  an order, visit a store/website, request further information) in  response to a communication from the marketer. The communication itself  could be in a variety of formats, including traditional mail,  telemarketing, e-mail, infomercials and point-of-sale (POS) displays.  Customer response to the campaign is usually measurable. (Also referred  to as Direct Mail or Direct Response.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;FAQs:&lt;/strong&gt; &lt;em&gt;Frequently Asked Questions.&lt;/em&gt; Often used as the webpage title of answers to commonly asked questions about an offering or company.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;HTML:&lt;/strong&gt; &lt;em&gt;HyperText Markup Language.&lt;/em&gt; HTML is the set of symbols/codes/tags that tell a browser how to display content on the web.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;IM:&lt;/strong&gt; &lt;em&gt;Instant Messaging.&lt;/em&gt; A communication  vehicle that enables a kind of private chat room with another individual  or group in real time. It’s similar to a telephone conversation but  uses text-based communication.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;POS:&lt;/strong&gt; &lt;em&gt;Point of Sale.&lt;/em&gt; A place where a sale is made. Commonly a business, place or display where an offering can be purchased. (Also called Point of Purchase.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;PR:&lt;/strong&gt; &lt;em&gt;Page Rank.&lt;/em&gt; An assessment by a search  engine, such as Google or Yahoo, of a website’s or webpage’s relevance  to a specific term/subject and possibly its popularity&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;PR:&lt;/strong&gt; &lt;em&gt;Press Release.&lt;/em&gt; A public relations announcement about a product,  service or company issued to the news media and other targeted  recipients for the purpose of drawing public attention to the subject  and letting the public know of new developments. (Also called a News  Release.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;PV:&lt;/strong&gt; &lt;em&gt;Page View.&lt;/em&gt; A measure of each time a user visits a webpage. (Also written Pageview.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;ROI:&lt;/strong&gt; &lt;em&gt;Return on Investment.&lt;/em&gt; This refers to  how much profit is made after all applicable costs have been accounted  for. ROI can be calculated for a business as a whole, or it can be  calculated for specific activities, divisions, etc. From a marketing  perspective, this is a commonly used metric that gauges the  effectiveness of a marketing campaign.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;RON:&lt;/strong&gt; &lt;em&gt;Run of Network.&lt;/em&gt; This is an arrangement  with an ad network to have your ad placed throughout all websites  within the network. Ad networks are basically a collection of websites  that provide ad space. Websites join ad networks to sell ad space  because they do not enjoy the economies of scale networks do in dealing  with ad sales, metrics, reporting, customer service, etc., to their  advertisers. Instead they contract their ad space to a network. Often  RON is cheaper than having your ad placed on selected sites.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;ROS:&lt;/strong&gt; &lt;em&gt;Run of Site.&lt;/em&gt; Similar to ROS, but ads  rotate across the pages of a single site instead of an entire network.  This is usually cheaper than having your ad placed on select pages.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;RSS:&lt;/strong&gt; &lt;em&gt;Really Simple Syndication/RDF Site Summary/Rich Site Summary.&lt;/em&gt;  Acronym used to describe a method of web content syndication. RSS is  XML based and allows publishers to distribute their content, which can  then be read by an RSS reader, on another website or even through mobile  applications.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;SEM:&lt;/strong&gt; &lt;em&gt;Search Engine Marketing.&lt;/em&gt; Marketing  tactic similar to SEO that stresses the importance of search engines and  search engine rankings to drive traffic to a website.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;SEO:&lt;/strong&gt; &lt;em&gt;Search Engine Optimization.&lt;/em&gt; The process of optimizing webpages and websites for high rankings in search engine results in order to attract more visitors.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;SERP:&lt;/strong&gt; &lt;em&gt;Search Engine Results Page.&lt;/em&gt; Page of results displayed after a successful search engine query.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;SMM:&lt;/strong&gt; &lt;em&gt;Social Media Marketing.&lt;/em&gt; The process of  generating interest and excitement in an offering through various  online social outlets, such as blogs, RSS feeds and social networks.  Programs usually center on creating content that attracts attention,  generates online conversations and encourages readers to share it with  their own social networks. The message spreads from user to user and  hopefully resonates since it is coming from a trusted source as opposed  to the brand or company itself. (Also referred to as Social Media  Optimization.)&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;USP:&lt;/strong&gt; &lt;em&gt;Unique Selling Proposition.&lt;/em&gt; The reason somebody should buy from you and not competitors. It is the unique set of benefits your product/service offers consumers.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;VOD:&lt;/strong&gt; &lt;em&gt;Video On Demand.&lt;/em&gt; Systems that allow  users to select and watch/listen to video content on demand to an  individual web browser, TV, handheld or other device whenever the user  requests it.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;WOMM:&lt;/strong&gt; &lt;em&gt;Word Of Mouth Marketing.&lt;/em&gt; A form of  viral marketing similar to Social Media Marketing that involves the  passing of information from person to person. Originally the term  referred specifically to oral communication, but has come to include any  form of human communication, such as face to face, telephone, email and  text messaging.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;WYSIWYG:&lt;/strong&gt; &lt;em&gt;What You See Is What You Get.&lt;/em&gt; A  website editor that converts your text, image and graphic layout into  HTML while displaying the content exactly as it will be seen by the end  user. Most Content Management Systems utilize a WYSIWYG editor.  Pronounced “Whizzy-Wig.”&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;XML:&lt;/strong&gt; &lt;em&gt;Extensible Markup Language.&lt;/em&gt; A generic  format intended for maximum flexibility that provides information in a  wide variety of structural formats. A variety of XML formats exist for  different applications, including RSS. Unlike HTML, XML is extensible,  meaning authors can create their own elements and attributes.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Definition of Marketing</title><link>http://pp-eye.blogspot.com/2012/01/definition-of-marketing.html</link><category>Definition of Marketing</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 03:34:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-6251794834255985718</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;                                 &lt;br /&gt;
&lt;div id="content_div-68" style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;div style="color: #cc0000;"&gt;&lt;b&gt;&amp;nbsp;&lt;em&gt;by John                   &lt;/em&gt;&lt;/b&gt;&lt;/div&gt;&lt;div class="copy fix"&gt;&lt;div class="post-header fix post-nothumb"&gt;&lt;div class="post-title-section fix"&gt;&lt;div class="post-title fix"&gt;&lt;div class="metabar" style="color: #cc0000;"&gt;         &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br /&gt;
“Marketing” seems to mean different things to different people. Some think of Ron Popeil  and late-night infomercials, while others may think of the circulars  and coupons they get in their Sunday paper. Many also think of the spam  in their inboxes and the junk mail the mailman delivers every day. In  reality all these views are correct, but marketing is much, much more.&lt;br /&gt;
&lt;br /&gt;
Marketing involves selling products and services, but that doesn’t mean marketing is limited to sales activities. The American Marketing Association defines marketing  as “the activity, set of institutions, and processes for creating,  communicating, delivering, and exchanging offerings that have value for  customers, clients, partners, and society at large.” Sounds impressive,  but what does that really mean? This definition is chocked full of  information, so let’s break down each component of the definition.&lt;br /&gt;
&lt;div style="text-align: center;"&gt;&lt;img alt="The Marketing Process" class="aligncenter" height="336" src="http://www.johnmossmarketing.com/images/definition_of_marketing/marketing_strategy.jpg" title="The Marketing Process" width="347" /&gt;&lt;/div&gt;&lt;span id="more-68"&gt;&lt;/span&gt;&lt;br /&gt;
&lt;strong style="color: #0b5394;"&gt;The Activity&lt;/strong&gt;&lt;br /&gt;
Marketing involves activity. That sounds obvious, but it is important to remember that marketing &lt;span style="text-decoration: underline;"&gt;is not&lt;/span&gt;  passive; It requires active participation on the part of the marketer.  It may sound like this active participation means solely promoting your product or service, but it really means employing the entire marketing mix (product, price, place and promotion), plus some of the legwork that goes into implementing the mix, such as market research, financial planning, strategy, etc.&lt;br /&gt;
&lt;br /&gt;
&lt;strong style="color: #0b5394;"&gt;Set of Institutions&lt;/strong&gt;&lt;br /&gt;
Even the best salesperson in the world knows that marketing is a group  effort that involves a variety of individuals and groups, internal and  external to his organization. From an overall perspective marketing  involves many institutions/groups, such as market researchers,  advertising agencies, sales support, research and development, financial  forecasting, distributors, etc. A key to good marketing is being able  to manage and coordinate all these institutions and groups.&lt;br /&gt;
&lt;div style="color: #0b5394;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;strong style="color: #0b5394;"&gt;Processes&lt;/strong&gt;&lt;br /&gt;
Marketing has to be process driven. While flying by the seat of your  pants may sound like fun to some people and may even work for the short  term, eventually it will land you in trouble. Without processes in  place, you will not be able to plan effectively, determine what is  working or not working, figure out which efforts have a positive or  negative effect on sales or even learn from your successes and mistakes.  To do all this, you really need a mapped-out process that can be honed  and replicated.&lt;br /&gt;
&lt;br /&gt;
&lt;strong style="color: #0b5394;"&gt;Creating&lt;/strong&gt;&lt;br /&gt;
Marketing is an innovative field that attracts very creative people.  Marketing ideas and strategies are limited only by your imagination, and  we see this high level of creativity in action every day. I have always  respected an artist who can make his audience feel a certain emotion or  understand a certain idea or point of view. But I admire a marketer who  can make his audience &lt;em&gt;act&lt;/em&gt; even more. Understanding and feeling  are just the first steps for a marketer, while mobilizing toward action  is what really counts. This is true creative power in action.&lt;br /&gt;
&lt;br /&gt;
&lt;strong style="color: #0b5394;"&gt;Communicating&lt;/strong&gt;&lt;br /&gt;
If a tree falls in the forest, but no one is around to hear it fall,  does it make a sound? This philosophical question mirrors a problem  marketers face; You may have the best product or service in the world, but if you don’t communicate the benefits and features of that product  or service well to the right audience (and not necessarily only through  advertising) how is the world going to find out about it? Communication  is important to marketing your product  or service, and this communication can come in many forms, from overt  advertisements and promotions to more subtle activities such as the  effectiveness of your supply/value chain and branding.&lt;br /&gt;
&lt;br /&gt;
&lt;strong style="color: #0b5394;"&gt;Delivering&lt;/strong&gt;&lt;br /&gt;
Again this seems obvious, but marketing isn’t just selling a product  or service. In essence it is delivering on the promise created by your  marketing mix. It is your job to accurately describe that brand promise,  and if you fail to deliver on that promise, you have failed as a  marketer. At the very least you need to deliver what you promise, but a  smart marketer over delivers to delight and wow his customers.&lt;br /&gt;
&lt;br /&gt;
&lt;strong style="color: #0b5394;"&gt;Exchanging Offerings That Have Value&lt;/strong&gt;&lt;br /&gt;
You provide customers value in the form of features and benefits  delivered by your products and services. In return you demand value,  usually in the form of financial payment. Only an unethical marketer  would expect to receive value for something of no value. And only an  ineffective marketer would deliver value yet not receive appropriate  value in exchange. One of the roles of a marketer is to determine the  fair value of the product/service he is marketing. He must then go about exchanging that product/service for the appropriate value.&lt;br /&gt;
&lt;br /&gt;
&lt;strong style="color: #0b5394;"&gt;Customers, Clients, Partners, and Society at Large&lt;/strong&gt;&lt;br /&gt;
Marketers must satisfy these constituents by marketing products and  services so that they fulfill customer needs/wants and attain their  clients’/partners’ goals. There is also an ethical question about the  role of the marketer to “protect” society at large by refusing to  misrepresent features/benefits or hide the negative aspects of a product or service. True marketers think of long-term, strategic goals, and trying to “make a quick buck” at the expense of others is &lt;span style="text-decoration: underline;"&gt;not&lt;/span&gt; how you attain these objectives.&lt;br /&gt;
&lt;br /&gt;
In conclusion, “marketing” seems to mean different things to  different people, but in reality marketing is a complex and robust  activity that encompasses many different skills, competencies and  people. It is a very exciting and rewarding field that offers a marketer  the chance to explore his own interests and develop strengths in areas  he may have never considered.&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>What is Marketing? What is PR?</title><link>http://pp-eye.blogspot.com/2012/01/what-is-marketing-what-is-pr.html</link><category>What is Marketing? What is PR?</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 03:29:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-1050375452477121669</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;h3&gt;&lt;/h3&gt;&lt;table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style="text-align: center;"&gt;&lt;a href="http://managementhelp.org/blogs/wp-content/themes/hybrid-managementhelp-sub-blog/images/headshots/Lisa-Chapman.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"&gt;&lt;img border="0" height="196" src="http://managementhelp.org/blogs/wp-content/themes/hybrid-managementhelp-sub-blog/images/headshots/Lisa-Chapman.jpg" width="200" /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="color: #cc0000; font-family: Verdana,sans-serif;"&gt;&lt;td class="tr-caption" style="text-align: center;"&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;Lisa Chapman&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;You’ve likely heard it before – in the digital world, “The lines have blurred between Marketing and PR.”&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;What does that mean? How have the lines blurred? &lt;/div&gt;&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;The OLD Rules of Marketing&lt;/h3&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The message was delivered ONE-WAY, and CREATIVITY was the secret  sauce that commanded the audience’s attention. Among the fundamental  concepts of the OLD marketing paradigm:&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;Advertising was the core tool&lt;/li&gt;
&lt;li&gt;The advertising message was generally crafted to appeal to the masses&lt;/li&gt;
&lt;li&gt;Advertising INTERRUPTED the audience with a one-way message&lt;/li&gt;
&lt;li&gt;Advertising engaged campaigns for a defined time period&lt;/li&gt;
&lt;li&gt;Creators focused on creativity – and award-winning campaigns&lt;/li&gt;
&lt;li&gt;Advertising and PR were different specialties, run by different people&lt;/li&gt;
&lt;/ul&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;The OLD Rules of PR&lt;/h3&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The ultimate goal: Spin a press release to capture reporters’  attention, then get a clip of the story, to show that the message was  viewed by the audience.&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;Media comprised the toolbox, in order to get the message out&lt;/li&gt;
&lt;li&gt;A press release was the core tool&lt;/li&gt;
&lt;li&gt;Only significant news commanded the attention of the media&lt;/li&gt;
&lt;li&gt;It was all in “the spin” (or HYPE!)&lt;/li&gt;
&lt;li&gt;Quotes from third parties were an important element of a press release&lt;/li&gt;
&lt;li&gt;Press releases were meaningless unless a reporter decided that it was worthy of a story&lt;/li&gt;
&lt;/ul&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;The NEW Rules of Marketing and PR&lt;/h3&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Since the internet is now one huge publisher, ANYONE can learn how to  create compelling messages and publish them. Getting found online is  the science and art. A few of the new rules include:&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;People don’t want “spin” – they want authenticity&lt;/li&gt;
&lt;li&gt;People don’t want to be interrupted anymore (it’s now called SPAM)&lt;/li&gt;
&lt;li&gt;People don’t want to be ‘told’ (push marketing), they want to be heard&lt;/li&gt;
&lt;li&gt;People want VALUE (content), which develops relationship and trust&lt;/li&gt;
&lt;li&gt;Marketing and PR can reach niche audiences online in a wider variety of ways&lt;/li&gt;
&lt;li&gt;Content is KING, and stays online, with no end to the campaign&lt;/li&gt;
&lt;/ul&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;The New TOOLS of Marketing and PR&lt;/h3&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;It’s no longer TV, radio, newspapers, magazines, direct mail, etc.  Meaningful, valuable CONTENT is the vehicle that captures audiences’  attention. It is now found on:&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;Websites&lt;/li&gt;
&lt;li&gt;Blogs&lt;/li&gt;
&lt;li&gt;Microblogs (Tweets)&lt;/li&gt;
&lt;li&gt;Social Media platforms (Facebook.com, Myspace.com, etc)&lt;/li&gt;
&lt;li&gt;Article Directories&lt;/li&gt;
&lt;li&gt;Videos&lt;/li&gt;
&lt;li&gt;Podcasts&lt;/li&gt;
&lt;li&gt;Etc, etc etc!&lt;/li&gt;
&lt;/ul&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>10 Marketing Musts</title><link>http://pp-eye.blogspot.com/2012/01/10-marketing-musts.html</link><category>10 Marketing Musts</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 03:23:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-5715889959000567686</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;h1&gt;&lt;/h1&gt;&lt;div class="deck" style="color: #cc0000; text-align: justify;"&gt;&lt;span style="font-size: large;"&gt;Are you are spending enough time and money marketing  your business? If not,you are ignoring a critical success component.  Customize these ideas to work for you and enjoy increased revenue in  2012!&lt;/span&gt;&lt;/div&gt;&lt;div class="byline"&gt;&lt;br /&gt;
&lt;img class="authorimage" src="http://www.inc.com/uploaded_files/image/100x100/Marla_Tabaka_bkt_8706.jpg" style="float: left; height: 100px; width: 100px;" /&gt;  &lt;br /&gt;
&lt;h3 class="articleauthorname" style="color: #0b5394; font-family: arial; font-size: 24px; font-weight: normal; margin-bottom: 10px; margin-left: 120px; margin-top: 0px;"&gt;Marla Tabaka&lt;/h3&gt;&lt;div class="articleauthorblurb" style="color: #0b5394; font-size: 13px; line-height: 17px; margin-left: 120px; margin-top: 0px; text-align: justify;"&gt;Marla Tabaka is a life and business coach  who helps entrepreneurs and owners of small businesses grow their  companies faster. She serves as a Success Coach for Make Mine a Million  and helps award recipients grow their businesses to $1 million and  beyond. Marla has 25 years of experience in corporate, start up and  entrepreneurial ventures.&lt;/div&gt;&lt;div class="articleauthorblurb" style="font-size: 13px; line-height: 17px; margin-left: 120px; margin-top: 0px;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class="articleauthorblurb" style="font-size: 13px; line-height: 17px; margin-left: 120px; margin-top: 0px;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class="articleauthorblurb" style="font-size: 13px; line-height: 17px; margin-left: 120px; margin-top: 0px;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/div&gt;&lt;div id="articlespacer" style="height: 1px; width: 1px;"&gt;&lt;/div&gt;&lt;div id="incsharebox" style="background-color: white; border: 1px solid rgb(204, 204, 204); color: #666666; float: left; font-family: arial,helvetica; font-size: 11px; left: 50%; margin-left: -575px; margin-top: 10px; position: fixed; text-align: center; top: 0px; width: 66px;"&gt;&lt;div style="margin: 5px;"&gt;&lt;span class="IN-widget" style="display: inline-block; line-height: 1; text-align: center; vertical-align: baseline;"&gt;&lt;span style="display: inline-block ! important; font-size: 1px ! important; margin: 0pt ! important; padding: 0pt ! important; text-indent: 0pt ! important; vertical-align: baseline ! important;"&gt;&lt;span class="IN-top" id="li_ui_li_gen_1325629175822_1-container"&gt;&lt;span class="IN-top" id="li_ui_li_gen_1325629175822_1"&gt;&lt;span class="IN-top" id="li_ui_li_gen_1325629175822_1-inner"&gt;&lt;span class="IN-top" id="li_ui_li_gen_1325629175822_1-content"&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;
&lt;span style="display: inline-block ! important; font-size: 1px ! important; margin: 0pt ! important; padding: 0pt ! important; text-indent: 0pt ! important; vertical-align: baseline ! important;"&gt;&lt;span id="li_ui_li_gen_1325629175804_0"&gt;&lt;a href="http://www.blogger.com/post-create.g?blogID=6941439556922516488" id="li_ui_li_gen_1325629175804_0-link"&gt;&lt;span id="li_ui_li_gen_1325629175804_0-logo"&gt;in&lt;/span&gt;&lt;span id="li_ui_li_gen_1325629175804_0-title"&gt;&lt;span id="li_ui_li_gen_1325629175804_0-mark"&gt;&lt;/span&gt;&lt;span id="li_ui_li_gen_1325629175804_0-title-text"&gt;Share&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;                  &lt;span class="tb"&gt;&lt;a href="http://twitter.com/share?url=http%3A%2F%2Fwww.inc.com%2Fmarla-tabaka%2F10-marketing-musts.html%3Futm_source%3Dtwitter%26utm_medium%3Dsocialmedia%26utm_campaign%3Dbutton&amp;amp;text=10+Marketing+Musts&amp;amp;related=marlatabaka:Marla+Tabaka&amp;amp;via=IncMagazine" target="_blank"&gt;Tweet&lt;/a&gt;&lt;/span&gt;                                            &lt;a href="http://www.inc.com/marla-tabaka/10-marketing-musts_Printer_Friendly.html" rel="nofollow" target="_blank"&gt;&lt;img src="http://www.inc.com/images/print.gif" /&gt;&lt;/a&gt;          &lt;a href="http://www.inc.com/marla-tabaka/10-marketing-musts.html#" id="share"&gt;&lt;img src="http://www.inc.com/images/email.gif" /&gt;&lt;/a&gt;                &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Small business owners and solo-practitioners are notorious for  ignoring marketing efforts. It's easy to do, isn't it? You are ensconced  in your business; serving clients, shipping product and doing what you  need to do to keep the money flowing in. But if you are not spending  time and money to market your business, then you are ignoring a critical  success component. &lt;br /&gt;
&lt;br /&gt;
If you are concerned about making time to market then download my audio and workbook on Increasing Productivity by 40%.  Almost anyone can increase the amount of available time in their  schedule by eliminating certain mistakes and behavior. This is your  first step.&lt;br /&gt;
&lt;br /&gt;
Begin by investing 10 – 20% of your time in  marketing. You can split this time into 2 hour segments during each day  or set aside a day for marketing. You may feel concerned about losing  revenue if you do this, but revenues will increase as you invest more of  your time and resources into your plan – it's a natural cycle.&amp;nbsp; Here  are some guidelines and ideas; customize them to work for you!&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;1.&amp;nbsp;Create a plan.&lt;/b&gt;  This does not have to be an intimidating process. You know what efforts  have garnered clients in the past. List them and expand on them. A  simple marketing plan includes a list of marketing practices and a  timeline. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;2.&amp;nbsp;Face-to-face networking.&lt;/b&gt; On-line businesses  benefit most significantly from social networking, search engine  optimization and pay per click campaigns, but most solopreneurs will  benefit by creating relationships off line- regardless of the type of  business you run. To meet like-minded people go to classes, lectures and  other events that interest you. Keep your eyes and ears open at the  grocery store, coffee house and other local establishments. Look into  your local Chamber of Commerce and networking groups to see if those are  up your alley as well.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;3.&amp;nbsp;Cold Calling.&lt;/b&gt; I know, yuck!  Here's how I look at it. I love meeting new people. I call with the  intent of having a nice conversation with someone new, and I've met the  most amazing people! You can buy a list or hire a college student, bring  on an intern, or have your virtual assistant compile a list for you.  Begin by writing a script and giving intention to your call. Know what  you wish to achieve; a face-to-face visit, permission to send  information, to close the sale or send a free sample.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;4.&amp;nbsp;Telemarketing.&lt;/b&gt;  If cold calling on your own is not an option, consider hiring a  professional telemarketing firm.&amp;nbsp; A few hours a week can garner one or  two solid leads for you. Depending on your business, this is a simple  and sure way to increase revenues.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;5.&amp;nbsp;Social Media.&amp;nbsp;&lt;/b&gt; A  good networker doesn't walk into a room and hand out 20 business cards,  tell everyone about himself and leave. They are there to build  relationships. It's the same in social media. Ask questions, express  interest, get to know people. This is a long term investment and you  won't be sorry. Great relationships, business and personal, are built  this way.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;6.&amp;nbsp;Podcasting.&lt;/b&gt; This intimidates and confuses  some people, but once you research how to create your own podcast you  will be amazed at how easy it is. Having your own podcast puts you in  the position of the “expert' and also helps you to expand your horizons.  My two shows have contributed to my growth and brought people into my  life who are truly important to me. Promote your show via social media,  your list, iTunes, in your blog and via your guests' lists. Create special offers to bring traffic to your site and to build your list.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;7.&amp;nbsp;Guest blogging and inviting guest bloggers.&lt;/b&gt;  If you are not blogging yet, do. This again, is a long term investment –  you probably won't see results right away, but they will come. Comment  on other blogs and contact popular bloggers who also target your  audience with ideas for their blog, offering to write for them.&amp;nbsp; You  will gain subscribers and expand your audience. After you build your  following invite popular bloggers to do a guest post on your blog. They  will bring followers, many of whom will stay.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;8.&amp;nbsp;Follow up with your list and past clients.&lt;/b&gt;  This one seems obvious but it's often neglected. When a new client  comes to me with cash flow problems this is the first area we look at.  There is much untapped business with existing customers, past clients  and prospects. What can you upsell? What special offers can you promote?  How can you recreate yourself or your product to spark new interest?&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;9.&amp;nbsp;Ask for referrals. &lt;/b&gt;Many  solo-practitioners hesitate to ask for referrals. We tend to assume  that if our clients like what we do for them they will spread the word.  Not always so.&amp;nbsp; If you recruit the assistance of your happy clients your  practice will grow. Supply them with materials to forward or hand to  their friends and family. Make it easy for people to spread the word  about you. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;10.&amp;nbsp;Be consistent in your message.&lt;/b&gt; It may take  time for your marketing efforts to have an impact and prompt a  significant response. People sometimes say “I've been following you for  years….' and we wonder what took them so long to act. We all have  different “buy' triggers and have to be in the right place emotionally  and financially before we buy. Market frequently and be consistent in  your key message. &lt;br /&gt;
&lt;br /&gt;
What's worked for you? What hasn't worked? How  consistent are you in your marketing? What frustrates you the most?  What do you enjoy the most about marketing? Share your insights and  experiences with us here!&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Get Everyone on Your Marketing Team – 3 Steps</title><link>http://pp-eye.blogspot.com/2012/01/get-everyone-on-your-marketing-team-3.html</link><category>Get Everyone on Your Marketing Team – 3 Steps</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 03:18:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-587794071795740325</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div class="headline_area"&gt;      &lt;h1 class="entry-title"&gt;&lt;/h1&gt;&lt;/div&gt;&lt;table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style="text-align: center;"&gt;&lt;img alt="Turn Your Staff and Board into a Marketing Team" class="alignright" height="320" src="http://www.nonprofitmarketingguide.com/images/lc/teamwork200.jpg" style="margin: 10px auto;" title="Turn Your Staff and Board into a Marketing Team" width="320" /&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="color: #38761d;"&gt;&lt;td class="tr-caption" style="text-align: center;"&gt;&lt;div class="headline_meta"&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;by &lt;span class="author vcard fn"&gt;Kivi Leroux Miller&lt;/span&gt; on &lt;abbr class="published" title="2011-02-28"&gt;February 28, 2011&lt;/abbr&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="headline_meta"&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;in &lt;span&gt;Nonprofit Communications,Nonprofit Marketing Strategy&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;On Tuesday, I’m presenting the webinar, Turning Your Whole Staff and Board into an Effective Marketing Team.  &amp;nbsp;Nonprofit marketers and fundraisers are overwhelmed and overworked.  The best way to solve that problem is to get some help with your to-do  list. The natural place to look for help is among your current staff and  board. But they’re busy too, right?&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Of course they are. But there are some very simple things you can do  to turn them into a marketing team, whether they know it or not, without  really increasing their workload.&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The reality is that they are&lt;em&gt; already &lt;/em&gt;marketing for you every  time they talk about work, inside and outside the office. All you have  to do is help them do that better.&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Start with a simple three-step approach:&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #38761d; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;1. Train Them.&lt;/strong&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Show them what you mean by marketing by starting with the  conversations they are already having. Some people refer to this as the  elevator pitch, but it’s just as likely to be the “on the train” pitch  or the “happy hour” pitch. Ask people to share how they talk about the  place they work (or volunteer) when they are with friends and family.  How do they explain their jobs? Go from there.&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #38761d; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;2. Encourage Them. &lt;/strong&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Make it easy to do the right thing. Use technology tools like shared  calendars so they know what’s coming up next and marketing banks so they  know exactly where to go for your logo files. Give them lots of  examples of what you consider good marketing and bad (“Check out this  post on Facebook . . . you could do that” or “Let’s try to avoid getting  ourselves into these kinds of debates on Twitter.”)&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #38761d; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;3. Appreciate Them. &lt;/strong&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Make praising the small victories a regular part of your routine (I  call this “blowing kisses”). Celebrate things like someone sharing a  great client story with you (even if you had to clean it up in order to  actually use it) or someone meeting one of your deadlines for submitting  ideas for the newsletter. Have some fun with it.&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Basic Definitions: Advertising  Marketing Promotion  Public Relations and Publicity  and Sales</title><link>http://pp-eye.blogspot.com/2012/01/basic-definitions-advertising-marketing.html</link><category>Basic Definitions: Advertising  Marketing Promotion  Public Relations and Publicity  and Sales</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 03:12:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-8558770785981933172</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style="text-align: center;"&gt;&lt;a href="http://refipost.com/wp-content/uploads/2009/06/help-definition.png" imageanchor="1" style="margin-left: auto; margin-right: auto;"&gt;&lt;img border="0" height="320" src="http://refipost.com/wp-content/uploads/2009/06/help-definition.png" width="320" /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="color: #0b5394;"&gt;&lt;td class="tr-caption" style="text-align: center;"&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;by Carter McNamara, MBA, PhD&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;h1&gt;&lt;/h1&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;It's easy to become confused about these terms: advertising, marketing, promotion, public relations and publicity, and sales. The terms are often used interchangeably. However, they refer to different -- but similar activities. Some basic definitions are provided below. A short example is also provided hopefully to help make the terms more clear to the reader.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h2 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;One Definition of Advertising&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Advertising is bringing a product (or service) to the attention of potential and current customers. Advertising is focused on one particular product or service. Thus, an advertising plan for one product might be very different than that for another product. Advertising is typically done with signs, brochures, commercials, direct mailings or e-mail messages, personal contact, etc.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h2 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;One Definition of Promotion&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Promotion keeps the product in the minds of the customer and helps stimulate demand for the product. Promotion involves ongoing advertising and publicity (mention in the press). The ongoing activities of advertising, sales and public relations are often considered aspects of promotions.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h2 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;One Definition of Marketing&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Marketing is the wide range of activities involved in making sure that you're continuing to meet the needs of your customers and getting value in return. Marketing is usually focused on one product or service. Thus, a marketing plan for one product might be very different than that for another product. Marketing activities include "inbound marketing," such as market research to find out, for example, what groups of potential customers exist, what their needs are, which of those needs you can meet, how you should meet them, etc. Inbound marketing also includes analyzing the competition, positioning your new product or service (finding your market niche), and pricing your products and services. "Outbound marketing" includes promoting a product through continued advertising, promotions, public relations and sales.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h2 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;One Definition of Public relations&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Public relations includes ongoing activities to ensure the overall company has a strong public image. Public relations activities include helping the public to understand the company and its products. Often, public relations are conducted through the media, that is, newspapers, television, magazines, etc. As noted above, public relations is often considered as one of the primary activities included in promotions.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h2 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;One Definition of Publicity&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Publicity is mention in the media. Organizations usually have little control over the message in the media, at least, not as they do in advertising. Regarding publicity, reporters and writers decide what will be said.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h2 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;One Definition of Sales&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Sales involves most or many of the following activities, including cultivating prospective buyers (or leads) in a market segment; conveying the features, advantages and benefits of a product or service to the lead; and closing the sale (or coming to agreement on pricing and services). A sales plan for one product might be very different than that for another product.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h2 style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;An Example of the Definitions&lt;/h2&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The following example may help to make the above five concepts more clear. I recently read that the story comes from the &lt;i&gt;Reader's Digest&lt;/i&gt;, a quote found in "Promoting Issues and Ideas" by M. Booth and Associates, Inc. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;"... if the circus is coming to town and you paint a sign saying 'Circus Coming to the Fairground Saturday', that's &lt;b&gt;advertising&lt;/b&gt;. If you put the sign on the back of an elephant and walk it into town, that's &lt;b&gt;promotion&lt;/b&gt;. If the elephant walks through the mayor's flower bed, that's &lt;b&gt;publicity&lt;/b&gt;. And if you get the mayor to laugh about it, that's &lt;b&gt;public relations&lt;/b&gt;." If the town's citizens go the circus, you show them the many entertainment booths, explain how much fun they'll have spending money at the booths, answer their questions and ultimately, they spend a lot at the circus, that's &lt;b&gt;sales&lt;/b&gt;.&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Basics -- and Misunderstandings -- About Marketing</title><link>http://pp-eye.blogspot.com/2012/01/basics-and-misunderstandings-about.html</link><category>Basics -- and Misunderstandings - About Marketing</category><author>noreply@blogger.com (Unknown)</author><pubDate>Wed, 4 Jan 2012 03:06:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-8674848986722333216</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style="text-align: center;"&gt;&lt;a href="http://www.rylanclayne.com/wp-content/uploads/2011/03/internet-marketing.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"&gt;&lt;img border="0" height="240" src="http://www.rylanclayne.com/wp-content/uploads/2011/03/internet-marketing.jpg" width="320" /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="color: #cc0000;"&gt;&lt;td class="tr-caption" style="text-align: center;"&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;Carter McNamara, MBA, PhD&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;h2&gt;&lt;br /&gt;
&lt;/h2&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;What is Marketing?&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Before you learn more about marketing in the many links later on below topic,    you should first understand what marketing is, because the topic is so often    misunderstood. Marketing is the wide range of activities involved in making    sure that you're continuing to meet the needs of your customers and are getting    appropriate value in return. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: justify;"&gt;How Marketing is So Misunderstood&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Far too often, organizations try to develop a product to meet customers’    needs without ever really verifying what the customers wanted in the first place.    Instead, those organizations make a strenuous effort to “sell” the    product through rigorous, ongoing advertising, promotions and publicity -- through    "outbound" marketing. These organizations may have built a beautiful    ladder – but it may be entirely on the wrong roof! Far too often, that    lesson comes from painful experience. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Experienced organizations have learned that it is not their opinion that matters    most regarding whether their product is needed or not. The opinion that matters    most is that of the customers. These organizations have learned that they might    not know what they don't know about their customers. That precious knowledge    about the customers comes from "inbound" marketing -- through market    research to clarify customers' needs and what they are willing to do to get    those needs met. If the inbound marketing is done well, the outbound marketing    is particularly easy -- and effective.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: left;"&gt;Inbound Marketing Includes Market Research to Find Out:&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;ol style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;What specific groups of potential customers/clients (markets) might have      which specific needs (nonprofits often already have a very clear community      need in mind when starting out with a new program -- however, the emerging      practice of nonprofit business development, or earned income development,      often starts by researching a broad group of clients to identify new opportunities      for programs)&lt;/li&gt;
&lt;li&gt;How those needs might be met for each group (or target market), which suggests      how a product might be designed to meet the need (nonprofits might think in      terms of outcomes, or changes, to accomplish among the groups of clients in      order to meet the needs)&lt;/li&gt;
&lt;li&gt;How each of the target markets might choose to access the product, etc.      (its "packaging")&lt;/li&gt;
&lt;li&gt;How much the customers/clients might be willing pay and how (pricing analysis)&lt;/li&gt;
&lt;li&gt;Who the competitors are (competitor analysis)&lt;/li&gt;
&lt;li&gt;How to design and describe the product such that customers/clients will      buy from the organization, rather than from its competitors (its unique value      proposition)&lt;/li&gt;
&lt;li&gt;How the product should be identified -- its personality -- to be most identifiable      (its naming and branding)&lt;/li&gt;
&lt;/ol&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;h3 style="color: #cc0000; font-family: Verdana,sans-serif; text-align: left;"&gt;Outbound Marketing Includes:&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;ol style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;Advertising and promotions (focused on the product)&lt;/li&gt;
&lt;li&gt;Sales&lt;/li&gt;
&lt;li&gt;Public and media relations (focused on the entire organization)&lt;/li&gt;
&lt;li&gt;Customer service&lt;/li&gt;
&lt;li&gt;Customer satisfaction&lt;/li&gt;
&lt;/ol&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>The Seven Habits of Spectacularly Unsuccessful Executives</title><link>http://pp-eye.blogspot.com/2012/01/seven-habits-of-spectacularly.html</link><category>The Seven Habits of Spectacularly Unsuccessful Executives</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 3 Jan 2012 17:26:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-4781739070553428495</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div class="fleft clearfix article" id="leftRail"&gt;&lt;div class="body"&gt;&lt;table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style="text-align: center;"&gt;&lt;a href="http://blogs-images.forbes.com/cache/gravatars/ericjackson_136.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"&gt;&lt;img border="0" src="http://blogs-images.forbes.com/cache/gravatars/ericjackson_136.jpg" /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="color: #b45f06;"&gt;&lt;td class="tr-caption" style="text-align: center;"&gt;&lt;h2&gt;Eric Jackson&lt;/h2&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;br /&gt;
&lt;div style="color: #cc0000;"&gt;&lt;b&gt;Sydney Finkelstein, the&amp;nbsp;Steven Roth Professor of Management at the Tuck School of Business at Dartmouth College, published “Why Smart Executives Fail” 8 years ago.&lt;/b&gt;&lt;/div&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;In it, he shared some of his research on what over 50 former  high-flying companies – like Enron, Tyco, WorldCom, Rubbermaid, and  Schwinn – did to become complete failures. &amp;nbsp;It turns out that the senior  executives at the companies all had 7 Habits in common. &amp;nbsp;Finkelstein  calls them the Seven Habits of Spectacularly Unsuccessful Executives.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;These traits can be found in the leaders of current failures like  Research In Motion (RIMM), but they should be early-warning signs  (cautionary tales) to currently unbeatable firms like Apple (AAPL),  Google (GOOG), and Amazon.com (AMZN). &amp;nbsp;Here are the habits, as Finkelstein described in a 2004 article:&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Habit # 1: &amp;nbsp;They see themselves and their companies as dominating their environment&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;This first habit may be the most insidious, since it appears to be  highly desirable. &amp;nbsp;Shouldn’t a company try to dominate its business  environment, shape thefuture of its markets and set the pace within  them? &amp;nbsp;Yes,but there’s a catch. &amp;nbsp;Unlike successful leaders, failed  leaders who never question their dominance fail torealize they are at  the mercy of changing circumstances.They vastly overestimate the extent  to which they actually control events and vastly underestimate the role  of chance and circumstance in their success.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;CEOs who fall prey to this belief suffer from the illusion of  personal pre-eminence: Like certain film directors, they see themselves  as the &lt;i&gt;auteurs&lt;/i&gt; of their companies. &amp;nbsp;As far as they’re  concerned, everyone else in the company is there to execute their  personal visionfor the company. &amp;nbsp;Samsung’s CEO Kun-Hee Lee was so  successful with electronics that he thought he could repeat this success  with automobiles. &amp;nbsp;He invested $5 billion in an already oversaturated  auto market. &amp;nbsp;Why? There was no business case. &amp;nbsp;Lee simply loved cars  and had dreamed of being in the auto business.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Warning Sign for #1: &amp;nbsp;A lack of respect&lt;/i&gt;&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Habit #2: &amp;nbsp;They  identify so completely with the company that there is no clear boundary  between their personal interests and their corporation’s interests&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Like the first habit, this one seems innocuous, perhaps even  beneficial. &amp;nbsp;We want business leaders to be completely committed to  their companies, with their interests tightly aligned with those of the  company. &amp;nbsp;But digging deeper, you find that failed executives weren’t  identifying too little with the company, but rather too much. &amp;nbsp;Instead  of treating companies as enterprises that they needed to nurture, failed  leaders treated them as extensions of themselves. &amp;nbsp;And with that, a  “private empire” mentality took hold.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;CEOs who possess this outlook often use their companies to carry out  personal ambitions. &amp;nbsp;The most slippery slope of all for these executives  is their tendency to use corporate funds for personal reasons. &amp;nbsp;CEOs  who have a long or impressive track record may come to feel that they’ve  made so much money for the company that the expenditures they make on  themselves, even if extravagant, are trivial by comparison. &amp;nbsp;This  twisted logic seems to have been one of the factors that shaped the  behavior of Dennis Kozlowski of Tyco. &amp;nbsp;His pride in his company and his  pride in his own extravagance seem to have reinforced each other. &amp;nbsp;This  is why he could sound so sincere making speeches about ethics while  using corporate funds for personal purposes. Being the CEO of a sizable  corporation today is probably the closest thing to being king of your  own country, and that’s a dangerous title to assume.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Warning Sign for #2: A question of character&lt;/i&gt;&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Habit #3: &amp;nbsp;They think they have all the answers&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Here’s the image of executive competence that we’ve been taught to  admire for decades: a dynamic leader making a dozen decisions a minute,  dealing with many crises simultaneously, and taking only seconds to size  up situations that have stumped everyone else for days. The problem  with this picture is that it’s a fraud. Leaders who are invariably crisp  and decisive tend to settle issues so quickly they have no opportunity  to grasp the ramifications. Worse, because these leaders need to feel  they have all the answers, they aren’t open to learning new ones. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;CEO Wolfgang Schmitt of Rubbermaid was fond of demonstrating his  ability to sort out difficult issues in a flash. A former colleague  remembers that under Schmitt,” the &amp;nbsp; joke &amp;nbsp; went, ‘Wolf &amp;nbsp;knows  everything about everything.’ &amp;nbsp;In one discussion, where we were talking  about a particularly complex acquisition we made in Europe, Wolf,  without hearing different points of view, just said, ‘Well, this is what  we are going to do.’” &amp;nbsp;Leaders who need to have all the answers shut  out other points of view. When your company or organization is run by  someone like this, you’d better hope the answers he comes up with are  going to be the right ones. &amp;nbsp;At Rubbermaid they weren’t. &amp;nbsp;The company  went from being Fortune’s most admired company in America in1993 to  being acquired by the conglomerate Newell a few years later.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Warning Sign for #3: &amp;nbsp;A leader without followers&lt;/i&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: left;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: left;"&gt;&lt;b&gt;Habit #4: &amp;nbsp;They ruthlessly eliminate anyone who isn’t completely behind them&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline;"&gt; &lt;/span&gt;&lt;/b&gt;CEOs  who think their job is to instill belief in their vision also think  that it is their job to get everyone to buy into it. &amp;nbsp;Anyone who doesn’t  rally to the cause is undermining the vision. &amp;nbsp;Hesitant managers have a  choice: Get with the plan or leave.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The problem with this approach is that it’s both unnecessary and  destructive. CEOs don’t need to have everyone unanimously endorse their  vision to have it carried out successfully. &amp;nbsp;In fact, by eliminating all  dissenting and contrasting viewpoints, destructive CEOs cut themselves  off from their best chance of seeing and correcting problems as they  arise. &amp;nbsp;Sometimes CEOs who seek to stifle dissent only drive it  underground. Once this happens, the entire organization falters. &amp;nbsp;At  Mattel, Jill Barad removed her senior lieutenants if she thought they  harbored serious reservations about the way that she was running things.  &amp;nbsp;Schmitt created such a threatening atmosphere at Rubbermaid that  firings were often unnecessary. &amp;nbsp;When new executives realized that  they’d get no support from the CEO, many of them left almost as fast as  they’d come on board. &amp;nbsp;Eventually, these CEOs had everyone on their  staff completely behind them. But where they were headed was toward  disaster. &amp;nbsp;And no one was left to warn them.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Warning Sign for #4: &amp;nbsp;Executive departures&lt;/i&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: left;"&gt;&lt;b&gt;Habit #5: They are consummate spokespersons, obsessed with the company image&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;You know these CEOs: high-profile executives whoare constantly in the  public eye. &amp;nbsp;The problem is that amid all the media frenzy and  accolades, these leaders’ management efforts become shallow and  ineffective. Instead of actually accomplishing things, they often settle  for the appearance of accomplishing things.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Behind these media darlings is a simple fact of executive life: CEOs  don’t achieve a high level of media attention without devoting  themselves assiduously to public relations. &amp;nbsp;When CEOs are obsessed with  their image, they have little time for operational details. Tyco’s  Dennis Kozlowski sometimes intervened in remarkably minor matters, but  left most of &amp;nbsp;the company’s day-to-day operations unsupervised.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;As a final negative twist, when CEOs make the company’s image their  top priority, they run the risk of&amp;nbsp;using financial-reporting practices  to promote that image. &amp;nbsp;Instead of treating their financial accounts as a  control tool, they treat them as a public-relations tool. The creative  accounting that was apparently&amp;nbsp;practiced&amp;nbsp;by such executives as Enron’s  Jeffrey Skilling or Tyco’sKozlowski is as much or more an attempt to  promote the company’s image as it is to deceive the public: In their  eyes, everything that the company does is public relations.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Warning Sign of #5: &amp;nbsp;Blatant attention-seeking&lt;/i&gt;&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Habit #6: They underestimate obstacles&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline;"&gt; &lt;/span&gt;&lt;/b&gt;Part  of the allure of being a CEO is the opportunity to espouse a vision.  Yet, when CEOs become so enamored of their vision, they often overlook  or underestimate the difficulty of actually getting there. &amp;nbsp;And when it  turns out that the obstacles they casually waved aside are more  troublesome than they anticipated, these CEO shave a habit of plunging  full-steam into the abyss. &amp;nbsp;For&amp;nbsp;example, when Webvan’s core business was  racking up huge losses, CEO George Shaheen was busy expanding those  operations at an awesome rate.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Why don’t CEOs in this situation re-evaluate their course of action,  or at least hold back for a while until it becomes clearer whether their  policies will work? &amp;nbsp;Some feel an enormous need to be right in every  important decision they make, because if they admit to being fallible,  their position as CEO might seem precarious. Once a CEO admits that he  or she made the wrong call, there will always be people who say the CEO  wasn’t up to the job. &amp;nbsp;These unrealistic expectations make it  exceedingly hard for a CEO to pull back from any chosen course of  action, which not surprisingly causes them to push that much harder.  &amp;nbsp;That’s why leaders at Iridium and Motorola (MMI) kept investing  billions of dollars to launch satellites even after it had become  apparent that land-based cellphones were a better alternative.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Warning Sign of #6: &amp;nbsp;Excessive hype&lt;/i&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #b45f06; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Habit #7: They stubbornly rely on what worked for them in the past&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Many CEOs on their way to becoming spectacularly unsuccessful  accelerate their company’s decline by reverting to what they regard as  tried-and-true methods. In their desire to make the most of what they  regard as their core strengths, they cling to a static business  model.They insist on providing a product to a market that no longer  exists, or they fail to consider innovations in areas other than those  that made the company successful in the past. Instead of considering a  range of options that fit new circumstances, they use their own careers  as the only point of reference and do the things that made them  successful in the past. &amp;nbsp;For example, when Jill Barad was trying to  promote educational software at Mattel,she used the promotional  techniques that had been effective for her when she was promoting Barbie  dolls, despite the fact that software is not distributed or bought the  way dolls are.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Frequently, CEOs who fall prey to this habit owe their careers to  some “defining moment,” a critical decision or policy choice that  resulted in their most notable success. &amp;nbsp;It’s usually the one thing that  they’re most known for and the thing that gets them all of their  subsequent jobs. &amp;nbsp;The problem is that after people have had the  experience of that defining moment, if theybecome the CEO of a large  company, they allow their defining moment to define the company as well –  no matter how unrealistic it has become.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Warning Sign of #7: &amp;nbsp;Constantly referring to what worked in the past&lt;/i&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The bottom line: If you exhibit several of these traits, now is the  time to stamp them out from your repertoire. &amp;nbsp;If your boss or several  senior executives at your company exhibit several of these traits, now  is the time to start looking for a new job.&lt;/div&gt;&lt;br /&gt;
&lt;div style="color: #38761d;"&gt;[Jackson was long AAPL at time of writing]&lt;/div&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Five Resolutions for Aspiring Leaders</title><link>http://pp-eye.blogspot.com/2012/01/five-resolutions-for-aspiring-leaders.html</link><category>Five Resolutions for Aspiring Leaders</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 3 Jan 2012 17:07:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-815348131828500329</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div id="articleBody"&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;img border="0" height="400" src="http://upload.wikimedia.org/wikipedia/commons/7/7a/Aspirine-1923.jpg" width="312" /&gt;&lt;/div&gt;&lt;div style="color: #cc0000; text-align: center;"&gt;&amp;nbsp;       &lt;b&gt;By :John Coleman and Bill George&lt;/b&gt;&lt;/div&gt;&lt;div style="color: #38761d; text-align: justify;"&gt;(John Coleman, HBS '10, is the author of &lt;i&gt;Passion and Purpose: Stories from the Best and Brightest Young Business Leaders.&lt;/i&gt; Bill George is professor of management practice at Harvard Business School and the author of five books, including &lt;i&gt;True North&lt;/i&gt; and &lt;i&gt;True North Groups&lt;/i&gt;. Follow them on twitter @johnwcoleman and @bill_george.)&lt;/div&gt;&lt;br /&gt;
&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;As the New Year approaches, people will be making resolutions to  eat better, exercise more, get that promotion at work, or spend more  time with their families. While these are worthwhile goals, we have a  more important challenge for young people: Think seriously about your  development as a leader.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;These are tough times. Many leaders of the baby boomer generation  have failed in their responsibilities by placing their self-interest  ahead of their organizations. In so doing, they have failed to serve  society's best interests. As a result, more young leaders from Gen X and  the Millennials are being asked to take on major leadership  responsibilities. To be prepared for the challenges you will face, we  propose the following resolutions this New Year's:&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Find a trustworthy mentor:&lt;/b&gt; Mentorship is a critical  component of your development as a leader. A 2004 study showed that  young leaders with mentors were more likely succeed professionally and  experience career satisfaction. The essence of effective mentoring is  developing a trusting relationship between the mentor and mentee.  Identify someone with whom you have a genuine chemistry and who is  committed to your development. Although many mentees do not realize it, a sound relationship is a two-way street  that benefits both parties — not just the mentee. We suggest looking  for mentors whom you admire for their values and character more than  their success.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Form a leadership development group:&lt;/b&gt; Most of us have  little time to reflect on the values and characteristics we want to  define us as leaders, the difficulties we're facing, or the long-term  impact we hope to have. Forming a leadership development group can give  you the space you need to think deeply about these subjects. Leadership  development groups are groups of six to eight people who meet to share  their personal challenges and discuss the most important questions in  their lives. Find people you can trust, and make a commitment to be one  another's confidential counselors. Meet regularly, and share openly your  life stories, crucibles, passions and fears, while offering each other  honest feedback. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Volunteer in a civic or service organization:&lt;/b&gt; Have  you served your community this year? In the Facebook era it's easy to  lose touch with our real-world neighbors. Long hours often cause us to  avoid volunteer opportunities. Participating in local organizations —  from religious organizations to civic groups — can give you early  leadership experiences, provide real connection to your neighbors, and   offer opportunities to serve others. It adds a dimension to your life  that work can't, and helps you develop and solidify your character while  giving back to the community. You will find your time serving a  community organization is highly rewarding while broadening your outlook  on people and life.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Work in or travel to one new country:&lt;/b&gt; "The world is  flat," as Tom Friedman puts it, so it has never been more important to  get global experience. In the future cultural sensitivity will be a more  important characteristic for leaders than pure intellectual ability.  John's survey of more than 500 top MBAs found that on average they had  worked in four countries prior to entering graduate school  and expect to work in five more in the next ten years. Having a global  mindset and the ability to collaborate effectively across cultures are  essential qualities for aspiring leaders of global organizations.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b&gt;Finally, ask more questions than you answer:&lt;/b&gt; With  the high velocity of change in the world, it is impossible to have  answers to all the important questions. Much more important is a deep  curiosity about the world and the ability to frame the right questions  in profound ways. The world's toughest problems cannot be solved by you  or any one organization. Your role will be to bring the right people  together to address the challenging issues you raise. Our research  demonstrates that the biggest mistakes result from decisions made by  people without deep consideration of thoughtful questions. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Young leaders will soon be asked to take on major leadership  responsibilities in their organizations and their communities. We  believe it is essential that they take steps like these in order to be  prepared for the difficult leadership challenges they will face. There's  no better time to get started than the coming year.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Five Predictions For Biotech And Medicine In 2012</title><link>http://pp-eye.blogspot.com/2012/01/five-predictions-for-biotech-and.html</link><category>Five Predictions For Biotech And Medicine In 2012</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 3 Jan 2012 16:52:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-7452861482522310285</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;h1&gt;&lt;/h1&gt;&lt;br /&gt;
&lt;div class="zemanta-img"&gt; &lt;div class="wp-caption alignright" style="width: 310px;"&gt;&lt;img alt="English: Storefront Psychic fortuneteller in D..." class="zemanta-img-configured" height="400" src="http://blogs-images.forbes.com/matthewherper/files/2011/12/300px-PsychicBoston.jpg" title="English: Storefront Psychic fortuneteller in D..." width="300" /&gt;&lt;div class="wp-caption-text" style="color: #351c75; font-family: Verdana,sans-serif; text-align: center;"&gt;&lt;b&gt;Image via Wikipedia&lt;/b&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Continuing a &lt;a href="http://www.forbes.com/2009/12/08/pfizer-glaxo-merck-business-healthcare-sneak-peek-10-pharmaceuticals.html"&gt;proud&lt;/a&gt; &lt;a href="http://www.forbes.com/2009/12/08/genomics-personalized-medicine-business-healthcare-sneak-peek-10-genomics.html"&gt;Forbes&lt;/a&gt; &lt;a href="http://www.forbes.com/2007/12/08/health-2008-predictions-sneakpeek_snkpk08_22_matthewherper_health.html"&gt;tradition&lt;/a&gt;, here is what I see happening as we move forward through 2012.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong style="color: #351c75;"&gt;1. We’ll see more super-expensive drugs.&lt;/strong&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Charging  $100,000, $200,000, or even $500,000 per patient per year is the most  successful strategy in the drug business. One case study: In 2008, the  Joint Economic Committee of the Senate and House heard testimony  alleging that drugs for rare, orphan diseases were getting too  expensive. One parent testified that  the treatment for her son had increased in price from $1,000 per vial  to more than $30,000. There was controversy and bad press, but Acthar  Gel’s maker, Questcor Pharmaceuticals, has become one of the best-performing stocks in any business, up more than 2,500% over the past five years.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Biotech’s other best recent performer is Alexion, which makes the  drug Soliris for a rare blood cancer. It costs $500,000 per year for the  average patient, making it the most expensive drug in the world. This  strategy has it’s limits, and the high prices in some diseases are  finally starting to meet resistance, particularly in cancer, where a de  facto limit of $100,000 per patient per year seems have been reached.  But the mass-market model no longer works. The vast majority of  medicines are now cheap generics. No longer able to make money on  volume, drug companies are going to focus more and more on price.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #351c75; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;2. New genetic technologies will brave the valley of death.&amp;nbsp;&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;&amp;nbsp;&lt;/strong&gt;DNA sequencing is getting cheaper and making its way into hospitals. Some cancer patients (notably Christopher Hitchens and Steve Jobs)  have used genetic tests to try and pick the right drugs for their  tumors. But right now using DNA sequencing on patients is not making  much money for companies that make DNA sequencers, such as market leader  Illumina, and big funders like the National Institutes of Health  are tightening their belts. The result is that the two publicly traded  genomics upstarts, Pacific Biosciences of California and Complete  Genomics, are trading below or near the value of the cash they have on  hand.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The beneficiary so far has been Ion Torrent, the new sequencer maker bought by lab giant Life Technologies in 2010.  It has been able to build a user base with its sequencing technology,  an it could use this bulwark to launch a bigger attack on Illumina. The  science will continue to advance. Whether its these DNA sequencer  companies or next generation efforts like Foundation Medicine, the Google Ventures-backed cancer sequencing startup, is anybody’s guess.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;&lt;span style="color: #351c75;"&gt;3. Medical devices will face an even tougher environment.&lt;/span&gt;&amp;nbsp;&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;&amp;nbsp;&lt;/strong&gt;From heart-focused Medtronic  and Boston Scientific to joint replacement makers like Stryker and  Biomet, it’s been an awful few years. Don’t expect it to get better  unless the industry can face its fundamental problem: too many of its  devices don’t face rigorous testing. The unfolding disaster over  metal-on-metal hip implants that are deteriorating and needing to be  replaced years before they should is just one example of this problem.  Fixing it will require these companies to rethink how they invent and  test products. It won’t be easy, and the industry’s response to a report  from the Institute of Medicine this summer that suggested more  large-scale clinical trials indicate that, as a group, these companies  are not facing facts.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong style="color: #351c75;"&gt;4. &amp;nbsp;Health information technology will stall.&lt;/strong&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;There’s a huge need for better computer systems to improve medicine, and  the government is pushing hospitals to adopt them. But I tend to agree  with analyst and fund manager Les Funtleyder at Miller, Tabak, who  argues that hospitals are going to be slow to adopt new computer systems  in 2012. What’s really needed is a disruptive innovation, a computer  system so good that it solves many of medicine’s problems. We’re  probably not there yet.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b style="color: #351c75;"&gt;&lt;strong&gt;5. Pharmacy benefit managers will struggle as their reason for existing vanishes&lt;/strong&gt;.&lt;/b&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; Companies like Medco and Express Scripts were created to help manage  the explosion of mass-market drugs being churned out by Merck and Pfizer  in the 1990s. Now they are merging, in part because they are going to get squeezed.  Richard Evans of policy analysis firm Sovereign &amp;amp; Sector has called  PBMS “the most compelling short story in healthcare” because they will  lose ability to make money off of generics as insurers and the  government move to new, better benchmarks for drug prices. When almost  all drugs are generic, companies no longer need to hire somebody to  switch people off the brand.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt; &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="color: #351c75; font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt;Bonus Prediction:&amp;nbsp;India will eliminate polio.&lt;/strong&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;strong&gt; &lt;/strong&gt;In a  positive step for the effort to eradicate the virus that paralyzed  Franklin Delano Roosevelt from the face of the planet, I’m going to  predict that India will have managed to banish the disease. It’s been  many months, as I write this, since there has been a case there. If that  keeps up, it will be a major victory for the effort, backed in part by  the Bill &amp;amp; Melinda Gates Foundation, to battle this disease. Even if  it’s true, there’s still a great deal of work to be done before this virus is gone.&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>The Best Big Drug Company Of 2011</title><link>http://pp-eye.blogspot.com/2012/01/best-big-drug-company-of-2011.html</link><category>The Best Big Drug Company Of 2011</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 3 Jan 2012 16:47:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-8261688685061684312</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;h1&gt;&lt;/h1&gt;&lt;div class="comment_bug article_header"&gt;      &lt;div class="wrapper"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/div&gt;&lt;table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style="text-align: center;"&gt;&lt;img alt="" class="size-full wp-image-3681" height="191" src="http://blogs-images.forbes.com/matthewherper/files/2011/12/andreotti_casual.jpg" style="margin-left: auto; margin-right: auto;" title="andreotti_casual" width="200" /&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="color: #0b5394;"&gt;&lt;td class="tr-caption" style="text-align: center;"&gt;&lt;span style="font-size: small;"&gt;&lt;b&gt;Bristol CEO Lamberto Andreotti&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div class="wp-caption alignright" id="attachment_3681" style="width: 140px;"&gt;&lt;div class="wp-caption-text"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;br style="font-family: Verdana,sans-serif;" /&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Among the ranks of large pharmaceutical companies this year, there was a clear standout:&lt;b style="color: #cc0000;"&gt; Bristol-Myers Squibb.&lt;/b&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;b style="color: #cc0000;"&gt;Pfizer, Abbott Laboratories, and Eli Lilly &lt;/b&gt;all managed to notch share price increases of greater than 15%. So did Amgen,  which continued to define the border between the biotechnology  companies and big pharma, which it looks a bit more like every single  year.&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;br style="font-family: Verdana,sans-serif;" /&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Bristol blew them all away. Its share price increased 32% to  $35 over the course of the year. And unlike Pfizer, Lilly, and Amgen,  Bristol’s share price is above where it was five years ago, too, showing  steady, long-term gains. Not bad considering the fact that investors  are bracing for the patent expiration of Plavix, the blood-thinner  Bristol shares with French drug giant Sanofi, next year. Plavix, with  annual sales of $7 billion, is the second-best-selling drug in the  world, and its loss will lead Bristol’s sales to drop by 13% to about  $18 billion, according to Sanford C. Bernstein.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;But Bristol has managed to innovate in the face of this impending  loss. In March, the Food and Drug Administration cleared Yervoy, the  first drug to extend the survival of patients with metastatic melanoma,  by several months. Like many other cancer drugs, it does have  potentially toxic side effects, but analysts expect it to be a  multi-billion dollar seller.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;In August, Bristol unveiled results of an 18,000-patient clinical  trial of the blood-thinner Eliquis, which it is developing with Pfizer.  Eliquis was the first anti-coagulant to prove that it reduced the risk  of death compared to warfarin, which has been the standard of care for  preventing strokes in patients with atrial fibrillation, a common heart  rhythm disorder, for seven decades. The other new blood thinners,  Pradaxa from Boehringer Ingelheim and Xarelto from Bayer and Johnson &amp;amp; Johnson, have reached the market before Eliquis but were deemed essentially similar. Eliquis is awaiting FDA approval.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Bristol chief executive Lamberto Andreotti, 60, who took over last  May, has built on the strategy put in place by drug-and-medical-device  industry veteran James Cornelius, who ran the company for four years  starting in 2006. Bristol had been hobbled by a series of drug research  failures, patent expirations, and accounting scandals that led to the  resignation of former chief executive Peter Dolan. The response was to  sell non-core businesses and brands, most notably the Mead Johnson baby  formula business, and focus on building a strong pharmaceutical presence  – partly by doing daring deals like its $2.4 billion purchase of  biotechnology firm Medarex in 2009. At the time, many researchers and  analysts viewed the deal with skepticism, but it gave Bristol full  rights to Yervoy.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Now other companies seem to be following the sell-off-and-focus  strategy Bristol pioneered. One reason for the rise in Pfizer shares  this year was that the company is openly talking about making  divestitures, including one of its baby formula business. Abbott, for  its part, announced plans to split in two, creating a large,  faster-growing medical devices and products company and an even bigger  standalone drug giant. By facing its crises six years ago, Bristol-Myers  Squibb became one of the drug industry’s trendsetters.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Over a longer horizon, Bristol still has not performed as well as  &lt;b style="color: #cc0000;"&gt;Novo Nordisk, &lt;/b&gt;the diabetes specialist that has outperformed most other  drug makers over the past year but which did not do as well this year,  or biotechnology firms like Alexion, focused on rare diseases, or Biogen  Idec, focused on multiple sclerosis. Both of those companies saw their  stocks increase by about 70% in 2011.&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>The Ten Most Annoying Management Terms Of 2011</title><link>http://pp-eye.blogspot.com/2012/01/ten-most-annoying-management-terms-of.html</link><category>The Ten Most Annoying Management Terms Of 2011</category><author>noreply@blogger.com (Unknown)</author><pubDate>Tue, 3 Jan 2012 16:32:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-5007682582040654183</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;img border="0" height="320" src="http://projecteino.org/wp-content/uploads/2010/12/project-management.jpg" width="298" /&gt;&lt;/div&gt;&lt;h1 style="color: #0b5394; font-family: Times,&amp;quot;Times New Roman&amp;quot;,serif; font-weight: normal; text-align: justify;"&gt;&lt;b&gt;We are nearly at the end of 2011 and another year of mayhem behind. We  will be judging our 2011 Non-Predictions and trying to dream up some new  ones for &lt;/b&gt;&lt;b&gt;2012 in the next fortnight or so but this week we have been  able to get some long needed admin done.&lt;/b&gt;&lt;/h1&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;With it came a realisation that even if the financial industry is  suffering, the creative management community has been in full swing  dreaming up new terms and phrases to camouflage the blindingly obvious.&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;The evolution of ‘management speak’ means some phrases die and some  survive and flourish. TMM really doesn't know what determines the  success of one term or phrase over another other than, as with the arts,  adoption and patronage by the most respected in the field. TMM hope  that this year’s rash of newcomers all die off naturally but we would  like to help with a shove into their deserved obscurity.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;span style="font-family: Verdana,sans-serif;"&gt;TMM have  noticed that every cause nowadays needs an "Awareness" campaign and  though we feel that "doing" is of much greater importance than  "awaring," we will go along with the fashion and launch a Management  Talk Awareness Week with the list of phrases and terms we have found  most irksome this year.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;span style="font-family: Verdana,sans-serif;"&gt;So here are TMM's top ten annoying phrases of 2011 (even if some are older) that we would like to see the back of.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;10 - Internalise &lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;-  As in "What you have all failed to internalise is that there has been a  paradigm shift. As a result you are all now behind the curve when it  comes to the multi-lateral interoperability needed to realise the  supra-organisational mission statement.” Even though there is an awful  lot to detest in that statement "Internalise" is the word we most object  to. It appears to just means learn or remember but as telling someone  to learn or remember something appears instructive, suggesting they  internalise it will sound more empathetic, but at the severe cost of  sounding like a clone-monkey.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;9 - Hi, I hope all is well &lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;-  With the birth of the email there came an awkward period when the  formality of letters, with their "Dear Sir / Yours sincerely" had to be  detuned to fit in with the new immediacy and informality. After a  stuttering start the world passed through an embarrassed joint squirm  and settled on "Hi" for anything other than legal representations. But  2011 has seen a pernicious ingress of a new form of insincerity with the  addition of "I hope all is well" to the "Hi". Rather than questioning  either the validity or sincerity of that statement, we would just ask  that the bulk senders of such missives consider where they are sent to,  as for many recipients things are blindingly obviously not well. We  suggest the only time this greeting is appropriate is when addressed to  bore-hole companies.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;8 - Weaponise price opacity&lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; - As the scarcity of new &lt;/span&gt;&lt;a href="http://macro-man.blogspot.com/2011/06/himalayan-pink-salt.html" style="font-family: Verdana,sans-serif;"&gt;Himalayan Pink Salt&lt;/a&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;  in the financial market takes its toll on the bottom lines of financial  institutions it is becoming more important for them to make sure that  they maximise the profitability of existing basic products. Opacity of  price is critical in this process but weaponising it? Wow.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;7 - Ideation&lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;  - What happened to good old "have a think" or "come up with some  ideas"? Even running things up flag poles is less irksome than  "ideation" which sounds as though it should involve radioactive iodine.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;6 - Stakeholder Community&lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;  - Not a Transylvanian village but the new plural of stakeholder.  Theoretically a stakeholder is anyone who can affect, or is impacted by,  your decisions and so could be a lowly minion in your company, but  deference only ever seems to be made to "stakeholders" when they are  either your bosses, investors or regulators. Please let's call them who  they really are.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;5 - Socialise &lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;- When issues got  out of hand in the old days you would normally either just tell the  boss, or perhaps "take it upstairs." But now a cunning adaptation of the  old mantra of "My profit, our loss" has invoked a caring sharing  attitude to screw-ups by "socialising" them. As in "I think we should  socialise this issue with senior management and the stakeholder  community."&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;4 - Complementary &lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt; - Odd one this,  and it's really down to our own stupidity, but we have regularly opened  emails this year expecting some nice free service only to re-read it and  find it's not "complimentary" but something expensive and homeopathic.  We expect the marketing world to soon be jumping on this and emailing  multitudes of complementary not-at-all-free offers. Such as Ryan-Air  offering "Complementary Flights" which sound as though they are free but  are actually expensive and just "complement" what a decent service  should be by being dreadful. Or have they done that already?  "Complementary" should be banned from subject lines so that the vaguely  dyslexic amongst us shouldn't be taken advantage of.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;3 - Bandwidth&lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;  - The adoption of IT geeky words into mainstream fashion is nothing new  but the latest over-usage of "Bandwidth" by management is particularly  grating. Just as "spending more time with my family" has become the  acceptable expression of "Just been  fired/stiffed/shafted/backstabbed/found out but have photos" so has "I'm  sorry I can't action that, I don't have the bandwidth” become the  generic replacement for "I don't have the time/resources/authority or  inclination." But the saddest part is the way it's used under the false  allusion that "bandwidth" is new and fashionable. Our grandmothers,  thanks to broadband adverts and home routers, know what bandwidth is so  please, unless you are the type of person who still uses "groovy" in the  boardroom, please drop "bandwidth."&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;2 - Geosourcing -&lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;  Why you lose your job to someone in a different part of the world. "The  support function has been geosourced" or "How's the front office  geosourcing project going?” It's the sharp end of a simple belief of  ours that if there is someone able and willing to do your job for less  than you, you are toast. But the use of "geo," which has connotations of  environmental friendliness married to "source," which conjures images  of babbling fresh springs in the mountains, results in a super-eco word  which actually means "You're fired."&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b style="font-family: Verdana,sans-serif;"&gt;1 &lt;/b&gt;&lt;b style="font-family: Verdana,sans-serif;"&gt;- Reaching out -&lt;/b&gt;&lt;span style="font-family: Verdana,sans-serif;"&gt;  TMM first came across 2011's winning term in July and since then it has  spread like wildfire, which has us looking like Irish Riverdancers as  we try to stamp it out as fast as we can. The origins and epidemiology  of this disease has us suspecting it's the product of some Class of 2011  Management School somewhere. It really is complete and utter rubbish.  If you are about to call an investor for some documents you don't "reach  out to the client," you phone or mail them. If you want to know why a  trade hasn't settled you don't "Reach out to Bangalore" you "call  back-office." So let's just kill that one right now before someone gets  accused of molestation.&lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;span style="font-family: Verdana,sans-serif;"&gt;And with that we open up "Management Talk  Awareness Week." We are sure you all have your own experiences to share  and we look forward to the comments column acting as a joint cognitive  pan-cohesual empathy forum leading to textualisation of common goal and  achievement recognition programs.&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;
&lt;b style="color: #0b5394;"&gt;Happy New Year.&lt;/b&gt;&lt;br /&gt;
&lt;i&gt;&lt;br /&gt;
&lt;/i&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Sexually Transmitted Disease (STD)</title><link>http://pp-eye.blogspot.com/2012/01/sexually-transmitted-disease-std.html</link><category>Sexual Health Guide</category><author>noreply@blogger.com (Unknown)</author><pubDate>Mon, 2 Jan 2012 17:22:00 +0500</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-6941439556922516488.post-7311668450856454490</guid><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;&lt;h1 class="headline" style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;What is an STD?&lt;/h1&gt;&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://drofdetox.com/wp-content/uploads/2011/06/STD-Test.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" height="279" src="http://drofdetox.com/wp-content/uploads/2011/06/STD-Test.jpg" width="320" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;h1 class="headline" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&amp;nbsp;&lt;/h1&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;A sexually transmitted disease (STD) is an infectious illness that is  transmitted through unprotected sexual activity...including vaginal,  anal and oral sex, or skin-to-skin contact with an infected area. STDs  can also be spread via skin-to-skin contact or through intravenous (IV)  drug use, and can be passed to an unborn child during pregnancy or  through breastfeeding.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;STDs are caused by some 30 viruses, bacteria and parasites that  survive and spread through sexual contact. STDs have been around for  hundreds of years and most people will experience an infection during  their lifetime...the Centers for Disease Control and Prevention (CDC)  estimate 19 million new cases every year, which presents a major public  health challenge. Indeed, untreated STDs are estimated to cause at least  24,000 women to become infertile every year.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;h3 style="font-family: Verdana,sans-serif; text-align: justify;"&gt;STDs vs. STIs&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Diseases that are passed from person to person through sexual  activity are sexually transmitted diseases (STDs). "Disease" implies a  clear medical problem, usually with obvious signs or symptoms. But some  common STDs are asymptomatic; in these cases, the sexually transmitted  virus or bacteria can be described as causing a sexually transmitted  infection (STI), which may or may not evolve into a "disease." Because  "STD" is preferred by most people, we generally use that term for both  sexually transmitted infections and diseases.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h1 class="headline" style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;STD Risk Factors&lt;/h1&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;How do people get infected with an STD?&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;STDs  can affect anyone of any background, lifestyle, race, ethnicity or  socioeconomic status and are most often passed from one person to  another through sexual activity...including genital, anal and oral sex.  STD risk factors include: &lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;A history of STDs&lt;/li&gt;
&lt;li&gt;A history of unprotected sex&lt;/li&gt;
&lt;li&gt;A new sexual partner&lt;/li&gt;
&lt;li&gt;Multiple sexual partners&lt;/li&gt;
&lt;li&gt;Meeting sexual partners on the Internet&lt;/li&gt;
&lt;li&gt;Men who have sex with men (MSM)&lt;/li&gt;
&lt;li&gt;Sexual contact with sex workers&lt;/li&gt;
&lt;li&gt;Sexual contact while under the influence of alcohol or drugs&lt;/li&gt;
&lt;li&gt;Illicit drug use&lt;/li&gt;
&lt;/ul&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Due  to reporting disparities and a number of other variables, there is a  higher prevalence of STDs among sexually active females, teenagers,  young adults, African-Americans and Hispanics...for example, women are  more likely to get screened, and some ethnic/minority groups are more  likely to use public clinics that report STD cases. As well, awareness  of STDs and how to prevent them, and access to regular healthcare are  inconsistent among populations that are disadvantaged by poverty and  other social determinants...these groups may therefore be more likely to  engage in risky sexual activity.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Even if you've been treated for an STD, you're not immune...you &lt;i&gt;can&lt;/i&gt;  be re-infected. That's why sexual partners should be treated at the  same time so that an untreated partner still carrying the bacteria or  virus doesn't re-infect the treated partner.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h1 class="headline" style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;Signs and Symptoms of STDs&lt;/h1&gt;&lt;div style="background-color: transparent; margin: 0px;"&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Many  sexually transmitted infections are "silent." That is, they have no  symptoms...at least not right away. And when symptoms are present (e.g.,  sores, bumps, painful urination, discharges, bleeding, fever, etc.),  they may resemble those of other conditions, which means that proper  diagnosis and treatment is often delayed.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Our STD Guides can help  you know what to look for...including an overview of risk factors,  symptoms, complications, testing and treatment for:&lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;Chlamydia&lt;/li&gt;
&lt;li&gt;Gonorrhea&lt;/li&gt;
&lt;li&gt;Hepatitis B&lt;/li&gt;
&lt;li&gt;Hepatitis C&lt;/li&gt;
&lt;li&gt;Herpes 1 &amp;amp; 2&lt;/li&gt;
&lt;li&gt;HIV&amp;nbsp;&lt;/li&gt;
&lt;li&gt;Syphilis&lt;/li&gt;
&lt;/ul&gt;&lt;h1 class="headline" style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;STD Complications&lt;/h1&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;What if an STD is untreated?&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Most  people aren't aware that complications from untreated STDs can include  everything from infertility and upper genital tract infections to heart  disease, certain cancers, HIV and many other diseases and  abnormalities...even death. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;For example, untreated syphilis can damage  the internal organs and neurological system, and untreated gonorrhea and  chlamydia infections can spread throughout the body and cause  infertility. STDs can also be seriously harmful to pregnant women and  their babies. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;So,  if you're sexually active, it's in your best interest to get tested  annually...or, if you have multiple sexual partners, get tested every  six months. Know what other STD risk factors  may also apply to you — from men who have sex with men (MSM) to  substance abuse and various social determinants. The better informed you  are, the better you can protect yourself and others from the  potentially debilitating effects of STDs.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h1 class="headline" style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;STD Testing&lt;/h1&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;According  to the Centers for Disease Control and Prevention (CDC), less than half  of  people who should be screened receive recommended STD testing. It's  important to detect and treat diseases early on to protect your health  and prevent the spread of STDs to others. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;We provide testing for the most common  bacterial and viral STDs that can be diagnosed through blood or urine  samples: &lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;Chlamydia&lt;/li&gt;
&lt;li&gt;Gonorrhea&lt;/li&gt;
&lt;li&gt;Hepatitis B&lt;/li&gt;
&lt;li&gt;Hepatitis C&lt;/li&gt;
&lt;li&gt;Herpes 1 &amp;amp; 2&lt;/li&gt;
&lt;li&gt;HIV&lt;/li&gt;
&lt;li&gt;Syphilis&lt;/li&gt;
&lt;/ul&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;We also provide treatment, counseling and therapy for certain diseases and individual circumstances.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;At  a test center that's most convenient for you, you can get tested  quickly, privately and effectively for all of these STDs (no undressing  or swabbing required!). Learn more about "testing windows" – the recommended amount of time between potential exposure to an STD  infection, and when screening is expected to identify the infection (or  re-infection). &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;To find out if you would benefit from STD testing, Medical Director Lisa Oldson, MD, offers guidance with a personalized Test Recommendation. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Note: &lt;/i&gt;See  your regular doctor to get tested and treated for other STDs –  like HPV – that require a pelvic exam or a swab test that cannot be  done at a standard testing facility. Be aware that most doctors don't  automatically screen for STDs...so be sure to specifically ask your  doctor for the tests you need. &lt;/div&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Are the test results accurate and reliable? &lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Rest assured that your test results will be as reliable as those you'd receive through your  regular doctor...and much more timely. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Through our partners at LabCorp and Quest Diagnostics – who, under the purview of the FDA, are subject to the Clinical  Laboratory Improvement Amendments (CLIA) of 1988 – the tests we offer  are the gold standard in the industry. CLIA establishes consistent  quality standards for all lab tests to ensure the timeliness,  reliability and accuracy of test results...regardless of the location of  a particular testing center. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Using type-specific testing, DNA  PCR technology and nucleic acid amplification technology,  SexualHealth.com offers you the highest degree of testing specificity  and sensitivity available today...helping you and one of our doctors to  make informed decisions about your treatment, and how to keep you as  healthy as possible.&amp;nbsp;&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h1 class="headline" style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;STD Treatment&lt;/h1&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Is there a cure or a treatment for STDs?&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Some infections can be cured and others are chronic, but  treatable with medication. Here's a snapshot of the most common STDs  that are curable or treatable:&lt;/div&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Common curable STDs&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;These STDs can be completely healed if you take the prescribed medications correctly:&lt;/i&gt;&lt;/div&gt;&lt;table id="internal-source-marker_0.7023046488355235" style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;&lt;b&gt;STD&lt;/b&gt;&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;&lt;b&gt;Treatment&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Chlamydia&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antibiotics&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Crabs and scabies&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Over-the-counter and prescription creams&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Gonorrhea&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antibiotics&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Non-Gonococcal Urethritis (NGU)&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antibiotics&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Shigella&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antibiotics&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Syphilis&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antibiotics&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Trichomoniasis&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antibiotics&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Molluscum contagiosum&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Various&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Common treatable STDs&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;These viruses can be treated and managed, but they cannot be cured: &lt;/i&gt;&lt;/div&gt;&lt;table id="internal-source-marker_0.7023046488355235" style="font-family: Verdana,sans-serif; margin-left: 0px; margin-right: 0px; text-align: left;"&gt;&lt;tbody&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;&lt;b&gt;STD&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;&lt;b&gt;Treatment&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Hepatitis A&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Rest, fluid, vaccine&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Hepatitis B&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antiviral medications, vaccine&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Hepatitis C&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antiviral medications&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Herpes (HSV)&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Antiviral medications&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;HIV&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Anti-retroviral therapy&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height: 0px;"&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Human Papilloma Virus (HPV)&lt;/td&gt;&lt;td style="border: 1px dotted rgb(170, 170, 170); padding: 7px; vertical-align: top;"&gt;Vaccine &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;i&gt;Note: &lt;/i&gt;We  provide testing and consultation for chlamydia, gonorrhea, hepatitis B,  hepatitis C, herpes 1 &amp;amp; 2, HIV and syphilis. See your regular  doctor to get tested and treated for other STDs that require a pelvic  exam.&lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;br /&gt;
&lt;/div&gt;&lt;h1 class="headline" style="color: #0b5394; font-family: Verdana,sans-serif; text-align: justify;"&gt;STD Prevention&lt;/h1&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;How can I protect myself and others from STDs?&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Abstinence  (no sexual contact) is the only sure way to prevent STDs. But if you  are sexually active, the best ways to stay healthy are:&lt;/div&gt;&lt;ul style="font-family: Verdana,sans-serif; text-align: justify;"&gt;&lt;li&gt;To be  mutually monogamous (ideally with a person who has tested negative for  STDs, or who has been tested and treated for any STDs, if necessary)&lt;/li&gt;
&lt;li&gt;To  use a latex condom or a dental dam every time you have vaginal, anal or  oral sex (you may also want to consider female condoms, FC1 and FC2)&lt;/li&gt;
&lt;/ul&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;The  best way for men and women to decrease their chance of infection when  having oral sex with women is to use a latex dental dam. &lt;/div&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Get tested and take charge of your health&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;If  you're sexually active, getting screened for STDs annually is the  surest way to know if your status. If you have multiple sexual partners  or unprotected sex, we recommend getting tested every six months.  Protect yourself, protect your partners...and give yourself peace of  mind. &lt;/div&gt;&lt;h3 class="parahead" style="font-family: Verdana,sans-serif; text-align: justify;"&gt;If you have an STD...&lt;/h3&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;First,  you're not alone. The Centers for Disease Control and Prevention (CDC)  estimate 19 million new STD cases in the United States every year. If  you are positive for an STD, it's critical to complete the recommended  treatment exactly as instructed. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;And while it's not easy to do,  be sure to tell everyone you've had sexual contact with in the last six  months so they can get tested and treated, too. If it's been more than  six months since you were sexually active, be sure to inform your most  recent partner. &lt;/div&gt;&lt;div style="font-family: Verdana,sans-serif; text-align: justify;"&gt;Remember, once you've been treated for an STD, you're not immune...you &lt;i&gt;can &lt;/i&gt;be  re-infected. That's why sexual partners should be treated at the same  time so that an untreated partner still carrying the bacteria or virus  doesn't re-infect the treated partner. Additionally, with gonorrhea and  chlamydia, you and your partner shouldn't have sexual contact again  until one week after you've both completed treatment.&lt;/div&gt;&amp;nbsp; &lt;/div&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item></channel></rss>